data_2k2y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k2y _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.408 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 67.1 m . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 118.898 -0.572 . . . . 20.0 112.293 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.02 -40.33 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.124 0.97 . . . . 20.0 110.485 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.5 t -56.02 -48.0 76.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.286 1.034 . . . . 20.0 111.018 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -73.56 -3.84 30.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.228 1.811 . . . . 20.0 113.585 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.12 0.41 89.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.129 1.347 . . . . 20.0 115.058 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -72.01 165.42 24.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.672 1.236 . . . . 20.0 112.296 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.81 -158.41 30.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.111 1.815 . . . . 20.0 111.792 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.21 116.49 6.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.35 1.06 . . . . 20.0 108.811 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.52 159.13 33.36 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.516 1.527 . . . . 20.0 110.02 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.27 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.246 2.631 . . . . 20.0 111.719 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -68.25 -8.67 41.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.729 1.612 . . . . 20.0 113.7 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.7 p -107.24 -29.74 9.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.509 1.524 . . . . 20.0 113.577 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.26 -26.08 19.17 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.8 0.727 . . . . 20.0 112.406 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -85.1 110.49 28.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.463 1.505 . . . . 20.0 109.634 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.75 167.2 26.4 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.786 2.324 . . . . 20.0 111.487 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.42 -8.17 44.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.031 1.332 . . . . 20.0 113.327 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.53 -28.25 16.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.246 1.418 . . . . 20.0 111.792 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.16 -15.41 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.244 1.418 . . . . 20.0 113.513 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -60.05 139.37 57.51 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.728 0.811 . . . . 20.0 110.129 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.14 158.43 15.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.641 0.734 . . . . 20.0 110.823 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t -80.22 9.05 6.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.781 1.632 . . . . 20.0 112.88 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.86 168.97 9.25 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.044 1.338 . . . . 20.0 112.77 -168.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.13 32.1 7.54 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.325 1.917 . . . . 20.0 113.01 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.408 ' HA3' ' H ' ' A' ' 3' ' ' CYS . . . -76.6 -0.02 66.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.28 1.419 . . . . 20.0 115.749 -173.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m -125.08 -172.18 2.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.905 2.082 . . . . 20.0 110.22 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -105.89 -3.97 21.24 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 20.0 113.232 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.9 t -144.29 -55.63 0.35 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.268 1.027 . . . . 20.0 110.816 171.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -145.8 152.31 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.549 1.54 . . . . 20.0 109.151 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -121.84 144.23 48.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.682 1.193 . . . . 20.0 109.535 172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -135.23 149.64 49.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.865 1.266 . . . . 20.0 109.603 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -74.91 175.41 8.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.874 0.87 . . . . 20.0 111.876 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 125.846 1.658 . . . . 20.0 112.117 175.237 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 111.867 0.321 . . . . 20.0 111.867 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.75 -22.93 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.263 1.025 . . . . 20.0 111.227 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -58.73 -33.89 70.74 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.84 0.856 . . . . 20.0 113.161 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -79.16 -11.23 59.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.542 1.537 . . . . 20.0 113.342 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.95 -2.89 31.7 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.175 1.845 . . . . 20.0 114.329 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -72.42 -178.85 2.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.041 1.336 . . . . 20.0 112.154 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.3 168.62 21.48 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.887 1.232 . . . . 20.0 111.187 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 t -126.49 68.62 1.23 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 20.0 110.669 -160.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.3 mt -72.78 153.59 91.28 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.268 0.627 . . . . 20.0 111.882 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.65 173.97 11.76 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.724 3.616 . . . . 20.0 111.931 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.24 -38.2 73.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.686 1.195 . . . . 20.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.3 p -67.53 -17.32 64.62 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.153 1.381 . . . . 20.0 113.874 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.73 -12.27 10.27 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.028 1.731 . . . . 20.0 111.777 -174.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 t -122.83 89.46 50.29 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.373 1.469 . . . . 20.0 109.026 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.04 166.81 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.145 2.563 . . . . 20.0 110.753 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.94 -33.02 70.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.628 1.171 . . . . 20.0 112.907 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.94 -32.98 74.79 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.118 1.367 . . . . 20.0 112.429 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.37 -10.05 45.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.37 1.468 . . . . 20.0 113.156 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -65.05 143.91 57.61 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.005 0.922 . . . . 20.0 110.056 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.89 175.86 10.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 20.0 111.178 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -73.5 -7.64 52.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.303 0.641 . . . . 20.0 112.322 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -137.13 173.17 11.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.847 2.059 . . . . 20.0 110.625 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.17 -95.21 0.9 Allowed Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.281 0.943 . . . . 20.0 111.607 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 -32.15 4.72 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.56 2.029 . . . . 20.0 113.554 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m -82.5 -177.98 6.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.081 0.94 . . . . 20.0 110.574 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -74.86 -31.95 61.77 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.792 1.237 . . . . 20.0 110.255 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 p -136.11 -55.02 0.76 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.456 1.502 . . . . 20.0 111.341 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -145.23 137.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.678 1.591 . . . . 20.0 108.836 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.2 t -125.98 155.05 42.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.528 1.531 . . . . 20.0 109.905 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.8 160.51 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.835 1.254 . . . . 20.0 110.826 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.08 35.6 0.99 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.998 1.481 . . . . 20.0 114.998 -164.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 114.856 1.428 . . . . 20.0 114.856 -174.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 110.702 -0.11 . . . . 20.0 110.702 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.97 -38.18 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.978 1.311 . . . . 20.0 111.471 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -67.36 -31.78 72.26 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.002 0.819 . . . . 20.0 112.666 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -73.45 -3.19 25.96 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.22 1.808 . . . . 20.0 113.426 171.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.77 -4.87 69.1 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.419 1.485 . . . . 20.0 114.542 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.97 -174.39 4.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.642 1.177 . . . . 20.0 111.155 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.13 -176.19 14.38 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.194 1.378 . . . . 20.0 111.499 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.3 m -134.56 88.77 2.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.989 1.315 . . . . 20.0 108.328 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.71 161.89 10.41 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.817 1.647 . . . . 20.0 111.367 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.7 165.1 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.471 2.114 . . . . 20.0 111.188 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.31 4.6 4.43 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.917 1.687 . . . . 20.0 113.287 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.0 p -115.7 -4.38 12.19 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.859 2.063 . . . . 20.0 113.711 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.18 -27.57 1.59 Allowed 'General case' 0 C--N 1.346 0.452 0 N-CA-C 114.081 1.141 . . . . 20.0 114.081 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 t -58.24 106.14 0.65 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 126.516 1.926 . . . . 20.0 110.508 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.75 155.9 35.14 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.601 2.2 . . . . 20.0 111.297 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -68.44 -17.84 64.29 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.631 0.604 . . . . 20.0 112.631 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -76.73 -33.5 58.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.847 1.259 . . . . 20.0 112.541 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.84 -5.82 59.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.015 1.116 . . . . 20.0 114.015 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -57.06 117.98 4.55 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.55 1.14 . . . . 20.0 110.529 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.9 mt -75.67 172.07 13.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.615 0.766 . . . . 20.0 110.717 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -70.2 -2.88 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.855 1.262 . . . . 20.0 113.289 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.55 163.3 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.965 1.706 . . . . 20.0 111.471 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.07 77.94 0.24 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.5 1.524 . . . . 20.0 110.663 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.23 6.4 76.12 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.699 1.142 . . . . 20.0 115.547 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 m -130.17 -175.73 3.72 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.883 2.073 . . . . 20.0 110.126 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.1 p -90.48 -7.37 53.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.026 1.33 . . . . 20.0 112.656 -171.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 p -131.85 -63.3 0.83 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.309 1.444 . . . . 20.0 109.971 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.55 152.58 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.734 1.213 . . . . 20.0 111.08 -171.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -133.74 67.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.239 1.816 . . . . 20.0 108.266 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.96 131.23 40.51 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 123.997 0.919 . . . . 20.0 109.451 167.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.77 159.78 21.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.208 0.603 . . . . 20.0 111.518 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 114.015 1.117 . . . . 20.0 114.015 164.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 111.786 0.291 . . . . 20.0 111.786 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.94 -18.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.139 1.376 . . . . 20.0 111.935 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.8 t -58.23 -42.15 85.68 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.755 1.222 . . . . 20.0 112.081 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -21.83 64.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.763 1.625 . . . . 20.0 112.942 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.54 -3.36 36.85 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.016 1.769 . . . . 20.0 113.937 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -70.45 168.64 15.71 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.554 1.177 . . . . 20.0 112.252 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.01 -175.32 50.63 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.188 1.375 . . . . 20.0 112.417 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 t -151.93 49.56 0.79 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.452 1.101 . . . . 20.0 109.274 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.07 153.87 16.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.829 1.251 . . . . 20.0 111.721 -173.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.59 170.67 19.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.404 2.736 . . . . 20.0 112.447 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -65.21 -4.07 4.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.687 1.995 . . . . 20.0 114.449 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.5 t -115.65 -11.56 11.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.562 1.545 . . . . 20.0 113.066 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.09 -26.53 5.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.1 -0.952 . . . . 20.0 113.233 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 t -65.23 107.21 1.31 Allowed Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.36 1.864 . . . . 20.0 109.605 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.22 152.45 50.33 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.323 2.015 . . . . 20.0 110.035 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.31 -25.66 68.41 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.668 1.187 . . . . 20.0 112.64 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.16 -31.63 49.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.932 1.293 . . . . 20.0 112.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.39 58.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.794 1.035 . . . . 20.0 113.794 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -60.71 117.21 5.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.361 1.064 . . . . 20.0 108.723 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.3 176.39 3.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.676 1.191 . . . . 20.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 t -69.95 -3.9 18.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.058 0.943 . . . . 20.0 113.023 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -138.88 169.18 18.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.55 1.94 . . . . 20.0 110.586 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.91 71.69 0.49 Allowed Glycine 0 C--N 1.341 0.809 0 C-N-CA 125.013 1.292 . . . . 20.0 111.259 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.12 -19.66 76.82 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.845 0.736 . . . . 20.0 114.103 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.32 174.55 9.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.576 1.15 . . . . 20.0 111.148 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.6 m -86.59 -5.66 59.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.663 1.185 . . . . 20.0 111.987 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -149.56 -53.15 0.16 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.849 1.26 . . . . 20.0 111.681 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.21 122.46 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.568 1.147 . . . . 20.0 111.505 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.4 t -106.24 82.94 1.82 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.339 2.256 . . . . 20.0 108.944 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.26 142.94 27.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.87 1.268 . . . . 20.0 111.098 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.93 170.25 16.97 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.92 0.888 . . . . 20.0 112.207 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 125.732 1.613 . . . . 20.0 112.117 177.266 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 119.747 -0.168 . . . . 20.0 111.272 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -67.14 -34.85 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.885 1.274 . . . . 20.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.5 m -66.94 -36.94 83.35 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.185 0.994 . . . . 20.0 111.865 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -73.46 -5.73 41.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.718 1.207 . . . . 20.0 113.158 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.04 85.2 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.885 1.231 . . . . 20.0 113.878 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -84.26 168.7 15.45 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.163 1.385 . . . . 20.0 112.117 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.11 167.86 24.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.387 0.994 . . . . 20.0 113.234 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.9 m -126.81 74.09 1.46 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.701 1.6 . . . . 20.0 108.388 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.04 162.23 40.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.776 1.231 . . . . 20.0 110.824 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.44 173.4 14.54 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.365 2.71 . . . . 20.0 110.959 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -66.67 -0.46 2.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.221 1.809 . . . . 20.0 113.733 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.6 p -125.96 -8.08 6.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.941 1.696 . . . . 20.0 114.583 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -128.9 -6.4 5.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.355 0.979 . . . . 20.0 113.222 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.0 t -76.92 116.08 53.98 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.847 0.859 . . . . 20.0 108.741 163.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.87 159.18 48.78 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.733 2.289 . . . . 20.0 110.443 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -63.54 -24.59 67.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.029 0.932 . . . . 20.0 112.259 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.46 -30.66 64.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.959 1.304 . . . . 20.0 112.43 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 -18.71 41.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.052 1.13 . . . . 20.0 114.052 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -60.85 120.5 10.27 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.895 1.278 . . . . 20.0 111.313 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.9 mt -82.4 171.11 14.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.449 1.099 . . . . 20.0 112.015 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -69.49 -12.62 61.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.27 1.428 . . . . 20.0 112.445 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -132.6 168.97 17.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.939 2.095 . . . . 20.0 110.838 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.61 71.56 0.49 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.625 1.583 . . . . 20.0 110.806 -173.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.58 -7.9 87.87 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.336 0.969 . . . . 20.0 114.853 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m -81.63 -168.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.516 1.526 . . . . 20.0 109.778 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.0 p -103.12 -6.53 22.13 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.664 1.185 . . . . 20.0 111.987 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.3 p -127.92 -74.48 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.005 2.122 . . . . 20.0 109.247 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 m -150.5 120.48 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.76 1.624 . . . . 20.0 109.119 -172.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.45 108.74 19.82 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.465 1.106 . . . . 20.0 109.257 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -126.16 113.17 16.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.169 1.387 . . . . 20.0 109.015 -168.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.57 172.25 3.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.059 1.344 . . . . 20.0 112.873 -172.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 69.6 mt . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 125.122 1.369 . . . . 20.0 111.932 -174.223 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 N-CA-C 112.765 0.654 . . . . 20.0 112.765 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.44 -46.17 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.19 1.396 . . . . 20.0 110.39 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -65.32 -29.4 70.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.14 1.376 . . . . 20.0 112.665 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -71.51 -6.05 37.64 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.546 1.938 . . . . 20.0 112.669 171.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.41 6.32 89.33 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.599 -1.111 . . . . 20.0 114.491 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -74.87 167.69 21.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.616 1.208 . . . . 20.0 111.694 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.64 128.26 9.43 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.083 0.849 . . . . 20.0 112.555 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.9 m -82.41 75.0 9.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.913 0.885 . . . . 20.0 108.752 163.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.36 162.96 36.49 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 20.0 110.975 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.66 167.85 25.58 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.818 2.346 . . . . 20.0 110.849 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -74.42 5.85 4.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.621 1.569 . . . . 20.0 113.727 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 t -129.57 12.84 5.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.865 1.666 . . . . 20.0 112.323 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -133.04 -45.93 0.85 Allowed 'General case' 0 C--N 1.346 0.42 0 C-N-CA 124.442 1.097 . . . . 20.0 112.513 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.21 104.31 0.42 Allowed Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 127.336 2.254 . . . . 20.0 111.807 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.78 145.4 36.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.682 2.255 . . . . 20.0 110.96 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -59.91 -26.82 66.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.521 0.934 . . . . 20.0 113.521 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.01 -29.93 70.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.627 1.571 . . . . 20.0 112.647 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.69 24.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.829 1.252 . . . . 20.0 113.64 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -61.23 120.09 9.69 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.754 1.161 . . . . 20.0 110.409 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.09 172.94 10.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.704 1.202 . . . . 20.0 111.773 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -69.85 -10.5 58.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.744 1.218 . . . . 20.0 112.215 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -139.34 172.95 12.07 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.344 2.257 . . . . 20.0 110.591 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.6 76.05 0.21 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.789 -0.924 . . . . 20.0 110.789 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.01 -13.33 66.59 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.841 1.21 . . . . 20.0 113.525 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.48 177.37 1.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.732 1.613 . . . . 20.0 111.244 167.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -93.65 -13.01 28.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.73 0.812 . . . . 20.0 112.798 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -135.39 -59.79 0.77 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.395 1.078 . . . . 20.0 110.819 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.9 m -148.22 153.62 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.652 1.581 . . . . 20.0 110.239 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.9 t -134.42 108.86 8.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.656 1.182 . . . . 20.0 109.502 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -102.46 137.22 41.0 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.133 0.973 . . . . 20.0 109.616 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.43 166.46 12.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.61 0.764 . . . . 20.0 111.618 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.539 0.545 0 C-N-CA 126.004 1.722 . . . . 20.0 110.882 177.343 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 113.009 0.744 . . . . 20.0 113.009 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.9 t -83.48 -41.19 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.436 1.495 . . . . 20.0 110.766 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -60.81 -35.2 75.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.704 1.202 . . . . 20.0 111.995 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -69.32 -14.16 62.78 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.887 2.075 . . . . 20.0 113.233 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 16.91 77.29 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.653 -1.082 . . . . 20.0 114.601 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -59.87 165.59 3.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.6 1.16 . . . . 20.0 112.567 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.51 -33.83 67.59 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.1 1.333 . . . . 20.0 113.986 -175.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 t 50.67 37.22 15.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.146 1.779 . . . . 20.0 112.008 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.49 154.12 56.66 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.934 1.294 . . . . 20.0 111.821 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.17 171.24 11.74 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.746 2.964 . . . . 20.0 111.342 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.65 -22.54 66.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.176 0.99 . . . . 20.0 112.475 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -80.99 -3.76 52.8 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.245 1.818 . . . . 20.0 114.161 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.5 -42.9 1.29 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.141 1.376 . . . . 20.0 112.918 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.86 109.78 5.36 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.218 1.807 . . . . 20.0 110.601 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.6 170.33 15.89 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.552 2.835 . . . . 20.0 112.199 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -66.77 -12.96 60.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.362 1.465 . . . . 20.0 113.411 173.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -96.32 -29.31 14.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.335 1.054 . . . . 20.0 112.82 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.68 -5.4 21.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.483 1.113 . . . . 20.0 113.633 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -60.43 136.2 57.97 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.774 0.716 . . . . 20.0 110.872 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.17 172.04 13.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.29 1.036 . . . . 20.0 111.186 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -72.46 -9.13 58.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.779 0.832 . . . . 20.0 112.318 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.22 172.22 13.33 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.781 2.032 . . . . 20.0 110.973 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.58 67.14 0.39 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.658 1.123 . . . . 20.0 111.654 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.49 -7.42 87.09 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.128 1.347 . . . . 20.0 114.388 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.4 m -66.98 179.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.854 1.327 . . . . 20.0 111.378 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 t -68.62 -29.6 68.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.342 1.057 . . . . 20.0 111.543 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -158.85 -28.25 0.07 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 20.0 113.744 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 p -139.13 135.82 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.106 1.362 . . . . 20.0 110.241 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.2 t -133.64 139.28 46.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.063 1.345 . . . . 20.0 110.812 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.01 140.77 34.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.879 1.672 . . . . 20.0 109.2 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.06 166.78 18.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.209 0.604 . . . . 20.0 110.956 172.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.715 1.606 . . . . 20.0 112.368 178.383 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 119.318 -0.373 . . . . 20.0 111.743 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.36 -36.85 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.061 0.945 . . . . 20.0 110.685 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -65.49 -30.5 71.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.108 1.363 . . . . 20.0 112.056 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -80.32 -12.02 59.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.719 1.608 . . . . 20.0 113.026 171.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.0 12.85 56.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.742 1.163 . . . . 20.0 114.928 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -89.18 167.56 13.0 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.832 1.316 . . . . 20.0 112.781 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.7 -175.87 47.0 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.991 1.281 . . . . 20.0 113.363 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 t -138.28 65.52 1.46 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.119 1.367 . . . . 20.0 109.133 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.57 156.15 78.75 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.38 1.472 . . . . 20.0 110.81 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.46 164.37 35.49 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.178 2.586 . . . . 20.0 110.937 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -64.9 -22.84 67.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.654 0.782 . . . . 20.0 112.993 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.7 m -82.79 -3.76 57.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.909 1.284 . . . . 20.0 113.626 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -129.55 0.92 5.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.336 1.454 . . . . 20.0 112.574 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -128.65 80.93 71.72 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.944 1.297 . . . . 20.0 110.443 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.14 175.41 10.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.176 3.251 . . . . 20.0 112.159 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -67.39 -6.89 21.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.735 1.013 . . . . 20.0 113.735 172.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -86.19 -25.1 25.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.915 1.286 . . . . 20.0 112.396 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.27 -7.77 14.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.447 1.499 . . . . 20.0 113.43 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.56 165.34 8.16 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.352 1.061 . . . . 20.0 112.168 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.9 mt -133.94 166.21 23.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.205 1.002 . . . . 20.0 111.599 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -82.67 -9.64 59.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.043 1.337 . . . . 20.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -109.27 2.76 21.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.931 1.692 . . . . 20.0 113.639 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -36.55 87.23 0.01 OUTLIER Glycine 0 CA--C 1.529 0.909 1 C-N-CA 130.987 4.137 . . . . 20.0 115.506 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.62 0.63 63.29 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.069 1.319 . . . . 20.0 113.963 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.7 m -66.54 173.48 3.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 20.0 111.728 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -86.63 -16.1 37.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.887 0.875 . . . . 20.0 111.923 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -132.16 -61.36 0.88 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.373 1.469 . . . . 20.0 110.302 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.5 m -152.18 153.01 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.967 1.307 . . . . 20.0 111.002 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.6 t -131.92 137.01 47.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.988 1.715 . . . . 20.0 109.251 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.3 m -137.21 156.35 48.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.715 1.206 . . . . 20.0 111.089 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.55 126.02 30.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.495 1.118 . . . . 20.0 112.571 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 125.836 1.655 . . . . 20.0 113.155 168.362 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 112.552 0.575 . . . . 20.0 112.552 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.36 -32.98 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.194 0.598 . . . . 20.0 111.394 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -67.35 -34.32 77.06 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.524 0.73 . . . . 20.0 111.794 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -9.51 58.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.362 1.065 . . . . 20.0 113.524 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.87 -2.4 84.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.757 1.17 . . . . 20.0 113.911 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -71.19 176.13 4.74 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.603 1.201 . . . . 20.0 110.852 168.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.14 -172.91 15.14 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 123.862 0.744 . . . . 20.0 112.818 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -117.68 82.01 1.76 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.447 1.499 . . . . 20.0 109.155 -173.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 151.8 81.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.185 0.994 . . . . 20.0 109.295 170.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.77 167.74 24.88 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.379 2.719 . . . . 20.0 111.598 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.24 -9.65 42.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.963 1.305 . . . . 20.0 113.272 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -95.63 -13.51 24.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.83 1.652 . . . . 20.0 113.548 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -137.55 20.17 2.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.059 1.344 . . . . 20.0 112.587 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 t -127.74 77.64 75.97 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.152 1.381 . . . . 20.0 109.354 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.34 171.11 18.68 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.068 3.179 . . . . 20.0 112.159 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -63.69 -13.35 42.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.799 1.64 . . . . 20.0 113.756 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.3 -25.98 25.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.75 1.22 . . . . 20.0 112.811 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.66 -8.21 14.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.3 1.44 . . . . 20.0 113.345 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -65.79 170.0 5.83 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.278 1.031 . . . . 20.0 111.789 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.8 mt -130.97 168.42 17.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 20.0 110.248 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -74.04 -19.93 60.46 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.237 1.015 . . . . 20.0 111.913 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -73.9 167.07 22.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.971 1.708 . . . . 20.0 111.675 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.12 87.31 0.12 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.923 0.773 . . . . 20.0 111.662 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.16 3.1 79.88 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.05 1.309 . . . . 20.0 114.172 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.0 m -131.93 -12.33 3.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.632 1.573 . . . . 20.0 114.762 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.3 p 64.79 6.8 3.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 130.889 3.676 . . . . 20.0 113.429 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.3 p -122.53 -57.18 1.76 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.78 1.232 . . . . 20.0 110.772 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.06 135.53 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 126.147 1.779 . . . . 20.0 109.402 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.4 t -145.42 121.71 10.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.839 1.656 . . . . 20.0 109.156 171.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 9.5 m -129.02 148.46 50.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.379 1.471 . . . . 20.0 110.414 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -73.26 107.64 5.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.797 1.239 . . . . 20.0 110.446 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 CA--C 1.536 0.407 0 C-N-CA 126.157 1.783 . . . . 20.0 112.367 170.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 112.87 0.692 . . . . 20.0 112.87 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.55 -37.41 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 124.131 0.972 . . . . 20.0 110.484 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.6 t -66.98 -30.53 70.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.257 1.023 . . . . 20.0 111.91 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.11 -2.07 46.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.138 1.375 . . . . 20.0 112.564 171.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.88 -5.01 84.95 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.903 1.716 . . . . 20.0 114.961 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -76.39 168.32 20.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.783 1.292 . . . . 20.0 112.14 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.14 170.93 32.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.639 1.114 . . . . 20.0 112.51 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.0 m -126.0 68.65 1.19 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.669 1.588 . . . . 20.0 107.936 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.66 161.47 65.77 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.999 1.72 . . . . 20.0 110.746 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.45 164.76 34.66 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.599 2.2 . . . . 20.0 111.329 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -66.94 -6.97 18.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.675 1.59 . . . . 20.0 113.738 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -121.05 -5.3 9.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.736 1.615 . . . . 20.0 113.964 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -105.58 -42.39 5.21 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.229 0.922 . . . . 20.0 112.026 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.6 115.46 27.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.39 1.076 . . . . 20.0 109.863 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.24 160.62 35.91 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.547 2.164 . . . . 20.0 110.381 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -63.9 -16.93 62.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.871 1.268 . . . . 20.0 112.643 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -70.6 -25.89 63.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.912 1.285 . . . . 20.0 112.669 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.79 2.74 10.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.858 1.663 . . . . 20.0 113.461 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.02 151.34 40.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.892 0.877 . . . . 20.0 109.821 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.6 mt -95.15 166.86 11.71 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.423 0.63 . . . . 20.0 110.214 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -74.15 -3.07 27.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.01 0.924 . . . . 20.0 112.32 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -143.78 169.11 18.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.687 1.995 . . . . 20.0 110.808 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.76 79.64 0.37 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 125.082 1.325 . . . . 20.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 -3.05 65.37 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.079 0.847 . . . . 20.0 114.247 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.1 m -85.08 -166.48 1.51 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.9 2.08 . . . . 20.0 110.314 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 t -91.62 -18.15 24.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.938 0.895 . . . . 20.0 112.479 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.7 p -134.22 -61.7 0.77 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.417 1.087 . . . . 20.0 110.622 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -150.09 157.92 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.301 1.84 . . . . 20.0 109.648 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.1 t -125.73 151.95 45.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.309 1.444 . . . . 20.0 110.176 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -137.78 125.96 23.03 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.653 0.781 . . . . 20.0 110.812 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 147.24 46.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.712 1.205 . . . . 20.0 110.052 169.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 41.8 mt . . . . . 0 CA--C 1.541 0.612 0 C-N-CA 125.263 1.425 . . . . 20.0 111.902 -176.024 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.5 m . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 109.997 -0.371 . . . . 20.0 109.997 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.8 -40.14 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.287 1.435 . . . . 20.0 111.171 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -62.32 -41.32 98.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.443 1.097 . . . . 20.0 111.756 -176.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -83.07 -7.31 59.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.331 1.052 . . . . 20.0 113.336 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.72 79.02 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.597 1.094 . . . . 20.0 114.955 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -65.37 164.74 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.043 1.422 . . . . 20.0 111.831 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.97 178.72 53.38 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 121.994 0.774 . . . . 20.0 112.103 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.6 t -150.34 76.81 1.28 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.118 -1.438 . . . . 20.0 107.118 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 157.44 86.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.841 1.257 . . . . 20.0 110.919 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.66 174.39 8.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.951 3.101 . . . . 20.0 111.352 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -16.67 34.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.571 1.148 . . . . 20.0 113.124 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 m -89.11 -11.02 45.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.711 1.604 . . . . 20.0 113.862 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.11 -0.88 4.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.896 1.678 . . . . 20.0 113.199 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -120.33 77.51 26.07 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.921 1.288 . . . . 20.0 109.406 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.15 170.57 19.53 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.533 2.822 . . . . 20.0 110.963 175.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -60.56 -26.02 66.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.397 1.079 . . . . 20.0 112.753 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.63 -46.26 72.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.758 1.623 . . . . 20.0 111.859 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.78 -4.54 56.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.749 1.219 . . . . 20.0 113.929 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -60.4 145.3 48.54 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.321 1.049 . . . . 20.0 111.618 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.81 173.75 9.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.835 1.254 . . . . 20.0 111.51 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 t -65.02 -14.13 59.65 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.634 1.574 . . . . 20.0 112.737 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.18 168.12 20.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.419 2.287 . . . . 20.0 110.269 -174.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.67 85.18 0.17 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 124.465 1.031 . . . . 20.0 111.305 -170.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.67 -13.37 80.09 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.557 1.075 . . . . 20.0 115.01 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.4 m -80.82 -179.71 7.41 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.548 1.139 . . . . 20.0 111.294 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -93.78 -9.83 36.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.9 1.28 . . . . 20.0 111.987 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.5 p -133.13 -65.61 0.69 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.982 1.313 . . . . 20.0 109.736 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.84 156.14 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.363 1.465 . . . . 20.0 110.507 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -144.37 115.95 8.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.186 1.394 . . . . 20.0 109.35 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.84 136.73 51.83 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.215 1.006 . . . . 20.0 111.93 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.73 124.83 28.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.36 1.464 . . . . 20.0 109.464 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 125.685 1.594 . . . . 20.0 112.942 174.423 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 111.774 0.287 . . . . 20.0 111.774 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.6 t -73.74 -25.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.655 1.182 . . . . 20.0 111.16 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -67.9 -32.78 73.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.46 0.704 . . . . 20.0 111.916 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -67.94 -20.73 65.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.286 1.034 . . . . 20.0 112.711 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.69 -2.34 21.61 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.087 1.803 . . . . 20.0 114.132 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -77.8 175.99 9.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.583 1.192 . . . . 20.0 112.587 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -23.45 30.48 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.295 -0.725 . . . . 20.0 114.206 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.9 t 49.92 49.56 20.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.086 1.754 . . . . 20.0 112.523 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.08 155.21 84.8 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.532 1.133 . . . . 20.0 111.291 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.13 169.98 21.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.505 2.803 . . . . 20.0 112.306 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -69.34 8.7 0.56 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.465 1.906 . . . . 20.0 114.036 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.3 p -120.03 -6.31 9.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.337 1.855 . . . . 20.0 113.122 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -136.73 -17.76 1.44 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 113.842 1.053 . . . . 20.0 113.842 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -85.68 114.75 58.42 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.067 0.947 . . . . 20.0 109.616 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.21 162.9 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.772 2.315 . . . . 20.0 111.741 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -70.96 -6.42 38.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.363 1.465 . . . . 20.0 114.313 -173.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.42 -32.11 10.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.775 1.23 . . . . 20.0 111.848 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.16 -21.28 39.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 113.818 1.044 . . . . 20.0 113.818 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -63.4 157.47 23.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.011 0.924 . . . . 20.0 111.804 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.67 162.98 12.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.154 1.381 . . . . 20.0 110.408 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -83.22 -3.89 57.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.377 1.071 . . . . 20.0 111.677 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -148.93 176.19 10.63 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.733 2.013 . . . . 20.0 111.069 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.29 -166.29 30.04 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.133 0.873 . . . . 20.0 112.317 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.82 7.69 4.19 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.499 1.523 . . . . 20.0 114.047 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.9 173.53 5.27 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.801 1.24 . . . . 20.0 111.918 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.2 t -96.76 -5.43 38.59 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.119 1.367 . . . . 20.0 112.544 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.2 t -147.27 -49.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.278 1.031 . . . . 20.0 111.76 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -162.94 145.01 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.975 1.71 . . . . 20.0 108.164 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.1 t -114.27 151.76 32.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.285 1.034 . . . . 20.0 110.567 166.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.82 129.04 22.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.127 1.371 . . . . 20.0 109.574 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.16 137.44 33.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.156 0.982 . . . . 20.0 110.445 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.9 mt . . . . . 0 CA--C 1.538 0.5 0 C-N-CA 125.502 1.521 . . . . 20.0 112.633 -177.589 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 119.724 -0.179 . . . . 20.0 110.555 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.46 -32.24 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.589 1.156 . . . . 20.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.4 t -64.03 -39.79 94.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.503 1.121 . . . . 20.0 111.56 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -72.47 -6.0 40.67 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.689 1.196 . . . . 20.0 113.262 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.53 4.22 64.15 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.338 1.447 . . . . 20.0 114.625 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -77.45 171.22 15.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.55 1.14 . . . . 20.0 112.069 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.97 177.8 31.68 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.262 1.41 . . . . 20.0 113.136 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -133.6 69.17 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.84 1.656 . . . . 20.0 107.451 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.43 159.84 47.18 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.973 1.709 . . . . 20.0 110.914 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.54 166.0 30.95 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.846 2.364 . . . . 20.0 111.0 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -67.72 -19.71 65.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.87 1.268 . . . . 20.0 112.786 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -83.69 -16.97 42.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.992 1.317 . . . . 20.0 113.062 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -124.84 5.45 8.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.285 1.434 . . . . 20.0 113.157 -174.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -120.08 78.15 24.8 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.092 0.957 . . . . 20.0 110.43 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.82 172.68 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.536 2.824 . . . . 20.0 111.7 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -65.19 -13.36 58.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.516 1.127 . . . . 20.0 113.33 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.41 -32.56 20.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.042 1.337 . . . . 20.0 112.215 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 -18.33 22.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.28 1.032 . . . . 20.0 113.454 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -70.04 155.48 40.53 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 118.606 0.639 . . . . 20.0 110.6 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.11 177.45 6.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.051 0.94 . . . . 20.0 110.204 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -68.73 -21.93 64.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.333 0.653 . . . . 20.0 111.835 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.21 171.4 14.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.294 1.838 . . . . 20.0 111.66 -168.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.98 177.36 31.01 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.239 0.923 . . . . 20.0 112.812 175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.96 21.58 0.59 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.083 1.325 . . . . 20.0 113.367 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -63.13 176.87 0.68 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.374 1.469 . . . . 20.0 112.234 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -69.22 -29.63 67.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.724 1.209 . . . . 20.0 111.47 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 t -143.5 -41.31 0.29 Allowed 'General case' 0 C--N 1.344 0.354 0 CA-C-O 117.944 -1.027 . . . . 20.0 113.435 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -153.88 151.79 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.538 1.135 . . . . 20.0 109.68 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -118.93 135.17 54.73 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 125.474 1.51 . . . . 20.0 109.226 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -131.94 148.16 52.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.984 1.314 . . . . 20.0 110.039 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -74.73 166.28 23.85 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.611 -0.722 . . . . 20.0 111.476 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 125.407 1.483 . . . . 20.0 111.521 179.182 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 110.4 -0.222 . . . . 20.0 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.4 -39.92 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.048 1.339 . . . . 20.0 111.161 173.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -68.1 -32.05 72.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.267 1.027 . . . . 20.0 112.35 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -75.28 -9.95 59.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.63 1.572 . . . . 20.0 112.479 171.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.11 -2.96 69.39 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.254 1.407 . . . . 20.0 114.572 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -77.14 170.19 16.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.762 1.281 . . . . 20.0 111.72 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.54 160.13 23.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.907 0.765 . . . . 20.0 113.067 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.1 m -124.35 65.78 1.07 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.866 1.666 . . . . 20.0 109.189 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 mt -65.43 163.22 34.85 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.88 1.272 . . . . 20.0 111.512 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.62 170.93 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.036 2.491 . . . . 20.0 110.753 168.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -60.69 -27.05 67.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.429 1.092 . . . . 20.0 112.505 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -74.31 -10.6 59.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.861 1.264 . . . . 20.0 113.847 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.96 -5.27 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.044 1.338 . . . . 20.0 113.174 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.9 t -124.19 83.49 56.36 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.219 1.408 . . . . 20.0 109.809 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.89 173.48 14.43 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.966 3.11 . . . . 20.0 111.933 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -14.81 56.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 20.0 113.048 173.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.78 -29.26 50.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.138 . . . . 20.0 112.909 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.68 -8.68 14.92 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.457 1.103 . . . . 20.0 113.477 -170.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -70.22 159.63 33.65 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.522 0.729 . . . . 20.0 112.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.11 176.91 5.39 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.878 1.271 . . . . 20.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -70.58 -4.96 25.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.841 1.256 . . . . 20.0 113.187 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -139.98 176.29 8.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.152 1.781 . . . . 20.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.4 72.91 0.36 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.688 1.137 . . . . 20.0 111.96 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.42 -18.88 79.94 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.83 -0.983 . . . . 20.0 114.103 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.5 m -70.16 179.68 2.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.938 1.295 . . . . 20.0 112.52 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.2 m -86.09 -8.77 57.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.955 1.302 . . . . 20.0 112.264 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 t -148.53 -52.62 0.18 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.863 -1.065 . . . . 20.0 111.845 170.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.13 145.31 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.328 0.967 . . . . 20.0 112.012 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.6 t -122.85 112.28 17.69 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.959 2.103 . . . . 20.0 109.309 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -121.02 142.71 49.55 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.101 1.361 . . . . 20.0 111.726 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.73 137.99 31.92 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.182 1.393 . . . . 20.0 109.947 172.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.9 mt . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 127.19 2.196 . . . . 20.0 111.891 -169.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 119.827 -0.13 . . . . 20.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.06 -39.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.622 1.169 . . . . 20.0 111.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.6 t -67.73 -32.72 73.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 20.0 112.603 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -70.33 -13.02 61.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.153 1.381 . . . . 20.0 112.483 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.4 61.09 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.362 1.458 . . . . 20.0 114.163 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -79.04 171.64 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.671 1.235 . . . . 20.0 111.672 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.54 176.62 41.64 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.169 1.366 . . . . 20.0 112.259 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -141.16 56.45 1.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.906 -1.146 . . . . 20.0 107.906 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.24 157.5 12.12 Favored Pre-proline 0 C--N 1.345 0.375 0 C-N-CA 125.601 1.56 . . . . 20.0 111.666 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.36 167.51 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.822 2.348 . . . . 20.0 110.513 173.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -62.32 -22.12 65.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.558 0.743 . . . . 20.0 112.451 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p -84.41 -12.55 54.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.216 1.806 . . . . 20.0 114.441 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -4.41 11.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.189 1.395 . . . . 20.0 112.977 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 t -116.45 80.76 10.38 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.16 1.384 . . . . 20.0 108.824 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.07 170.73 18.26 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.654 2.903 . . . . 20.0 111.665 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -58.51 -28.78 65.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.708 1.603 . . . . 20.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.22 -40.43 64.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.832 1.253 . . . . 20.0 112.169 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.2 -5.66 57.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.934 1.087 . . . . 20.0 113.934 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -61.96 140.09 58.35 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.883 0.873 . . . . 20.0 110.957 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mt -75.86 173.04 11.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.115 0.96 . . . . 20.0 110.743 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -66.94 -12.62 60.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.373 1.069 . . . . 20.0 112.691 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.05 165.65 26.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.075 2.15 . . . . 20.0 110.869 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.65 86.79 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 125.798 1.666 . . . . 20.0 110.404 -172.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.5 1.37 60.18 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 118.448 -1.196 . . . . 20.0 115.575 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.1 m -97.42 174.35 6.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.643 1.177 . . . . 20.0 110.791 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -88.05 -5.13 58.65 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.403 1.081 . . . . 20.0 112.178 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 t -137.53 -61.26 0.64 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.676 1.591 . . . . 20.0 110.362 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -150.82 135.79 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.318 1.047 . . . . 20.0 110.952 -171.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.9 t -120.51 115.31 23.2 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.5 1.92 . . . . 20.0 109.146 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 m -126.12 146.7 49.83 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.776 1.63 . . . . 20.0 109.916 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.93 164.96 24.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.957 0.503 . . . . 20.0 111.82 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 125.364 1.466 . . . . 20.0 111.861 177.311 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 112.686 0.624 . . . . 20.0 112.686 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.83 -36.42 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.729 0.812 . . . . 20.0 109.62 173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.0 m -69.32 -13.46 62.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.631 1.173 . . . . 20.0 113.249 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -69.6 -10.04 56.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.347 1.059 . . . . 20.0 112.085 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.15 -3.06 56.74 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.558 1.551 . . . . 20.0 113.791 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.07 -96.59 0.11 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.296 1.048 . . . . 20.0 109.583 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.37 -155.06 25.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.303 1.43 . . . . 20.0 111.188 -170.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -149.89 145.11 26.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.749 1.22 . . . . 20.0 109.378 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mp -123.55 160.58 50.19 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.581 . . . . 20.0 110.152 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.82 171.79 16.75 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.163 3.242 . . . . 20.0 112.705 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -67.96 -2.13 6.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.855 2.462 . . . . 20.0 114.298 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.9 m -130.06 5.63 4.94 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.564 1.546 . . . . 20.0 112.933 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -136.04 9.59 3.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.552 1.141 . . . . 20.0 112.896 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.9 t -115.59 80.72 8.38 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 20.0 109.361 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.8 161.53 43.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.238 2.625 . . . . 20.0 110.705 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -58.77 -28.5 65.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.086 1.354 . . . . 20.0 113.106 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.8 -44.88 84.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.925 1.29 . . . . 20.0 111.789 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.28 -8.07 59.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.7 1.2 . . . . 20.0 113.848 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -62.74 141.9 58.38 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.338 0.972 . . . . 20.0 110.579 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.67 170.23 15.67 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.305 0.574 . . . . 20.0 110.874 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 t -66.89 -11.24 55.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.397 1.079 . . . . 20.0 112.381 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -144.68 165.65 27.45 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.575 2.35 . . . . 20.0 110.291 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.24 -169.67 15.05 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.481 1.515 . . . . 20.0 112.153 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.68 -7.22 0.33 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.891 1.234 . . . . 20.0 113.523 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 m -73.15 -179.1 3.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.457 1.503 . . . . 20.0 113.043 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -65.58 -30.14 70.83 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.49 1.516 . . . . 20.0 111.393 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -155.55 -38.28 0.09 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.152 0.981 . . . . 20.0 113.009 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m -140.5 139.85 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.328 0.967 . . . . 20.0 111.056 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 14.6 t -129.68 131.21 46.31 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.165 1.386 . . . . 20.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.0 m -133.09 148.0 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.049 1.739 . . . . 20.0 109.601 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -70.39 148.77 48.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.051 0.94 . . . . 20.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 123.834 0.854 . . . . 20.0 112.279 172.659 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 108.936 -0.764 . . . . 20.0 108.936 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.21 -27.38 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.02 1.728 . . . . 20.0 112.15 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -60.0 -44.61 94.44 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.718 1.207 . . . . 20.0 111.695 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -85.88 -5.11 59.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.74 1.216 . . . . 20.0 113.423 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.96 -7.44 57.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.7 1.619 . . . . 20.0 114.918 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.11 171.03 6.04 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.339 1.456 . . . . 20.0 111.932 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.09 -167.09 13.18 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.658 1.123 . . . . 20.0 113.293 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.02 83.56 1.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.57 1.948 . . . . 20.0 107.874 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.97 159.84 73.7 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.844 1.258 . . . . 20.0 110.233 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -69.47 162.75 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 20.0 110.977 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -69.72 3.92 2.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.742 1.617 . . . . 20.0 113.464 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.5 t -113.3 -0.68 14.48 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.997 2.119 . . . . 20.0 112.616 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.21 0.11 2.54 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.187 1.181 . . . . 20.0 114.187 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.5 t -111.39 110.22 55.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.171 0.989 . . . . 20.0 110.758 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.57 158.9 55.56 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.877 2.384 . . . . 20.0 111.119 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.21 -23.95 66.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.746 1.218 . . . . 20.0 113.534 -171.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -83.37 -30.97 26.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.324 1.45 . . . . 20.0 112.246 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.42 -11.97 58.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.723 1.209 . . . . 20.0 112.968 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -71.37 108.36 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.307 1.443 . . . . 20.0 109.219 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.91 159.63 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.957 0.903 . . . . 20.0 110.89 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -77.47 1.09 20.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.903 1.281 . . . . 20.0 113.165 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.2 170.0 18.81 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.752 1.621 . . . . 20.0 111.148 -172.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.82 171.56 21.71 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.29 0.947 . . . . 20.0 113.055 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.26 -16.18 38.68 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.681 1.134 . . . . 20.0 113.332 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.0 m -72.71 175.21 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.372 1.086 . . . . 20.0 110.587 168.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.2 t -126.82 8.63 6.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.003 1.321 . . . . 20.0 111.92 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -126.58 -64.28 1.03 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.298 1.439 . . . . 20.0 109.404 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.69 156.91 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.932 1.693 . . . . 20.0 110.151 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.5 t -142.12 82.72 1.81 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.257 2.223 . . . . 20.0 107.082 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 152.64 40.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.819 -0.628 . . . . 20.0 111.613 -173.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -102.18 104.61 15.2 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.734 1.214 . . . . 20.0 110.129 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.54 0.596 0 C-N-CA 128.585 2.754 . . . . 20.0 112.153 169.186 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.227 -0.114 0 CA-C-O 118.888 -0.577 . . . . 20.0 112.236 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.0 t -67.04 -39.71 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.68 0.792 . . . . 20.0 110.741 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -62.72 -35.5 79.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.38 1.072 . . . . 20.0 111.662 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -81.1 -4.97 57.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.856 1.662 . . . . 20.0 113.302 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.54 85.53 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.784 1.183 . . . . 20.0 114.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -75.54 174.84 9.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.391 1.476 . . . . 20.0 111.487 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.63 173.09 16.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.973 0.797 . . . . 20.0 114.139 -174.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 75.8 m -126.28 72.15 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.711 . . . . 20.0 109.239 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.2 mt -68.33 162.02 64.61 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.873 1.269 . . . . 20.0 111.514 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.23 169.8 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.488 2.792 . . . . 20.0 110.665 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.95 -21.17 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.888 0.699 . . . . 20.0 112.888 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 t -65.26 -54.51 28.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.49 1.516 . . . . 20.0 111.21 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.51 -7.63 57.36 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.755 1.02 . . . . 20.0 113.755 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -115.86 81.07 9.31 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.82 1.248 . . . . 20.0 110.322 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.69 172.96 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.926 3.084 . . . . 20.0 112.477 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.03 -7.41 22.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.567 1.547 . . . . 20.0 113.52 174.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.24 -28.1 17.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.308 1.443 . . . . 20.0 112.209 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.08 -11.11 19.11 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 20.0 113.851 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -59.99 139.56 57.34 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.182 0.993 . . . . 20.0 111.291 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.35 165.65 17.08 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.339 0.59 . . . . 20.0 110.423 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.3 t -76.49 -7.61 55.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.834 0.854 . . . . 20.0 112.321 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.23 173.24 11.7 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.402 2.281 . . . . 20.0 110.488 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.67 171.1 32.41 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 121.559 0.533 . . . . 20.0 113.713 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.85 20.53 2.52 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.525 1.536 . . . . 20.0 112.847 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -68.17 179.21 1.61 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.706 1.202 . . . . 20.0 110.698 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.3 t -84.5 -21.74 30.48 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.034 0.534 . . . . 20.0 111.814 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -136.5 -60.35 0.71 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.72 1.208 . . . . 20.0 111.048 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.1 153.99 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.39 1.476 . . . . 20.0 110.476 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.12 132.08 41.26 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.213 1.405 . . . . 20.0 110.371 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.4 m -130.96 144.14 51.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.114 1.366 . . . . 20.0 110.37 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -74.19 103.96 4.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.16 0.984 . . . . 20.0 109.405 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.536 0.41 0 C-N-CA 126.092 1.757 . . . . 20.0 112.543 170.483 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 118.93 -0.557 . . . . 20.0 112.364 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.35 -38.26 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.864 0.866 . . . . 20.0 110.479 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -62.98 -35.51 80.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.038 0.935 . . . . 20.0 111.918 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -81.72 -4.68 56.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.502 1.521 . . . . 20.0 113.041 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.1 2.71 90.6 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.966 1.269 . . . . 20.0 114.948 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -71.53 174.11 7.1 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.802 1.301 . . . . 20.0 112.38 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.54 -177.96 51.86 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.097 1.332 . . . . 20.0 112.744 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.94 59.02 0.79 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.567 1.147 . . . . 20.0 110.006 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.57 153.38 95.76 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.039 0.536 . . . . 20.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.03 172.71 14.15 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.6 3.533 . . . . 20.0 111.475 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -62.28 -13.9 33.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.716 1.376 . . . . 20.0 114.716 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.7 m -95.28 -9.54 32.82 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.294 1.438 . . . . 20.0 113.476 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.83 -2.69 9.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.032 1.733 . . . . 20.0 112.354 175.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.98 85.71 40.95 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.539 1.535 . . . . 20.0 109.721 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.18 175.87 10.68 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.184 3.256 . . . . 20.0 112.326 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.69 -12.99 52.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.33 1.452 . . . . 20.0 113.42 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 -39.02 17.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.389 1.075 . . . . 20.0 112.04 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.72 -10.45 26.82 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.739 1.014 . . . . 20.0 113.739 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -63.37 149.78 45.02 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.92 0.782 . . . . 20.0 111.251 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.99 171.83 11.12 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.225 0.536 . . . . 20.0 110.528 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -67.71 -4.73 13.1 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.202 1.401 . . . . 20.0 112.907 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -148.97 162.21 40.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.316 1.846 . . . . 20.0 110.763 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.8 75.35 0.23 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 125.101 1.334 . . . . 20.0 111.022 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 7.7 61.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.986 1.279 . . . . 20.0 114.786 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 55.7 m -102.93 -172.72 2.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.23 1.812 . . . . 20.0 110.384 170.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -72.45 -27.16 62.13 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.586 1.154 . . . . 20.0 112.082 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 t -155.82 -32.81 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.44 0.904 . . . . 20.0 113.44 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -138.6 130.09 36.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 124.905 1.282 . . . . 20.0 110.732 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.78 141.46 48.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.724 1.61 . . . . 20.0 110.716 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -135.47 157.56 46.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.101 1.76 . . . . 20.0 110.495 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.24 160.34 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.175 0.59 . . . . 20.0 111.614 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 125.912 1.685 . . . . 20.0 113.341 171.768 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 111.742 0.275 . . . . 20.0 111.742 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.23 -37.87 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.1 . . . . 20.0 110.811 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -65.4 -34.69 78.89 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.2 1.0 . . . . 20.0 112.214 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -68.16 -17.67 64.4 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.778 1.231 . . . . 20.0 112.66 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.53 38.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.721 1.629 . . . . 20.0 114.245 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -68.79 168.5 13.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.908 1.354 . . . . 20.0 112.022 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.84 -160.94 27.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.406 1.479 . . . . 20.0 113.171 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 t -154.1 72.6 0.89 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.019 0.928 . . . . 20.0 108.793 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.56 162.36 43.51 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.3 1.44 . . . . 20.0 111.154 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.85 157.76 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.815 2.343 . . . . 20.0 110.766 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -63.37 -20.09 65.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.636 1.174 . . . . 20.0 113.112 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.9 m -87.79 -0.49 57.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.556 1.542 . . . . 20.0 113.715 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.53 -36.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.612 1.096 . . . . 20.0 113.362 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.79 113.2 38.33 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 20.0 109.182 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.78 168.33 23.75 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.99 2.46 . . . . 20.0 111.994 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.49 -4.79 32.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.937 1.295 . . . . 20.0 113.544 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -91.69 -34.55 14.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.634 1.174 . . . . 20.0 112.217 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.19 -18.11 35.07 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.636 1.174 . . . . 20.0 113.605 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -62.01 149.6 40.44 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.357 0.663 . . . . 20.0 112.205 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.62 172.09 8.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.202 1.401 . . . . 20.0 110.451 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -73.93 -7.22 51.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.689 1.196 . . . . 20.0 113.338 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -85.65 -179.63 6.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.712 1.605 . . . . 20.0 113.063 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.62 32.85 2.41 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.114 1.816 . . . . 20.0 112.852 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.22 1.9 54.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.221 1.391 . . . . 20.0 115.708 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.16 172.36 11.07 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.202 1.401 . . . . 20.0 110.197 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -92.25 -12.83 31.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.939 0.896 . . . . 20.0 112.353 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.6 p -130.18 -65.03 0.83 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.092 1.357 . . . . 20.0 109.574 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 m -151.36 159.32 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.451 1.1 . . . . 20.0 111.228 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -133.49 149.19 51.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.732 2.013 . . . . 20.0 108.507 172.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.11 149.37 52.42 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.313 1.045 . . . . 20.0 111.069 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -89.57 77.44 7.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.737 1.215 . . . . 20.0 113.398 -168.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 114.703 1.371 . . . . 20.0 114.703 178.418 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 121.623 0.725 . . . . 20.0 111.249 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -64.66 -42.58 95.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.401 1.48 . . . . 20.0 111.917 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.408 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 67.1 m -68.61 -39.06 81.03 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.38 1.072 . . . . 20.0 112.293 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.02 -40.33 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.124 0.97 . . . . 20.0 110.485 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.5 t -56.02 -48.0 76.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.286 1.034 . . . . 20.0 111.018 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -73.56 -3.84 30.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.228 1.811 . . . . 20.0 113.585 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.12 0.41 89.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.129 1.347 . . . . 20.0 115.058 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -72.01 165.42 24.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.672 1.236 . . . . 20.0 112.296 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.81 -158.41 30.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.111 1.815 . . . . 20.0 111.792 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.21 116.49 6.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.35 1.06 . . . . 20.0 108.811 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.52 159.13 33.36 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.516 1.527 . . . . 20.0 110.02 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.27 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.246 2.631 . . . . 20.0 111.719 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -68.25 -8.67 41.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.729 1.612 . . . . 20.0 113.7 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.7 p -107.24 -29.74 9.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.509 1.524 . . . . 20.0 113.577 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.26 -26.08 19.17 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.8 0.727 . . . . 20.0 112.406 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -85.1 110.49 28.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.463 1.505 . . . . 20.0 109.634 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.75 167.2 26.4 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.786 2.324 . . . . 20.0 111.487 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.42 -8.17 44.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.031 1.332 . . . . 20.0 113.327 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.53 -28.25 16.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.246 1.418 . . . . 20.0 111.792 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.16 -15.41 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.244 1.418 . . . . 20.0 113.513 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -60.05 139.37 57.51 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.728 0.811 . . . . 20.0 110.129 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.14 158.43 15.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.641 0.734 . . . . 20.0 110.823 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t -80.22 9.05 6.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.781 1.632 . . . . 20.0 112.88 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.86 168.97 9.25 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.044 1.338 . . . . 20.0 112.77 -168.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.13 32.1 7.54 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.325 1.917 . . . . 20.0 113.01 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.408 ' HA3' ' H ' ' A' ' 3' ' ' CYS . . . -76.6 -0.02 66.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.28 1.419 . . . . 20.0 115.749 -173.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m -125.08 -172.18 2.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.905 2.082 . . . . 20.0 110.22 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -105.89 -3.97 21.24 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 20.0 113.232 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.9 t -144.29 -55.63 0.35 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.268 1.027 . . . . 20.0 110.816 171.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -145.8 152.31 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.549 1.54 . . . . 20.0 109.151 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -121.84 144.23 48.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.682 1.193 . . . . 20.0 109.535 172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -135.23 149.64 49.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.865 1.266 . . . . 20.0 109.603 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -74.91 175.41 8.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.874 0.87 . . . . 20.0 111.876 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.3 mt -125.21 5.32 7.81 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.846 1.658 . . . . 20.0 112.117 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 t -67.4 -19.86 65.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.448 1.099 . . . . 20.0 113.475 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -68.03 -27.66 66.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.394 0.997 . . . . 20.0 112.349 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.2 mt -72.03 -39.97 68.74 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.667 1.187 . . . . 20.0 111.112 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -79.83 -12.86 59.74 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.772 1.229 . . . . 20.0 113.158 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.507 -1.718 . . . . 20.0 111.592 -179.451 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.133 -0.321 . . . . 20.0 110.133 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.12 -36.38 81.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.624 0.77 . . . . 20.0 111.369 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.74 -43.84 71.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.708 0.685 . . . . 20.0 111.867 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.75 -22.93 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.263 1.025 . . . . 20.0 111.227 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -58.73 -33.89 70.74 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.84 0.856 . . . . 20.0 113.161 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -79.16 -11.23 59.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.542 1.537 . . . . 20.0 113.342 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.95 -2.89 31.7 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.175 1.845 . . . . 20.0 114.329 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -72.42 -178.85 2.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.041 1.336 . . . . 20.0 112.154 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.3 168.62 21.48 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.887 1.232 . . . . 20.0 111.187 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 t -126.49 68.62 1.23 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 20.0 110.669 -160.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.3 mt -72.78 153.59 91.28 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.268 0.627 . . . . 20.0 111.882 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.65 173.97 11.76 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.724 3.616 . . . . 20.0 111.931 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.24 -38.2 73.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.686 1.195 . . . . 20.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.3 p -67.53 -17.32 64.62 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.153 1.381 . . . . 20.0 113.874 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.73 -12.27 10.27 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.028 1.731 . . . . 20.0 111.777 -174.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 t -122.83 89.46 50.29 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.373 1.469 . . . . 20.0 109.026 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.04 166.81 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.145 2.563 . . . . 20.0 110.753 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.94 -33.02 70.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.628 1.171 . . . . 20.0 112.907 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.94 -32.98 74.79 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.118 1.367 . . . . 20.0 112.429 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.37 -10.05 45.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.37 1.468 . . . . 20.0 113.156 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -65.05 143.91 57.61 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.005 0.922 . . . . 20.0 110.056 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.89 175.86 10.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 20.0 111.178 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -73.5 -7.64 52.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.303 0.641 . . . . 20.0 112.322 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -137.13 173.17 11.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.847 2.059 . . . . 20.0 110.625 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.17 -95.21 0.9 Allowed Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.281 0.943 . . . . 20.0 111.607 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 -32.15 4.72 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.56 2.029 . . . . 20.0 113.554 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m -82.5 -177.98 6.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.081 0.94 . . . . 20.0 110.574 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -74.86 -31.95 61.77 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.792 1.237 . . . . 20.0 110.255 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 p -136.11 -55.02 0.76 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.456 1.502 . . . . 20.0 111.341 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -145.23 137.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.678 1.591 . . . . 20.0 108.836 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.2 t -125.98 155.05 42.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.528 1.531 . . . . 20.0 109.905 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.8 160.51 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.835 1.254 . . . . 20.0 110.826 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.08 35.6 0.99 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.998 1.481 . . . . 20.0 114.998 -164.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.0 16.35 1.52 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.856 1.428 . . . . 20.0 114.856 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.7 t -54.16 -40.22 67.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.773 1.229 . . . . 20.0 111.795 167.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -65.95 -20.22 66.13 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.004 1.112 . . . . 20.0 114.004 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.16 -48.43 7.4 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.623 1.169 . . . . 20.0 110.256 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 m -66.02 -26.25 67.44 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.819 1.648 . . . . 20.0 112.312 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 C-N-CA 126.067 1.794 . . . . 20.0 113.815 173.821 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 110.517 -0.179 . . . . 20.0 110.517 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -67.16 -37.71 84.21 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.987 1.315 . . . . 20.0 111.958 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 t -61.99 -44.7 96.18 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.918 0.887 . . . . 20.0 110.702 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.97 -38.18 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.978 1.311 . . . . 20.0 111.471 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -67.36 -31.78 72.26 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.002 0.819 . . . . 20.0 112.666 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -73.45 -3.19 25.96 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.22 1.808 . . . . 20.0 113.426 171.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.77 -4.87 69.1 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.419 1.485 . . . . 20.0 114.542 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.97 -174.39 4.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.642 1.177 . . . . 20.0 111.155 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.13 -176.19 14.38 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.194 1.378 . . . . 20.0 111.499 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.3 m -134.56 88.77 2.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.989 1.315 . . . . 20.0 108.328 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.71 161.89 10.41 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.817 1.647 . . . . 20.0 111.367 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.7 165.1 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.471 2.114 . . . . 20.0 111.188 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.31 4.6 4.43 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.917 1.687 . . . . 20.0 113.287 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.0 p -115.7 -4.38 12.19 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.859 2.063 . . . . 20.0 113.711 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.18 -27.57 1.59 Allowed 'General case' 0 C--N 1.346 0.452 0 N-CA-C 114.081 1.141 . . . . 20.0 114.081 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 t -58.24 106.14 0.65 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 126.516 1.926 . . . . 20.0 110.508 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.75 155.9 35.14 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.601 2.2 . . . . 20.0 111.297 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -68.44 -17.84 64.29 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.631 0.604 . . . . 20.0 112.631 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -76.73 -33.5 58.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.847 1.259 . . . . 20.0 112.541 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.84 -5.82 59.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.015 1.116 . . . . 20.0 114.015 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -57.06 117.98 4.55 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.55 1.14 . . . . 20.0 110.529 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.9 mt -75.67 172.07 13.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.615 0.766 . . . . 20.0 110.717 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -70.2 -2.88 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.855 1.262 . . . . 20.0 113.289 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.55 163.3 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.965 1.706 . . . . 20.0 111.471 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.07 77.94 0.24 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.5 1.524 . . . . 20.0 110.663 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.23 6.4 76.12 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.699 1.142 . . . . 20.0 115.547 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 m -130.17 -175.73 3.72 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.883 2.073 . . . . 20.0 110.126 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.1 p -90.48 -7.37 53.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.026 1.33 . . . . 20.0 112.656 -171.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 p -131.85 -63.3 0.83 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.309 1.444 . . . . 20.0 109.971 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.55 152.58 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.734 1.213 . . . . 20.0 111.08 -171.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -133.74 67.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.239 1.816 . . . . 20.0 108.266 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.96 131.23 40.51 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 123.997 0.919 . . . . 20.0 109.451 167.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.77 159.78 21.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.208 0.603 . . . . 20.0 111.518 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 pp -133.79 -6.51 2.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.015 1.117 . . . . 20.0 114.015 164.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 t -65.96 -29.84 70.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.809 0.844 . . . . 20.0 111.707 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -89.41 -25.26 21.62 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.937 1.295 . . . . 20.0 111.289 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.5 mt -72.66 -38.45 67.63 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.62 1.168 . . . . 20.0 111.386 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 t -89.77 -6.42 55.99 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.917 1.287 . . . . 20.0 112.654 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.954 1.74 . . . . 20.0 111.336 -179.524 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.463 0.173 . . . . 20.0 110.614 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -68.17 -45.17 74.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.449 1.5 . . . . 20.0 112.255 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.0 t -66.76 -44.33 81.72 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.796 1.238 . . . . 20.0 111.786 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.94 -18.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.139 1.376 . . . . 20.0 111.935 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.8 t -58.23 -42.15 85.68 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.755 1.222 . . . . 20.0 112.081 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -21.83 64.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.763 1.625 . . . . 20.0 112.942 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.54 -3.36 36.85 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.016 1.769 . . . . 20.0 113.937 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -70.45 168.64 15.71 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.554 1.177 . . . . 20.0 112.252 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.01 -175.32 50.63 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.188 1.375 . . . . 20.0 112.417 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 t -151.93 49.56 0.79 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.452 1.101 . . . . 20.0 109.274 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.07 153.87 16.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.829 1.251 . . . . 20.0 111.721 -173.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.59 170.67 19.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.404 2.736 . . . . 20.0 112.447 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -65.21 -4.07 4.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.687 1.995 . . . . 20.0 114.449 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.5 t -115.65 -11.56 11.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.562 1.545 . . . . 20.0 113.066 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.09 -26.53 5.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.1 -0.952 . . . . 20.0 113.233 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 t -65.23 107.21 1.31 Allowed Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.36 1.864 . . . . 20.0 109.605 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.22 152.45 50.33 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.323 2.015 . . . . 20.0 110.035 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.31 -25.66 68.41 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.668 1.187 . . . . 20.0 112.64 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.16 -31.63 49.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.932 1.293 . . . . 20.0 112.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.39 58.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.794 1.035 . . . . 20.0 113.794 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -60.71 117.21 5.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.361 1.064 . . . . 20.0 108.723 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.3 176.39 3.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.676 1.191 . . . . 20.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 t -69.95 -3.9 18.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.058 0.943 . . . . 20.0 113.023 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -138.88 169.18 18.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.55 1.94 . . . . 20.0 110.586 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.91 71.69 0.49 Allowed Glycine 0 C--N 1.341 0.809 0 C-N-CA 125.013 1.292 . . . . 20.0 111.259 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.12 -19.66 76.82 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.845 0.736 . . . . 20.0 114.103 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.32 174.55 9.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.576 1.15 . . . . 20.0 111.148 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.6 m -86.59 -5.66 59.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.663 1.185 . . . . 20.0 111.987 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -149.56 -53.15 0.16 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.849 1.26 . . . . 20.0 111.681 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.21 122.46 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.568 1.147 . . . . 20.0 111.505 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.4 t -106.24 82.94 1.82 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.339 2.256 . . . . 20.0 108.944 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.26 142.94 27.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.87 1.268 . . . . 20.0 111.098 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.93 170.25 16.97 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.92 0.888 . . . . 20.0 112.207 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.37 -5.79 8.79 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.732 1.613 . . . . 20.0 112.117 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 t -70.58 -19.75 62.83 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.194 1.398 . . . . 20.0 112.614 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -62.53 -22.02 65.98 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.889 1.276 . . . . 20.0 113.652 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.84 -56.4 10.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.562 1.145 . . . . 20.0 110.343 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 t -72.16 -10.71 60.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.321 1.048 . . . . 20.0 113.193 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 CA-C-O 116.323 -2.376 . . . . 20.0 113.613 177.195 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 110.22 -0.289 . . . . 20.0 110.22 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.87 -42.65 99.32 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.185 0.994 . . . . 20.0 111.553 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.9 t -61.8 -45.82 92.21 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.069 0.947 . . . . 20.0 111.272 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -67.14 -34.85 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.885 1.274 . . . . 20.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.5 m -66.94 -36.94 83.35 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.185 0.994 . . . . 20.0 111.865 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -73.46 -5.73 41.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.718 1.207 . . . . 20.0 113.158 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.04 85.2 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.885 1.231 . . . . 20.0 113.878 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -84.26 168.7 15.45 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.163 1.385 . . . . 20.0 112.117 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.11 167.86 24.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.387 0.994 . . . . 20.0 113.234 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.9 m -126.81 74.09 1.46 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.701 1.6 . . . . 20.0 108.388 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.04 162.23 40.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.776 1.231 . . . . 20.0 110.824 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.44 173.4 14.54 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.365 2.71 . . . . 20.0 110.959 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -66.67 -0.46 2.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.221 1.809 . . . . 20.0 113.733 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.6 p -125.96 -8.08 6.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.941 1.696 . . . . 20.0 114.583 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -128.9 -6.4 5.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.355 0.979 . . . . 20.0 113.222 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.0 t -76.92 116.08 53.98 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.847 0.859 . . . . 20.0 108.741 163.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.87 159.18 48.78 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.733 2.289 . . . . 20.0 110.443 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -63.54 -24.59 67.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.029 0.932 . . . . 20.0 112.259 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.46 -30.66 64.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.959 1.304 . . . . 20.0 112.43 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 -18.71 41.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.052 1.13 . . . . 20.0 114.052 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -60.85 120.5 10.27 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.895 1.278 . . . . 20.0 111.313 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.9 mt -82.4 171.11 14.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.449 1.099 . . . . 20.0 112.015 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -69.49 -12.62 61.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.27 1.428 . . . . 20.0 112.445 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -132.6 168.97 17.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.939 2.095 . . . . 20.0 110.838 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.61 71.56 0.49 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.625 1.583 . . . . 20.0 110.806 -173.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.58 -7.9 87.87 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.336 0.969 . . . . 20.0 114.853 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m -81.63 -168.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.516 1.526 . . . . 20.0 109.778 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.0 p -103.12 -6.53 22.13 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.664 1.185 . . . . 20.0 111.987 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.3 p -127.92 -74.48 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.005 2.122 . . . . 20.0 109.247 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 m -150.5 120.48 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.76 1.624 . . . . 20.0 109.119 -172.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.45 108.74 19.82 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.465 1.106 . . . . 20.0 109.257 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -126.16 113.17 16.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.169 1.387 . . . . 20.0 109.015 -168.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.57 172.25 3.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.059 1.344 . . . . 20.0 112.873 -172.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 69.6 mt -126.36 7.93 7.1 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.122 1.369 . . . . 20.0 111.932 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -64.07 -25.66 68.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.336 1.054 . . . . 20.0 113.329 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -65.06 -31.87 73.3 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 124.254 1.021 . . . . 20.0 111.906 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.8 mt -72.74 -14.83 61.64 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.568 1.147 . . . . 20.0 113.315 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.0 t -123.29 6.52 9.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.376 1.87 . . . . 20.0 111.077 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 CA-C-O 117.184 -1.898 . . . . 20.0 111.425 -176.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 109.806 -0.442 . . . . 20.0 109.806 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.55 -46.1 80.8 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.788 -0.625 . . . . 20.0 111.494 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.37 -32.6 71.45 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.765 0.654 . . . . 20.0 112.765 -177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.44 -46.17 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.19 1.396 . . . . 20.0 110.39 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -65.32 -29.4 70.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.14 1.376 . . . . 20.0 112.665 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -71.51 -6.05 37.64 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.546 1.938 . . . . 20.0 112.669 171.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.41 6.32 89.33 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.599 -1.111 . . . . 20.0 114.491 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -74.87 167.69 21.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.616 1.208 . . . . 20.0 111.694 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.64 128.26 9.43 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.083 0.849 . . . . 20.0 112.555 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.9 m -82.41 75.0 9.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.913 0.885 . . . . 20.0 108.752 163.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.36 162.96 36.49 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 20.0 110.975 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.66 167.85 25.58 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.818 2.346 . . . . 20.0 110.849 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -74.42 5.85 4.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.621 1.569 . . . . 20.0 113.727 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 t -129.57 12.84 5.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.865 1.666 . . . . 20.0 112.323 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -133.04 -45.93 0.85 Allowed 'General case' 0 C--N 1.346 0.42 0 C-N-CA 124.442 1.097 . . . . 20.0 112.513 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.21 104.31 0.42 Allowed Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 127.336 2.254 . . . . 20.0 111.807 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.78 145.4 36.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.682 2.255 . . . . 20.0 110.96 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -59.91 -26.82 66.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.521 0.934 . . . . 20.0 113.521 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.01 -29.93 70.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.627 1.571 . . . . 20.0 112.647 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.69 24.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.829 1.252 . . . . 20.0 113.64 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -61.23 120.09 9.69 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.754 1.161 . . . . 20.0 110.409 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.09 172.94 10.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.704 1.202 . . . . 20.0 111.773 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -69.85 -10.5 58.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.744 1.218 . . . . 20.0 112.215 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -139.34 172.95 12.07 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.344 2.257 . . . . 20.0 110.591 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.6 76.05 0.21 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.789 -0.924 . . . . 20.0 110.789 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.01 -13.33 66.59 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.841 1.21 . . . . 20.0 113.525 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.48 177.37 1.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.732 1.613 . . . . 20.0 111.244 167.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -93.65 -13.01 28.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.73 0.812 . . . . 20.0 112.798 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -135.39 -59.79 0.77 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.395 1.078 . . . . 20.0 110.819 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.9 m -148.22 153.62 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.652 1.581 . . . . 20.0 110.239 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.9 t -134.42 108.86 8.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.656 1.182 . . . . 20.0 109.502 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -102.46 137.22 41.0 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.133 0.973 . . . . 20.0 109.616 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.43 166.46 12.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.61 0.764 . . . . 20.0 111.618 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.17 7.7 9.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.004 1.722 . . . . 20.0 110.882 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 t -60.88 -28.55 68.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.882 2.073 . . . . 20.0 113.44 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.98 -14.92 63.34 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.404 1.261 . . . . 20.0 114.404 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.35 -60.58 2.47 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.153 0.981 . . . . 20.0 109.876 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 p -74.86 -10.49 59.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.935 1.294 . . . . 20.0 113.243 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.237 0 CA-C-O 116.818 -2.101 . . . . 20.0 111.89 -178.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 121.162 0.506 . . . . 20.0 111.657 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -67.09 -48.82 67.05 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.04 0.936 . . . . 20.0 111.561 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -26.8 68.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.009 0.744 . . . . 20.0 113.009 -175.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.9 t -83.48 -41.19 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.436 1.495 . . . . 20.0 110.766 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -60.81 -35.2 75.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.704 1.202 . . . . 20.0 111.995 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -69.32 -14.16 62.78 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.887 2.075 . . . . 20.0 113.233 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 16.91 77.29 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.653 -1.082 . . . . 20.0 114.601 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -59.87 165.59 3.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.6 1.16 . . . . 20.0 112.567 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.51 -33.83 67.59 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.1 1.333 . . . . 20.0 113.986 -175.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 t 50.67 37.22 15.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.146 1.779 . . . . 20.0 112.008 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.49 154.12 56.66 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.934 1.294 . . . . 20.0 111.821 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.17 171.24 11.74 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.746 2.964 . . . . 20.0 111.342 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.65 -22.54 66.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.176 0.99 . . . . 20.0 112.475 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -80.99 -3.76 52.8 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.245 1.818 . . . . 20.0 114.161 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.5 -42.9 1.29 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.141 1.376 . . . . 20.0 112.918 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.86 109.78 5.36 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.218 1.807 . . . . 20.0 110.601 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.6 170.33 15.89 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.552 2.835 . . . . 20.0 112.199 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -66.77 -12.96 60.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.362 1.465 . . . . 20.0 113.411 173.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -96.32 -29.31 14.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.335 1.054 . . . . 20.0 112.82 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.68 -5.4 21.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.483 1.113 . . . . 20.0 113.633 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -60.43 136.2 57.97 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.774 0.716 . . . . 20.0 110.872 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.17 172.04 13.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.29 1.036 . . . . 20.0 111.186 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -72.46 -9.13 58.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.779 0.832 . . . . 20.0 112.318 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.22 172.22 13.33 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.781 2.032 . . . . 20.0 110.973 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.58 67.14 0.39 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.658 1.123 . . . . 20.0 111.654 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.49 -7.42 87.09 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.128 1.347 . . . . 20.0 114.388 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.4 m -66.98 179.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.854 1.327 . . . . 20.0 111.378 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 t -68.62 -29.6 68.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.342 1.057 . . . . 20.0 111.543 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -158.85 -28.25 0.07 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 20.0 113.744 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 p -139.13 135.82 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.106 1.362 . . . . 20.0 110.241 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.2 t -133.64 139.28 46.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.063 1.345 . . . . 20.0 110.812 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.01 140.77 34.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.879 1.672 . . . . 20.0 109.2 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.06 166.78 18.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.209 0.604 . . . . 20.0 110.956 172.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.6 mt -128.99 0.42 5.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.715 1.606 . . . . 20.0 112.368 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 t -62.71 -25.03 67.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.948 1.299 . . . . 20.0 113.908 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 36' ' ' LYS . 10.7 mmpt? -67.3 -18.77 65.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.415 1.086 . . . . 20.0 113.144 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.86 -25.85 67.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.111 0.964 . . . . 20.0 112.823 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.3 p -119.19 1.59 11.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.225 1.81 . . . . 20.0 112.477 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.7 -1.611 . . . . 20.0 110.918 178.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.709 -0.478 . . . . 20.0 109.709 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -59.68 -41.41 90.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.126 1.37 . . . . 20.0 112.513 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -39.15 76.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.117 0.567 . . . . 20.0 111.743 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.36 -36.85 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.061 0.945 . . . . 20.0 110.685 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -65.49 -30.5 71.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.108 1.363 . . . . 20.0 112.056 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -80.32 -12.02 59.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.719 1.608 . . . . 20.0 113.026 171.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.0 12.85 56.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.742 1.163 . . . . 20.0 114.928 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -89.18 167.56 13.0 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.832 1.316 . . . . 20.0 112.781 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.7 -175.87 47.0 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.991 1.281 . . . . 20.0 113.363 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 t -138.28 65.52 1.46 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.119 1.367 . . . . 20.0 109.133 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.57 156.15 78.75 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.38 1.472 . . . . 20.0 110.81 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.46 164.37 35.49 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.178 2.586 . . . . 20.0 110.937 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -64.9 -22.84 67.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.654 0.782 . . . . 20.0 112.993 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.7 m -82.79 -3.76 57.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.909 1.284 . . . . 20.0 113.626 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -129.55 0.92 5.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.336 1.454 . . . . 20.0 112.574 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -128.65 80.93 71.72 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.944 1.297 . . . . 20.0 110.443 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.14 175.41 10.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.176 3.251 . . . . 20.0 112.159 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -67.39 -6.89 21.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.735 1.013 . . . . 20.0 113.735 172.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -86.19 -25.1 25.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.915 1.286 . . . . 20.0 112.396 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.27 -7.77 14.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.447 1.499 . . . . 20.0 113.43 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.56 165.34 8.16 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.352 1.061 . . . . 20.0 112.168 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.9 mt -133.94 166.21 23.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.205 1.002 . . . . 20.0 111.599 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -82.67 -9.64 59.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.043 1.337 . . . . 20.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -109.27 2.76 21.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.931 1.692 . . . . 20.0 113.639 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -36.55 87.23 0.01 OUTLIER Glycine 0 CA--C 1.529 0.909 1 C-N-CA 130.987 4.137 . . . . 20.0 115.506 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.62 0.63 63.29 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.069 1.319 . . . . 20.0 113.963 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.7 m -66.54 173.48 3.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 20.0 111.728 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -86.63 -16.1 37.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.887 0.875 . . . . 20.0 111.923 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -132.16 -61.36 0.88 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.373 1.469 . . . . 20.0 110.302 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.5 m -152.18 153.01 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.967 1.307 . . . . 20.0 111.002 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.6 t -131.92 137.01 47.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.988 1.715 . . . . 20.0 109.251 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.3 m -137.21 156.35 48.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.715 1.206 . . . . 20.0 111.089 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.55 126.02 30.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.495 1.118 . . . . 20.0 112.571 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.8 mt -117.87 8.88 12.73 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.836 1.655 . . . . 20.0 113.155 168.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -64.15 -19.21 65.14 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.498 1.045 . . . . 20.0 112.085 171.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -65.24 -14.72 61.37 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.194 1.398 . . . . 20.0 114.042 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.21 -45.13 74.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.972 0.806 . . . . 20.0 110.745 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 p -82.12 -7.52 59.62 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.239 1.416 . . . . 20.0 113.492 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.308 -1.829 . . . . 20.0 111.498 179.019 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.356 -0.238 . . . . 20.0 110.356 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.23 -63.25 1.32 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.719 0.808 . . . . 20.0 110.883 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.4 m -61.29 -45.6 93.8 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 123.593 0.757 . . . . 20.0 112.552 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.36 -32.98 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.194 0.598 . . . . 20.0 111.394 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -67.35 -34.32 77.06 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.524 0.73 . . . . 20.0 111.794 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -9.51 58.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.362 1.065 . . . . 20.0 113.524 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.87 -2.4 84.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.757 1.17 . . . . 20.0 113.911 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -71.19 176.13 4.74 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.603 1.201 . . . . 20.0 110.852 168.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.14 -172.91 15.14 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 123.862 0.744 . . . . 20.0 112.818 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -117.68 82.01 1.76 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.447 1.499 . . . . 20.0 109.155 -173.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 151.8 81.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.185 0.994 . . . . 20.0 109.295 170.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.77 167.74 24.88 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.379 2.719 . . . . 20.0 111.598 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.24 -9.65 42.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.963 1.305 . . . . 20.0 113.272 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -95.63 -13.51 24.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.83 1.652 . . . . 20.0 113.548 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -137.55 20.17 2.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.059 1.344 . . . . 20.0 112.587 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 t -127.74 77.64 75.97 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.152 1.381 . . . . 20.0 109.354 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.34 171.11 18.68 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.068 3.179 . . . . 20.0 112.159 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -63.69 -13.35 42.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.799 1.64 . . . . 20.0 113.756 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.3 -25.98 25.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.75 1.22 . . . . 20.0 112.811 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.66 -8.21 14.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.3 1.44 . . . . 20.0 113.345 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -65.79 170.0 5.83 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.278 1.031 . . . . 20.0 111.789 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.8 mt -130.97 168.42 17.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 20.0 110.248 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -74.04 -19.93 60.46 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.237 1.015 . . . . 20.0 111.913 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -73.9 167.07 22.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.971 1.708 . . . . 20.0 111.675 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.12 87.31 0.12 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.923 0.773 . . . . 20.0 111.662 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.16 3.1 79.88 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.05 1.309 . . . . 20.0 114.172 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.0 m -131.93 -12.33 3.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.632 1.573 . . . . 20.0 114.762 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.3 p 64.79 6.8 3.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 130.889 3.676 . . . . 20.0 113.429 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.3 p -122.53 -57.18 1.76 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.78 1.232 . . . . 20.0 110.772 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.06 135.53 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 126.147 1.779 . . . . 20.0 109.402 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.4 t -145.42 121.71 10.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.839 1.656 . . . . 20.0 109.156 171.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 9.5 m -129.02 148.46 50.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.379 1.471 . . . . 20.0 110.414 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -73.26 107.64 5.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.797 1.239 . . . . 20.0 110.446 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 pp -101.14 -16.07 17.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.157 1.783 . . . . 20.0 112.367 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 t -66.51 -19.54 65.81 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.008 1.323 . . . . 20.0 112.614 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -56.63 -19.59 17.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.372 1.869 . . . . 20.0 114.558 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -66.64 -31.75 72.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.739 1.216 . . . . 20.0 113.47 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.3 m -123.69 -43.43 2.14 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.541 1.536 . . . . 20.0 110.064 -172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 117.297 -1.835 . . . . 20.0 110.284 179.353 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 120.641 0.257 . . . . 20.0 111.045 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -60.16 -58.07 10.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.69 1.596 . . . . 20.0 112.065 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -61.6 -36.46 80.76 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.87 0.692 . . . . 20.0 112.87 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.55 -37.41 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 124.131 0.972 . . . . 20.0 110.484 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.6 t -66.98 -30.53 70.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.257 1.023 . . . . 20.0 111.91 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.11 -2.07 46.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.138 1.375 . . . . 20.0 112.564 171.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.88 -5.01 84.95 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.903 1.716 . . . . 20.0 114.961 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -76.39 168.32 20.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.783 1.292 . . . . 20.0 112.14 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.14 170.93 32.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.639 1.114 . . . . 20.0 112.51 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.0 m -126.0 68.65 1.19 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.669 1.588 . . . . 20.0 107.936 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.66 161.47 65.77 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.999 1.72 . . . . 20.0 110.746 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.45 164.76 34.66 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.599 2.2 . . . . 20.0 111.329 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -66.94 -6.97 18.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.675 1.59 . . . . 20.0 113.738 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -121.05 -5.3 9.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.736 1.615 . . . . 20.0 113.964 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -105.58 -42.39 5.21 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.229 0.922 . . . . 20.0 112.026 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.6 115.46 27.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.39 1.076 . . . . 20.0 109.863 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.24 160.62 35.91 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.547 2.164 . . . . 20.0 110.381 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -63.9 -16.93 62.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.871 1.268 . . . . 20.0 112.643 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -70.6 -25.89 63.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.912 1.285 . . . . 20.0 112.669 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.79 2.74 10.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.858 1.663 . . . . 20.0 113.461 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.02 151.34 40.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.892 0.877 . . . . 20.0 109.821 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.6 mt -95.15 166.86 11.71 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.423 0.63 . . . . 20.0 110.214 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -74.15 -3.07 27.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.01 0.924 . . . . 20.0 112.32 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -143.78 169.11 18.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.687 1.995 . . . . 20.0 110.808 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.76 79.64 0.37 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 125.082 1.325 . . . . 20.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 -3.05 65.37 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.079 0.847 . . . . 20.0 114.247 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.1 m -85.08 -166.48 1.51 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.9 2.08 . . . . 20.0 110.314 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 t -91.62 -18.15 24.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.938 0.895 . . . . 20.0 112.479 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.7 p -134.22 -61.7 0.77 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.417 1.087 . . . . 20.0 110.622 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -150.09 157.92 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.301 1.84 . . . . 20.0 109.648 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.1 t -125.73 151.95 45.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.309 1.444 . . . . 20.0 110.176 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -137.78 125.96 23.03 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.653 0.781 . . . . 20.0 110.812 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 147.24 46.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.712 1.205 . . . . 20.0 110.052 169.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 41.8 mt -126.38 -3.92 6.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.263 1.425 . . . . 20.0 111.902 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.2 t -69.57 -18.72 63.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.528 1.131 . . . . 20.0 113.089 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -21.88 66.6 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.343 1.057 . . . . 20.0 112.994 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.41 -17.66 61.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.765 1.226 . . . . 20.0 113.242 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.5 t -117.85 4.01 12.21 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.706 1.602 . . . . 20.0 111.804 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 117.853 -1.526 . . . . 20.0 110.859 177.27 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.477 -0.194 . . . . 20.0 110.477 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.15 -33.22 74.08 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.677 1.191 . . . . 20.0 112.399 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.5 m -58.25 -52.1 67.0 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.018 1.327 . . . . 20.0 109.997 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.8 -40.14 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.287 1.435 . . . . 20.0 111.171 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -62.32 -41.32 98.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.443 1.097 . . . . 20.0 111.756 -176.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -83.07 -7.31 59.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.331 1.052 . . . . 20.0 113.336 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.72 79.02 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.597 1.094 . . . . 20.0 114.955 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -65.37 164.74 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.043 1.422 . . . . 20.0 111.831 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.97 178.72 53.38 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 121.994 0.774 . . . . 20.0 112.103 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.6 t -150.34 76.81 1.28 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.118 -1.438 . . . . 20.0 107.118 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 157.44 86.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.841 1.257 . . . . 20.0 110.919 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.66 174.39 8.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.951 3.101 . . . . 20.0 111.352 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -16.67 34.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.571 1.148 . . . . 20.0 113.124 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 m -89.11 -11.02 45.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.711 1.604 . . . . 20.0 113.862 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.11 -0.88 4.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.896 1.678 . . . . 20.0 113.199 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -120.33 77.51 26.07 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.921 1.288 . . . . 20.0 109.406 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.15 170.57 19.53 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.533 2.822 . . . . 20.0 110.963 175.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -60.56 -26.02 66.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.397 1.079 . . . . 20.0 112.753 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.63 -46.26 72.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.758 1.623 . . . . 20.0 111.859 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.78 -4.54 56.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.749 1.219 . . . . 20.0 113.929 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -60.4 145.3 48.54 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.321 1.049 . . . . 20.0 111.618 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.81 173.75 9.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.835 1.254 . . . . 20.0 111.51 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 t -65.02 -14.13 59.65 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.634 1.574 . . . . 20.0 112.737 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.18 168.12 20.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.419 2.287 . . . . 20.0 110.269 -174.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.67 85.18 0.17 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 124.465 1.031 . . . . 20.0 111.305 -170.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.67 -13.37 80.09 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.557 1.075 . . . . 20.0 115.01 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.4 m -80.82 -179.71 7.41 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.548 1.139 . . . . 20.0 111.294 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -93.78 -9.83 36.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.9 1.28 . . . . 20.0 111.987 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.5 p -133.13 -65.61 0.69 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.982 1.313 . . . . 20.0 109.736 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.84 156.14 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.363 1.465 . . . . 20.0 110.507 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -144.37 115.95 8.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.186 1.394 . . . . 20.0 109.35 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.84 136.73 51.83 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.215 1.006 . . . . 20.0 111.93 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.73 124.83 28.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.36 1.464 . . . . 20.0 109.464 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.82 -8.05 10.38 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.685 1.594 . . . . 20.0 112.942 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.0 t -70.56 -15.51 62.78 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.598 1.559 . . . . 20.0 112.489 174.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -60.55 -21.05 62.13 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.377 1.071 . . . . 20.0 112.908 167.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.31 -56.18 2.36 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.93 1.692 . . . . 20.0 109.396 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.9 p -87.14 68.99 10.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.622 1.569 . . . . 20.0 110.123 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.389 -1.784 . . . . 20.0 110.955 177.674 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.483 0.182 . . . . 20.0 111.058 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -125.23 -51.09 1.65 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.358 1.463 . . . . 20.0 111.21 -172.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.0 t -66.71 -26.82 67.19 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.407 0.549 . . . . 20.0 111.774 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.6 t -73.74 -25.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.655 1.182 . . . . 20.0 111.16 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -67.9 -32.78 73.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.46 0.704 . . . . 20.0 111.916 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -67.94 -20.73 65.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.286 1.034 . . . . 20.0 112.711 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.69 -2.34 21.61 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.087 1.803 . . . . 20.0 114.132 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -77.8 175.99 9.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.583 1.192 . . . . 20.0 112.587 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -23.45 30.48 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.295 -0.725 . . . . 20.0 114.206 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.9 t 49.92 49.56 20.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.086 1.754 . . . . 20.0 112.523 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.08 155.21 84.8 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.532 1.133 . . . . 20.0 111.291 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.13 169.98 21.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.505 2.803 . . . . 20.0 112.306 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -69.34 8.7 0.56 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.465 1.906 . . . . 20.0 114.036 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.3 p -120.03 -6.31 9.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.337 1.855 . . . . 20.0 113.122 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -136.73 -17.76 1.44 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 113.842 1.053 . . . . 20.0 113.842 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -85.68 114.75 58.42 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.067 0.947 . . . . 20.0 109.616 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.21 162.9 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.772 2.315 . . . . 20.0 111.741 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -70.96 -6.42 38.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.363 1.465 . . . . 20.0 114.313 -173.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.42 -32.11 10.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.775 1.23 . . . . 20.0 111.848 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.16 -21.28 39.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 113.818 1.044 . . . . 20.0 113.818 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -63.4 157.47 23.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.011 0.924 . . . . 20.0 111.804 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.67 162.98 12.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.154 1.381 . . . . 20.0 110.408 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -83.22 -3.89 57.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.377 1.071 . . . . 20.0 111.677 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -148.93 176.19 10.63 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.733 2.013 . . . . 20.0 111.069 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.29 -166.29 30.04 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.133 0.873 . . . . 20.0 112.317 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.82 7.69 4.19 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.499 1.523 . . . . 20.0 114.047 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.9 173.53 5.27 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.801 1.24 . . . . 20.0 111.918 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.2 t -96.76 -5.43 38.59 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.119 1.367 . . . . 20.0 112.544 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.2 t -147.27 -49.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.278 1.031 . . . . 20.0 111.76 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -162.94 145.01 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.975 1.71 . . . . 20.0 108.164 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.1 t -114.27 151.76 32.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.285 1.034 . . . . 20.0 110.567 166.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.82 129.04 22.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.127 1.371 . . . . 20.0 109.574 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.16 137.44 33.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.156 0.982 . . . . 20.0 110.445 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.9 mt -111.16 0.68 16.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.502 1.521 . . . . 20.0 112.633 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -60.15 -32.08 70.7 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.075 0.95 . . . . 20.0 111.917 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -68.44 -31.3 70.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.227 1.411 . . . . 20.0 112.284 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.1 mt -70.42 -48.85 54.08 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.142 0.977 . . . . 20.0 111.054 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 t -75.07 -4.68 39.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.55 1.14 . . . . 20.0 113.06 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 117.695 -1.614 . . . . 20.0 110.602 174.528 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.511 -0.551 . . . . 20.0 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -62.14 -30.96 71.4 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.985 0.914 . . . . 20.0 112.741 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -50.46 53.59 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.359 0.664 . . . . 20.0 110.555 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.46 -32.24 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.589 1.156 . . . . 20.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.4 t -64.03 -39.79 94.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.503 1.121 . . . . 20.0 111.56 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -72.47 -6.0 40.67 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.689 1.196 . . . . 20.0 113.262 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.53 4.22 64.15 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.338 1.447 . . . . 20.0 114.625 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -77.45 171.22 15.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.55 1.14 . . . . 20.0 112.069 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.97 177.8 31.68 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.262 1.41 . . . . 20.0 113.136 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -133.6 69.17 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.84 1.656 . . . . 20.0 107.451 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.43 159.84 47.18 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.973 1.709 . . . . 20.0 110.914 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.54 166.0 30.95 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.846 2.364 . . . . 20.0 111.0 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -67.72 -19.71 65.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.87 1.268 . . . . 20.0 112.786 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -83.69 -16.97 42.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.992 1.317 . . . . 20.0 113.062 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -124.84 5.45 8.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.285 1.434 . . . . 20.0 113.157 -174.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -120.08 78.15 24.8 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.092 0.957 . . . . 20.0 110.43 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.82 172.68 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.536 2.824 . . . . 20.0 111.7 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -65.19 -13.36 58.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.516 1.127 . . . . 20.0 113.33 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.41 -32.56 20.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.042 1.337 . . . . 20.0 112.215 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 -18.33 22.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.28 1.032 . . . . 20.0 113.454 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -70.04 155.48 40.53 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 118.606 0.639 . . . . 20.0 110.6 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.11 177.45 6.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.051 0.94 . . . . 20.0 110.204 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -68.73 -21.93 64.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.333 0.653 . . . . 20.0 111.835 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.21 171.4 14.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.294 1.838 . . . . 20.0 111.66 -168.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.98 177.36 31.01 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.239 0.923 . . . . 20.0 112.812 175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.96 21.58 0.59 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.083 1.325 . . . . 20.0 113.367 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -63.13 176.87 0.68 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.374 1.469 . . . . 20.0 112.234 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -69.22 -29.63 67.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.724 1.209 . . . . 20.0 111.47 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 t -143.5 -41.31 0.29 Allowed 'General case' 0 C--N 1.344 0.354 0 CA-C-O 117.944 -1.027 . . . . 20.0 113.435 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -153.88 151.79 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.538 1.135 . . . . 20.0 109.68 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -118.93 135.17 54.73 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 125.474 1.51 . . . . 20.0 109.226 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -131.94 148.16 52.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.984 1.314 . . . . 20.0 110.039 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -74.73 166.28 23.85 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.611 -0.722 . . . . 20.0 111.476 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt -124.43 11.49 8.66 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.407 1.483 . . . . 20.0 111.521 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.0 t -63.9 -19.7 65.29 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.815 1.646 . . . . 20.0 113.449 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -63.13 -24.93 68.12 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.628 1.171 . . . . 20.0 113.498 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.4 mt -77.48 -43.46 32.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.323 1.049 . . . . 20.0 110.882 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -82.66 70.53 9.65 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.015 1.726 . . . . 20.0 110.255 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.145 -1.919 . . . . 20.0 111.204 176.636 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 27' ' ' CYS . 19.1 t-20 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.636 -0.505 . . . . 20.0 109.636 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -66.64 -32.92 74.55 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.706 0.803 . . . . 20.0 112.756 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t -70.59 -43.4 69.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.392 0.277 . . . . 20.0 110.4 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.4 -39.92 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.048 1.339 . . . . 20.0 111.161 173.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -68.1 -32.05 72.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.267 1.027 . . . . 20.0 112.35 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -75.28 -9.95 59.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.63 1.572 . . . . 20.0 112.479 171.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.11 -2.96 69.39 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.254 1.407 . . . . 20.0 114.572 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -77.14 170.19 16.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.762 1.281 . . . . 20.0 111.72 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.54 160.13 23.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.907 0.765 . . . . 20.0 113.067 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.1 m -124.35 65.78 1.07 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.866 1.666 . . . . 20.0 109.189 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 mt -65.43 163.22 34.85 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.88 1.272 . . . . 20.0 111.512 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.62 170.93 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.036 2.491 . . . . 20.0 110.753 168.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -60.69 -27.05 67.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.429 1.092 . . . . 20.0 112.505 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -74.31 -10.6 59.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.861 1.264 . . . . 20.0 113.847 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.96 -5.27 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.044 1.338 . . . . 20.0 113.174 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.9 t -124.19 83.49 56.36 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.219 1.408 . . . . 20.0 109.809 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.89 173.48 14.43 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.966 3.11 . . . . 20.0 111.933 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -14.81 56.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 20.0 113.048 173.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.78 -29.26 50.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.138 . . . . 20.0 112.909 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.68 -8.68 14.92 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.457 1.103 . . . . 20.0 113.477 -170.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -70.22 159.63 33.65 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.522 0.729 . . . . 20.0 112.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.11 176.91 5.39 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.878 1.271 . . . . 20.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -70.58 -4.96 25.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.841 1.256 . . . . 20.0 113.187 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -139.98 176.29 8.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.152 1.781 . . . . 20.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.4 72.91 0.36 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.688 1.137 . . . . 20.0 111.96 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.42 -18.88 79.94 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.83 -0.983 . . . . 20.0 114.103 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.451 ' HA ' HD21 ' A' ' 1' ' ' ASN . 83.5 m -70.16 179.68 2.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.938 1.295 . . . . 20.0 112.52 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.2 m -86.09 -8.77 57.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.955 1.302 . . . . 20.0 112.264 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 t -148.53 -52.62 0.18 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.863 -1.065 . . . . 20.0 111.845 170.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.13 145.31 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.328 0.967 . . . . 20.0 112.012 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.6 t -122.85 112.28 17.69 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.959 2.103 . . . . 20.0 109.309 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -121.02 142.71 49.55 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.101 1.361 . . . . 20.0 111.726 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.73 137.99 31.92 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.182 1.393 . . . . 20.0 109.947 172.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.9 mt -124.84 14.43 8.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.19 2.196 . . . . 20.0 111.891 -169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.7 t -59.94 -17.63 39.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.791 2.036 . . . . 20.0 114.961 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -63.84 -22.12 66.77 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.473 1.033 . . . . 20.0 112.706 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.6 mt -117.14 -72.39 0.69 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.811 2.045 . . . . 20.0 109.096 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.1 p -86.08 68.3 10.25 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.979 1.712 . . . . 20.0 109.687 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.212 -1.882 . . . . 20.0 110.395 176.717 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 110.132 -0.321 . . . . 20.0 110.132 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -59.54 -46.75 87.97 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 121.889 -0.507 . . . . 20.0 112.288 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t -56.28 -48.07 77.36 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.605 1.162 . . . . 20.0 111.212 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.06 -39.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.622 1.169 . . . . 20.0 111.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.6 t -67.73 -32.72 73.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 20.0 112.603 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -70.33 -13.02 61.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.153 1.381 . . . . 20.0 112.483 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.4 61.09 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.362 1.458 . . . . 20.0 114.163 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -79.04 171.64 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.671 1.235 . . . . 20.0 111.672 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.54 176.62 41.64 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.169 1.366 . . . . 20.0 112.259 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -141.16 56.45 1.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.906 -1.146 . . . . 20.0 107.906 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.24 157.5 12.12 Favored Pre-proline 0 C--N 1.345 0.375 0 C-N-CA 125.601 1.56 . . . . 20.0 111.666 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.36 167.51 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.822 2.348 . . . . 20.0 110.513 173.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -62.32 -22.12 65.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.558 0.743 . . . . 20.0 112.451 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p -84.41 -12.55 54.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.216 1.806 . . . . 20.0 114.441 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -4.41 11.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.189 1.395 . . . . 20.0 112.977 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 t -116.45 80.76 10.38 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.16 1.384 . . . . 20.0 108.824 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.07 170.73 18.26 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.654 2.903 . . . . 20.0 111.665 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -58.51 -28.78 65.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.708 1.603 . . . . 20.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.22 -40.43 64.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.832 1.253 . . . . 20.0 112.169 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.2 -5.66 57.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.934 1.087 . . . . 20.0 113.934 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -61.96 140.09 58.35 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.883 0.873 . . . . 20.0 110.957 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mt -75.86 173.04 11.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.115 0.96 . . . . 20.0 110.743 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -66.94 -12.62 60.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.373 1.069 . . . . 20.0 112.691 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.05 165.65 26.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.075 2.15 . . . . 20.0 110.869 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.65 86.79 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 125.798 1.666 . . . . 20.0 110.404 -172.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.5 1.37 60.18 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 118.448 -1.196 . . . . 20.0 115.575 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.1 m -97.42 174.35 6.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.643 1.177 . . . . 20.0 110.791 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -88.05 -5.13 58.65 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.403 1.081 . . . . 20.0 112.178 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 t -137.53 -61.26 0.64 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.676 1.591 . . . . 20.0 110.362 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -150.82 135.79 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.318 1.047 . . . . 20.0 110.952 -171.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.9 t -120.51 115.31 23.2 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.5 1.92 . . . . 20.0 109.146 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 m -126.12 146.7 49.83 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.776 1.63 . . . . 20.0 109.916 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.93 164.96 24.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.957 0.503 . . . . 20.0 111.82 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.45 6.04 10.63 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.364 1.466 . . . . 20.0 111.861 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.8 t -71.03 -9.79 58.64 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.551 0.945 . . . . 20.0 113.551 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -69.01 -27.64 65.86 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 119.166 0.894 . . . . 20.0 112.134 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.67 -45.16 83.93 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.687 0.795 . . . . 20.0 110.759 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.3 p -78.19 -12.73 60.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.928 1.291 . . . . 20.0 112.856 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.299 0 CA-C-O 117.8 -1.555 . . . . 20.0 112.334 174.705 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.573 0.225 . . . . 20.0 111.134 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -73.02 -46.02 54.4 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.122 0.969 . . . . 20.0 112.539 -175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.9 t -72.02 -25.5 61.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.389 0.676 . . . . 20.0 112.686 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.83 -36.42 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.729 0.812 . . . . 20.0 109.62 173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.0 m -69.32 -13.46 62.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.631 1.173 . . . . 20.0 113.249 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -69.6 -10.04 56.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.347 1.059 . . . . 20.0 112.085 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.15 -3.06 56.74 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.558 1.551 . . . . 20.0 113.791 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.07 -96.59 0.11 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.296 1.048 . . . . 20.0 109.583 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.37 -155.06 25.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.303 1.43 . . . . 20.0 111.188 -170.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -149.89 145.11 26.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.749 1.22 . . . . 20.0 109.378 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mp -123.55 160.58 50.19 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.581 . . . . 20.0 110.152 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.82 171.79 16.75 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.163 3.242 . . . . 20.0 112.705 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -67.96 -2.13 6.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.855 2.462 . . . . 20.0 114.298 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.9 m -130.06 5.63 4.94 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.564 1.546 . . . . 20.0 112.933 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -136.04 9.59 3.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.552 1.141 . . . . 20.0 112.896 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.9 t -115.59 80.72 8.38 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 20.0 109.361 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.8 161.53 43.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.238 2.625 . . . . 20.0 110.705 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -58.77 -28.5 65.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.086 1.354 . . . . 20.0 113.106 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.8 -44.88 84.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.925 1.29 . . . . 20.0 111.789 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.28 -8.07 59.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.7 1.2 . . . . 20.0 113.848 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -62.74 141.9 58.38 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.338 0.972 . . . . 20.0 110.579 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.67 170.23 15.67 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.305 0.574 . . . . 20.0 110.874 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 t -66.89 -11.24 55.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.397 1.079 . . . . 20.0 112.381 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -144.68 165.65 27.45 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.575 2.35 . . . . 20.0 110.291 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.24 -169.67 15.05 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.481 1.515 . . . . 20.0 112.153 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.68 -7.22 0.33 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.891 1.234 . . . . 20.0 113.523 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 m -73.15 -179.1 3.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.457 1.503 . . . . 20.0 113.043 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -65.58 -30.14 70.83 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.49 1.516 . . . . 20.0 111.393 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -155.55 -38.28 0.09 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.152 0.981 . . . . 20.0 113.009 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m -140.5 139.85 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.328 0.967 . . . . 20.0 111.056 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 14.6 t -129.68 131.21 46.31 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.165 1.386 . . . . 20.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.0 m -133.09 148.0 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.049 1.739 . . . . 20.0 109.601 176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -70.39 148.77 48.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.051 0.94 . . . . 20.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -102.19 -6.21 23.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.834 0.854 . . . . 20.0 112.279 172.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 t -64.55 -29.88 70.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.269 1.028 . . . . 20.0 111.941 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -62.4 -32.55 73.4 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.159 1.384 . . . . 20.0 112.958 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.02 -44.41 65.91 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.486 1.114 . . . . 20.0 111.013 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 p -77.72 -20.36 53.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.016 1.327 . . . . 20.0 113.015 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 116.98 -2.011 . . . . 20.0 113.542 173.196 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.712 -0.477 . . . . 20.0 109.712 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.12 -26.53 68.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.25 1.02 . . . . 20.0 112.833 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -60.03 -62.46 1.85 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.38 1.072 . . . . 20.0 108.936 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.21 -27.38 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.02 1.728 . . . . 20.0 112.15 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -60.0 -44.61 94.44 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.718 1.207 . . . . 20.0 111.695 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -85.88 -5.11 59.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.74 1.216 . . . . 20.0 113.423 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.96 -7.44 57.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.7 1.619 . . . . 20.0 114.918 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.11 171.03 6.04 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.339 1.456 . . . . 20.0 111.932 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.09 -167.09 13.18 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.658 1.123 . . . . 20.0 113.293 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.02 83.56 1.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.57 1.948 . . . . 20.0 107.874 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.3 mp -66.97 159.84 73.7 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.844 1.258 . . . . 20.0 110.233 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -69.47 162.75 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 20.0 110.977 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -69.72 3.92 2.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.742 1.617 . . . . 20.0 113.464 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.5 t -113.3 -0.68 14.48 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.997 2.119 . . . . 20.0 112.616 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.21 0.11 2.54 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.187 1.181 . . . . 20.0 114.187 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.5 t -111.39 110.22 55.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.171 0.989 . . . . 20.0 110.758 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.57 158.9 55.56 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.877 2.384 . . . . 20.0 111.119 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.21 -23.95 66.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.746 1.218 . . . . 20.0 113.534 -171.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -83.37 -30.97 26.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.324 1.45 . . . . 20.0 112.246 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.42 -11.97 58.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.723 1.209 . . . . 20.0 112.968 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -71.37 108.36 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.307 1.443 . . . . 20.0 109.219 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.91 159.63 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.957 0.903 . . . . 20.0 110.89 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -77.47 1.09 20.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.903 1.281 . . . . 20.0 113.165 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.2 170.0 18.81 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.752 1.621 . . . . 20.0 111.148 -172.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.82 171.56 21.71 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.29 0.947 . . . . 20.0 113.055 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.26 -16.18 38.68 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.681 1.134 . . . . 20.0 113.332 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.0 m -72.71 175.21 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.372 1.086 . . . . 20.0 110.587 168.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.2 t -126.82 8.63 6.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.003 1.321 . . . . 20.0 111.92 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -126.58 -64.28 1.03 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.298 1.439 . . . . 20.0 109.404 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.69 156.91 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.932 1.693 . . . . 20.0 110.151 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.5 t -142.12 82.72 1.81 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.257 2.223 . . . . 20.0 107.082 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 152.64 40.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.819 -0.628 . . . . 20.0 111.613 -173.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -102.18 104.61 15.2 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.734 1.214 . . . . 20.0 110.129 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -114.89 3.77 14.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.585 2.754 . . . . 20.0 112.153 169.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.7 t -63.6 -24.44 67.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.247 1.019 . . . . 20.0 111.072 165.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -71.37 -21.26 62.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.062 1.345 . . . . 20.0 113.082 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.0 mt -91.2 -41.51 10.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.849 1.26 . . . . 20.0 112.113 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.2 t -143.59 -22.23 0.59 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.251 1.021 . . . . 20.0 113.638 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 116.516 -2.269 . . . . 20.0 112.676 -177.774 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.607 -0.146 . . . . 20.0 110.607 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -65.87 -53.16 43.37 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.515 0.726 . . . . 20.0 111.6 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 m -63.87 -38.2 90.22 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 118.888 -0.577 . . . . 20.0 112.236 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.0 t -67.04 -39.71 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.68 0.792 . . . . 20.0 110.741 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -62.72 -35.5 79.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.38 1.072 . . . . 20.0 111.662 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -81.1 -4.97 57.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.856 1.662 . . . . 20.0 113.302 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.54 85.53 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.784 1.183 . . . . 20.0 114.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -75.54 174.84 9.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.391 1.476 . . . . 20.0 111.487 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.63 173.09 16.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.973 0.797 . . . . 20.0 114.139 -174.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 75.8 m -126.28 72.15 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.711 . . . . 20.0 109.239 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.2 mt -68.33 162.02 64.61 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.873 1.269 . . . . 20.0 111.514 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.23 169.8 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.488 2.792 . . . . 20.0 110.665 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.95 -21.17 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.888 0.699 . . . . 20.0 112.888 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 t -65.26 -54.51 28.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.49 1.516 . . . . 20.0 111.21 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.51 -7.63 57.36 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.755 1.02 . . . . 20.0 113.755 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -115.86 81.07 9.31 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.82 1.248 . . . . 20.0 110.322 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.69 172.96 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.926 3.084 . . . . 20.0 112.477 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.03 -7.41 22.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.567 1.547 . . . . 20.0 113.52 174.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.24 -28.1 17.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.308 1.443 . . . . 20.0 112.209 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.08 -11.11 19.11 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 20.0 113.851 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -59.99 139.56 57.34 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.182 0.993 . . . . 20.0 111.291 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.35 165.65 17.08 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.339 0.59 . . . . 20.0 110.423 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.3 t -76.49 -7.61 55.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.834 0.854 . . . . 20.0 112.321 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.23 173.24 11.7 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.402 2.281 . . . . 20.0 110.488 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.67 171.1 32.41 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 121.559 0.533 . . . . 20.0 113.713 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.85 20.53 2.52 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.525 1.536 . . . . 20.0 112.847 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -68.17 179.21 1.61 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.706 1.202 . . . . 20.0 110.698 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.3 t -84.5 -21.74 30.48 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.034 0.534 . . . . 20.0 111.814 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -136.5 -60.35 0.71 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.72 1.208 . . . . 20.0 111.048 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.1 153.99 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.39 1.476 . . . . 20.0 110.476 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.12 132.08 41.26 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.213 1.405 . . . . 20.0 110.371 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.4 m -130.96 144.14 51.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.114 1.366 . . . . 20.0 110.37 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -74.19 103.96 4.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.16 0.984 . . . . 20.0 109.405 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.4 pp -113.05 0.44 15.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.092 1.757 . . . . 20.0 112.543 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -61.65 -23.23 65.93 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.288 1.835 . . . . 20.0 113.376 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -62.42 -48.2 80.74 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.322 1.049 . . . . 20.0 111.511 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.6 mt -78.15 -55.32 5.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.275 1.43 . . . . 20.0 110.437 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . 0.258 12.5 t 41.47 44.11 2.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.218 2.607 . . . . 20.0 113.951 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 C-N-CA 124.97 1.271 . . . . 20.0 113.392 -175.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 109.857 -0.423 . . . . 20.0 109.857 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.0 -35.87 79.04 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.741 0.817 . . . . 20.0 111.997 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -64.62 -36.11 83.19 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.653 0.781 . . . . 20.0 112.364 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.35 -38.26 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.864 0.866 . . . . 20.0 110.479 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -62.98 -35.51 80.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.038 0.935 . . . . 20.0 111.918 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -81.72 -4.68 56.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.502 1.521 . . . . 20.0 113.041 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.1 2.71 90.6 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.966 1.269 . . . . 20.0 114.948 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -71.53 174.11 7.1 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.802 1.301 . . . . 20.0 112.38 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.54 -177.96 51.86 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.097 1.332 . . . . 20.0 112.744 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.94 59.02 0.79 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.567 1.147 . . . . 20.0 110.006 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.57 153.38 95.76 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.039 0.536 . . . . 20.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.03 172.71 14.15 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.6 3.533 . . . . 20.0 111.475 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -62.28 -13.9 33.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.716 1.376 . . . . 20.0 114.716 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.7 m -95.28 -9.54 32.82 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.294 1.438 . . . . 20.0 113.476 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.83 -2.69 9.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.032 1.733 . . . . 20.0 112.354 175.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.98 85.71 40.95 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.539 1.535 . . . . 20.0 109.721 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.18 175.87 10.68 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.184 3.256 . . . . 20.0 112.326 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.69 -12.99 52.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.33 1.452 . . . . 20.0 113.42 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 -39.02 17.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.389 1.075 . . . . 20.0 112.04 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.72 -10.45 26.82 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.739 1.014 . . . . 20.0 113.739 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -63.37 149.78 45.02 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.92 0.782 . . . . 20.0 111.251 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.99 171.83 11.12 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.225 0.536 . . . . 20.0 110.528 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -67.71 -4.73 13.1 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.202 1.401 . . . . 20.0 112.907 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -148.97 162.21 40.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.316 1.846 . . . . 20.0 110.763 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.8 75.35 0.23 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 125.101 1.334 . . . . 20.0 111.022 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 7.7 61.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.986 1.279 . . . . 20.0 114.786 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 55.7 m -102.93 -172.72 2.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.23 1.812 . . . . 20.0 110.384 170.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -72.45 -27.16 62.13 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.586 1.154 . . . . 20.0 112.082 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 t -155.82 -32.81 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.44 0.904 . . . . 20.0 113.44 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -138.6 130.09 36.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 124.905 1.282 . . . . 20.0 110.732 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.78 141.46 48.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.724 1.61 . . . . 20.0 110.716 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -135.47 157.56 46.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.101 1.76 . . . . 20.0 110.495 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.24 160.34 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.175 0.59 . . . . 20.0 111.614 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pp -123.85 6.48 8.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.912 1.685 . . . . 20.0 113.341 171.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.5 t -60.39 -26.09 66.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.079 1.352 . . . . 20.0 112.562 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -73.32 -35.88 66.13 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.53 1.132 . . . . 20.0 112.287 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.72 -42.98 73.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.256 1.022 . . . . 20.0 111.251 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.7 p -75.33 -9.53 58.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.315 1.446 . . . . 20.0 112.914 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.591 -1.672 . . . . 20.0 111.331 178.265 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.8 p30 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.075 0.464 . . . . 20.0 111.724 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.5 -48.27 70.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.326 1.05 . . . . 20.0 111.347 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.24 -41.77 97.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.392 1.077 . . . . 20.0 111.742 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.23 -37.87 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.1 . . . . 20.0 110.811 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -65.4 -34.69 78.89 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.2 1.0 . . . . 20.0 112.214 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -68.16 -17.67 64.4 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.778 1.231 . . . . 20.0 112.66 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.53 38.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.721 1.629 . . . . 20.0 114.245 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -68.79 168.5 13.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.908 1.354 . . . . 20.0 112.022 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.84 -160.94 27.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.406 1.479 . . . . 20.0 113.171 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 t -154.1 72.6 0.89 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.019 0.928 . . . . 20.0 108.793 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.56 162.36 43.51 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.3 1.44 . . . . 20.0 111.154 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.85 157.76 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.815 2.343 . . . . 20.0 110.766 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -63.37 -20.09 65.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.636 1.174 . . . . 20.0 113.112 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.9 m -87.79 -0.49 57.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.556 1.542 . . . . 20.0 113.715 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.53 -36.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.612 1.096 . . . . 20.0 113.362 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.79 113.2 38.33 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 20.0 109.182 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.78 168.33 23.75 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.99 2.46 . . . . 20.0 111.994 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.49 -4.79 32.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.937 1.295 . . . . 20.0 113.544 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -91.69 -34.55 14.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.634 1.174 . . . . 20.0 112.217 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.19 -18.11 35.07 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.636 1.174 . . . . 20.0 113.605 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -62.01 149.6 40.44 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.357 0.663 . . . . 20.0 112.205 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.62 172.09 8.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.202 1.401 . . . . 20.0 110.451 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -73.93 -7.22 51.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.689 1.196 . . . . 20.0 113.338 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -85.65 -179.63 6.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.712 1.605 . . . . 20.0 113.063 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.62 32.85 2.41 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.114 1.816 . . . . 20.0 112.852 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.22 1.9 54.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.221 1.391 . . . . 20.0 115.708 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.16 172.36 11.07 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.202 1.401 . . . . 20.0 110.197 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -92.25 -12.83 31.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.939 0.896 . . . . 20.0 112.353 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.6 p -130.18 -65.03 0.83 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.092 1.357 . . . . 20.0 109.574 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 m -151.36 159.32 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.451 1.1 . . . . 20.0 111.228 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -133.49 149.19 51.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.732 2.013 . . . . 20.0 108.507 172.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.11 149.37 52.42 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.313 1.045 . . . . 20.0 111.069 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -89.57 77.44 7.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.737 1.215 . . . . 20.0 113.398 -168.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.48 -3.37 17.52 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.703 1.371 . . . . 20.0 114.703 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -64.32 -15.97 61.31 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.944 1.298 . . . . 20.0 113.222 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -64.13 -24.98 67.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.948 1.299 . . . . 20.0 112.511 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.45 -17.11 63.6 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.919 1.288 . . . . 20.0 113.395 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -119.66 5.13 11.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.667 1.587 . . . . 20.0 111.891 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 117.228 -1.873 . . . . 20.0 110.305 179.126 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.1 m . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 118.898 -0.572 . . . . 20.0 112.293 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.02 -40.33 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.124 0.97 . . . . 20.0 110.485 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.5 t -56.02 -48.0 76.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.286 1.034 . . . . 20.0 111.018 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -73.56 -3.84 30.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.228 1.811 . . . . 20.0 113.585 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.12 0.41 89.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.129 1.347 . . . . 20.0 115.058 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -72.01 165.42 24.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.672 1.236 . . . . 20.0 112.296 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.81 -158.41 30.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.111 1.815 . . . . 20.0 111.792 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.21 116.49 6.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.35 1.06 . . . . 20.0 108.811 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.52 159.13 33.36 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.516 1.527 . . . . 20.0 110.02 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.27 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.246 2.631 . . . . 20.0 111.719 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -68.25 -8.67 41.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.729 1.612 . . . . 20.0 113.7 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.7 p -107.24 -29.74 9.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.509 1.524 . . . . 20.0 113.577 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.26 -26.08 19.17 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.8 0.727 . . . . 20.0 112.406 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -85.1 110.49 28.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.463 1.505 . . . . 20.0 109.634 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.75 167.2 26.4 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.786 2.324 . . . . 20.0 111.487 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.42 -8.17 44.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.031 1.332 . . . . 20.0 113.327 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.53 -28.25 16.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.246 1.418 . . . . 20.0 111.792 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.16 -15.41 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.244 1.418 . . . . 20.0 113.513 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -60.05 139.37 57.51 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.728 0.811 . . . . 20.0 110.129 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.14 158.43 15.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.641 0.734 . . . . 20.0 110.823 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t -80.22 9.05 6.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.781 1.632 . . . . 20.0 112.88 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.86 168.97 9.25 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.044 1.338 . . . . 20.0 112.77 -168.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.13 32.1 7.54 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.325 1.917 . . . . 20.0 113.01 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.6 -0.02 66.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.28 1.419 . . . . 20.0 115.749 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m -125.08 -172.18 2.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.905 2.082 . . . . 20.0 110.22 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -105.89 -3.97 21.24 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 20.0 113.232 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.9 t -144.29 -55.63 0.35 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.268 1.027 . . . . 20.0 110.816 171.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -145.8 152.31 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.549 1.54 . . . . 20.0 109.151 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -121.84 144.23 48.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.682 1.193 . . . . 20.0 109.535 172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -135.23 149.64 49.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.865 1.266 . . . . 20.0 109.603 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -74.91 175.41 8.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.874 0.87 . . . . 20.0 111.876 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 125.846 1.658 . . . . 20.0 112.117 175.237 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 111.867 0.321 . . . . 20.0 111.867 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.75 -22.93 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.263 1.025 . . . . 20.0 111.227 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -58.73 -33.89 70.74 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.84 0.856 . . . . 20.0 113.161 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -79.16 -11.23 59.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.542 1.537 . . . . 20.0 113.342 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.95 -2.89 31.7 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.175 1.845 . . . . 20.0 114.329 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -72.42 -178.85 2.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.041 1.336 . . . . 20.0 112.154 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.3 168.62 21.48 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.887 1.232 . . . . 20.0 111.187 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 t -126.49 68.62 1.23 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 20.0 110.669 -160.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.3 mt -72.78 153.59 91.28 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.268 0.627 . . . . 20.0 111.882 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.65 173.97 11.76 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.724 3.616 . . . . 20.0 111.931 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.24 -38.2 73.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.686 1.195 . . . . 20.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.3 p -67.53 -17.32 64.62 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.153 1.381 . . . . 20.0 113.874 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.73 -12.27 10.27 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.028 1.731 . . . . 20.0 111.777 -174.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 t -122.83 89.46 50.29 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.373 1.469 . . . . 20.0 109.026 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.04 166.81 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.145 2.563 . . . . 20.0 110.753 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.94 -33.02 70.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.628 1.171 . . . . 20.0 112.907 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.94 -32.98 74.79 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.118 1.367 . . . . 20.0 112.429 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.37 -10.05 45.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.37 1.468 . . . . 20.0 113.156 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -65.05 143.91 57.61 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.005 0.922 . . . . 20.0 110.056 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.89 175.86 10.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 20.0 111.178 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -73.5 -7.64 52.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.303 0.641 . . . . 20.0 112.322 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -137.13 173.17 11.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.847 2.059 . . . . 20.0 110.625 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.17 -95.21 0.9 Allowed Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.281 0.943 . . . . 20.0 111.607 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 -32.15 4.72 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.56 2.029 . . . . 20.0 113.554 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m -82.5 -177.98 6.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.081 0.94 . . . . 20.0 110.574 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -74.86 -31.95 61.77 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.792 1.237 . . . . 20.0 110.255 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 p -136.11 -55.02 0.76 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.456 1.502 . . . . 20.0 111.341 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -145.23 137.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.678 1.591 . . . . 20.0 108.836 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.2 t -125.98 155.05 42.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.528 1.531 . . . . 20.0 109.905 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.8 160.51 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.835 1.254 . . . . 20.0 110.826 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.08 35.6 0.99 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.998 1.481 . . . . 20.0 114.998 -164.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 114.856 1.428 . . . . 20.0 114.856 -174.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 110.702 -0.11 . . . . 20.0 110.702 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.97 -38.18 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.978 1.311 . . . . 20.0 111.471 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -67.36 -31.78 72.26 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.002 0.819 . . . . 20.0 112.666 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -73.45 -3.19 25.96 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.22 1.808 . . . . 20.0 113.426 171.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.77 -4.87 69.1 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.419 1.485 . . . . 20.0 114.542 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.97 -174.39 4.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.642 1.177 . . . . 20.0 111.155 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.13 -176.19 14.38 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.194 1.378 . . . . 20.0 111.499 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.3 m -134.56 88.77 2.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.989 1.315 . . . . 20.0 108.328 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.71 161.89 10.41 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.817 1.647 . . . . 20.0 111.367 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.7 165.1 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.471 2.114 . . . . 20.0 111.188 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.31 4.6 4.43 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.917 1.687 . . . . 20.0 113.287 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.0 p -115.7 -4.38 12.19 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.859 2.063 . . . . 20.0 113.711 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.18 -27.57 1.59 Allowed 'General case' 0 C--N 1.346 0.452 0 N-CA-C 114.081 1.141 . . . . 20.0 114.081 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 t -58.24 106.14 0.65 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 126.516 1.926 . . . . 20.0 110.508 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.75 155.9 35.14 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.601 2.2 . . . . 20.0 111.297 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -68.44 -17.84 64.29 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.631 0.604 . . . . 20.0 112.631 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -76.73 -33.5 58.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.847 1.259 . . . . 20.0 112.541 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.84 -5.82 59.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.015 1.116 . . . . 20.0 114.015 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -57.06 117.98 4.55 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.55 1.14 . . . . 20.0 110.529 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.9 mt -75.67 172.07 13.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.615 0.766 . . . . 20.0 110.717 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -70.2 -2.88 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.855 1.262 . . . . 20.0 113.289 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.55 163.3 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.965 1.706 . . . . 20.0 111.471 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.07 77.94 0.24 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.5 1.524 . . . . 20.0 110.663 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.23 6.4 76.12 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.699 1.142 . . . . 20.0 115.547 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 m -130.17 -175.73 3.72 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.883 2.073 . . . . 20.0 110.126 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.1 p -90.48 -7.37 53.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.026 1.33 . . . . 20.0 112.656 -171.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 p -131.85 -63.3 0.83 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.309 1.444 . . . . 20.0 109.971 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.55 152.58 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.734 1.213 . . . . 20.0 111.08 -171.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -133.74 67.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.239 1.816 . . . . 20.0 108.266 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.96 131.23 40.51 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 123.997 0.919 . . . . 20.0 109.451 167.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.77 159.78 21.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.208 0.603 . . . . 20.0 111.518 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 114.015 1.117 . . . . 20.0 114.015 164.965 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 111.786 0.291 . . . . 20.0 111.786 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.94 -18.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.139 1.376 . . . . 20.0 111.935 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.8 t -58.23 -42.15 85.68 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.755 1.222 . . . . 20.0 112.081 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -21.83 64.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.763 1.625 . . . . 20.0 112.942 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.54 -3.36 36.85 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.016 1.769 . . . . 20.0 113.937 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -70.45 168.64 15.71 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.554 1.177 . . . . 20.0 112.252 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.01 -175.32 50.63 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.188 1.375 . . . . 20.0 112.417 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 t -151.93 49.56 0.79 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.452 1.101 . . . . 20.0 109.274 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.07 153.87 16.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.829 1.251 . . . . 20.0 111.721 -173.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.59 170.67 19.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.404 2.736 . . . . 20.0 112.447 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -65.21 -4.07 4.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.687 1.995 . . . . 20.0 114.449 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.5 t -115.65 -11.56 11.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.562 1.545 . . . . 20.0 113.066 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.09 -26.53 5.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.1 -0.952 . . . . 20.0 113.233 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 t -65.23 107.21 1.31 Allowed Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.36 1.864 . . . . 20.0 109.605 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.22 152.45 50.33 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.323 2.015 . . . . 20.0 110.035 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.31 -25.66 68.41 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.668 1.187 . . . . 20.0 112.64 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.16 -31.63 49.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.932 1.293 . . . . 20.0 112.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.39 58.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.794 1.035 . . . . 20.0 113.794 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -60.71 117.21 5.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.361 1.064 . . . . 20.0 108.723 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.3 176.39 3.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.676 1.191 . . . . 20.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 t -69.95 -3.9 18.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.058 0.943 . . . . 20.0 113.023 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -138.88 169.18 18.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.55 1.94 . . . . 20.0 110.586 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.91 71.69 0.49 Allowed Glycine 0 C--N 1.341 0.809 0 C-N-CA 125.013 1.292 . . . . 20.0 111.259 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.12 -19.66 76.82 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.845 0.736 . . . . 20.0 114.103 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.32 174.55 9.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.576 1.15 . . . . 20.0 111.148 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.6 m -86.59 -5.66 59.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.663 1.185 . . . . 20.0 111.987 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -149.56 -53.15 0.16 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.849 1.26 . . . . 20.0 111.681 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.21 122.46 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.568 1.147 . . . . 20.0 111.505 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.4 t -106.24 82.94 1.82 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.339 2.256 . . . . 20.0 108.944 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.26 142.94 27.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.87 1.268 . . . . 20.0 111.098 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.93 170.25 16.97 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.92 0.888 . . . . 20.0 112.207 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 125.732 1.613 . . . . 20.0 112.117 177.266 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 119.747 -0.168 . . . . 20.0 111.272 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -67.14 -34.85 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.885 1.274 . . . . 20.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.5 m -66.94 -36.94 83.35 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.185 0.994 . . . . 20.0 111.865 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -73.46 -5.73 41.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.718 1.207 . . . . 20.0 113.158 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.04 85.2 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.885 1.231 . . . . 20.0 113.878 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -84.26 168.7 15.45 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.163 1.385 . . . . 20.0 112.117 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.11 167.86 24.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.387 0.994 . . . . 20.0 113.234 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.9 m -126.81 74.09 1.46 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.701 1.6 . . . . 20.0 108.388 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.04 162.23 40.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.776 1.231 . . . . 20.0 110.824 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.44 173.4 14.54 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.365 2.71 . . . . 20.0 110.959 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -66.67 -0.46 2.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.221 1.809 . . . . 20.0 113.733 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.6 p -125.96 -8.08 6.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.941 1.696 . . . . 20.0 114.583 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -128.9 -6.4 5.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.355 0.979 . . . . 20.0 113.222 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.0 t -76.92 116.08 53.98 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.847 0.859 . . . . 20.0 108.741 163.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.87 159.18 48.78 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.733 2.289 . . . . 20.0 110.443 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -63.54 -24.59 67.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.029 0.932 . . . . 20.0 112.259 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.46 -30.66 64.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.959 1.304 . . . . 20.0 112.43 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 -18.71 41.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.052 1.13 . . . . 20.0 114.052 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -60.85 120.5 10.27 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.895 1.278 . . . . 20.0 111.313 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.9 mt -82.4 171.11 14.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.449 1.099 . . . . 20.0 112.015 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -69.49 -12.62 61.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.27 1.428 . . . . 20.0 112.445 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -132.6 168.97 17.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.939 2.095 . . . . 20.0 110.838 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.61 71.56 0.49 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.625 1.583 . . . . 20.0 110.806 -173.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.58 -7.9 87.87 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.336 0.969 . . . . 20.0 114.853 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m -81.63 -168.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.516 1.526 . . . . 20.0 109.778 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.0 p -103.12 -6.53 22.13 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.664 1.185 . . . . 20.0 111.987 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.3 p -127.92 -74.48 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.005 2.122 . . . . 20.0 109.247 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 m -150.5 120.48 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.76 1.624 . . . . 20.0 109.119 -172.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.45 108.74 19.82 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.465 1.106 . . . . 20.0 109.257 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -126.16 113.17 16.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.169 1.387 . . . . 20.0 109.015 -168.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.57 172.25 3.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.059 1.344 . . . . 20.0 112.873 -172.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 69.6 mt . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 125.122 1.369 . . . . 20.0 111.932 -174.223 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 N-CA-C 112.765 0.654 . . . . 20.0 112.765 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.44 -46.17 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.19 1.396 . . . . 20.0 110.39 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -65.32 -29.4 70.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.14 1.376 . . . . 20.0 112.665 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -71.51 -6.05 37.64 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.546 1.938 . . . . 20.0 112.669 171.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.41 6.32 89.33 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.599 -1.111 . . . . 20.0 114.491 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -74.87 167.69 21.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.616 1.208 . . . . 20.0 111.694 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.64 128.26 9.43 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.083 0.849 . . . . 20.0 112.555 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.9 m -82.41 75.0 9.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.913 0.885 . . . . 20.0 108.752 163.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.36 162.96 36.49 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 20.0 110.975 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.66 167.85 25.58 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.818 2.346 . . . . 20.0 110.849 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -74.42 5.85 4.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.621 1.569 . . . . 20.0 113.727 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 t -129.57 12.84 5.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.865 1.666 . . . . 20.0 112.323 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -133.04 -45.93 0.85 Allowed 'General case' 0 C--N 1.346 0.42 0 C-N-CA 124.442 1.097 . . . . 20.0 112.513 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.21 104.31 0.42 Allowed Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 127.336 2.254 . . . . 20.0 111.807 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.78 145.4 36.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.682 2.255 . . . . 20.0 110.96 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -59.91 -26.82 66.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.521 0.934 . . . . 20.0 113.521 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.01 -29.93 70.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.627 1.571 . . . . 20.0 112.647 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.69 24.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.829 1.252 . . . . 20.0 113.64 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -61.23 120.09 9.69 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.754 1.161 . . . . 20.0 110.409 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.09 172.94 10.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.704 1.202 . . . . 20.0 111.773 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -69.85 -10.5 58.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.744 1.218 . . . . 20.0 112.215 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -139.34 172.95 12.07 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.344 2.257 . . . . 20.0 110.591 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.6 76.05 0.21 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.789 -0.924 . . . . 20.0 110.789 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . -69.01 -13.33 66.59 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.841 1.21 . . . . 20.0 113.525 176.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.48 177.37 1.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.732 1.613 . . . . 20.0 111.244 167.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -93.65 -13.01 28.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.73 0.812 . . . . 20.0 112.798 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -135.39 -59.79 0.77 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.395 1.078 . . . . 20.0 110.819 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.9 m -148.22 153.62 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.652 1.581 . . . . 20.0 110.239 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.9 t -134.42 108.86 8.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.656 1.182 . . . . 20.0 109.502 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -102.46 137.22 41.0 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.133 0.973 . . . . 20.0 109.616 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.43 166.46 12.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.61 0.764 . . . . 20.0 111.618 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.539 0.545 0 C-N-CA 126.004 1.722 . . . . 20.0 110.882 177.343 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 113.009 0.744 . . . . 20.0 113.009 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.9 t -83.48 -41.19 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.436 1.495 . . . . 20.0 110.766 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -60.81 -35.2 75.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.704 1.202 . . . . 20.0 111.995 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -69.32 -14.16 62.78 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.887 2.075 . . . . 20.0 113.233 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 16.91 77.29 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.653 -1.082 . . . . 20.0 114.601 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -59.87 165.59 3.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.6 1.16 . . . . 20.0 112.567 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.51 -33.83 67.59 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.1 1.333 . . . . 20.0 113.986 -175.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 t 50.67 37.22 15.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.146 1.779 . . . . 20.0 112.008 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.49 154.12 56.66 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.934 1.294 . . . . 20.0 111.821 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.17 171.24 11.74 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.746 2.964 . . . . 20.0 111.342 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.65 -22.54 66.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.176 0.99 . . . . 20.0 112.475 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -80.99 -3.76 52.8 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.245 1.818 . . . . 20.0 114.161 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.5 -42.9 1.29 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.141 1.376 . . . . 20.0 112.918 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.86 109.78 5.36 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.218 1.807 . . . . 20.0 110.601 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.6 170.33 15.89 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.552 2.835 . . . . 20.0 112.199 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -66.77 -12.96 60.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.362 1.465 . . . . 20.0 113.411 173.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -96.32 -29.31 14.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.335 1.054 . . . . 20.0 112.82 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.68 -5.4 21.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.483 1.113 . . . . 20.0 113.633 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -60.43 136.2 57.97 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.774 0.716 . . . . 20.0 110.872 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.17 172.04 13.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.29 1.036 . . . . 20.0 111.186 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -72.46 -9.13 58.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.779 0.832 . . . . 20.0 112.318 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.22 172.22 13.33 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.781 2.032 . . . . 20.0 110.973 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.58 67.14 0.39 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.658 1.123 . . . . 20.0 111.654 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . -77.49 -7.42 87.09 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.128 1.347 . . . . 20.0 114.388 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.4 m -66.98 179.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.854 1.327 . . . . 20.0 111.378 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 t -68.62 -29.6 68.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.342 1.057 . . . . 20.0 111.543 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -158.85 -28.25 0.07 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 20.0 113.744 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 p -139.13 135.82 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.106 1.362 . . . . 20.0 110.241 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.2 t -133.64 139.28 46.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.063 1.345 . . . . 20.0 110.812 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.01 140.77 34.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.879 1.672 . . . . 20.0 109.2 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.06 166.78 18.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.209 0.604 . . . . 20.0 110.956 172.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.715 1.606 . . . . 20.0 112.368 178.383 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 119.318 -0.373 . . . . 20.0 111.743 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.36 -36.85 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.061 0.945 . . . . 20.0 110.685 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -65.49 -30.5 71.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.108 1.363 . . . . 20.0 112.056 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -80.32 -12.02 59.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.719 1.608 . . . . 20.0 113.026 171.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.0 12.85 56.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.742 1.163 . . . . 20.0 114.928 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -89.18 167.56 13.0 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.832 1.316 . . . . 20.0 112.781 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.7 -175.87 47.0 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.991 1.281 . . . . 20.0 113.363 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 t -138.28 65.52 1.46 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.119 1.367 . . . . 20.0 109.133 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.57 156.15 78.75 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.38 1.472 . . . . 20.0 110.81 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.46 164.37 35.49 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.178 2.586 . . . . 20.0 110.937 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -64.9 -22.84 67.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.654 0.782 . . . . 20.0 112.993 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.7 m -82.79 -3.76 57.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.909 1.284 . . . . 20.0 113.626 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -129.55 0.92 5.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.336 1.454 . . . . 20.0 112.574 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -128.65 80.93 71.72 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.944 1.297 . . . . 20.0 110.443 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.14 175.41 10.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.176 3.251 . . . . 20.0 112.159 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -67.39 -6.89 21.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.735 1.013 . . . . 20.0 113.735 172.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -86.19 -25.1 25.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.915 1.286 . . . . 20.0 112.396 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.27 -7.77 14.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.447 1.499 . . . . 20.0 113.43 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.56 165.34 8.16 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.352 1.061 . . . . 20.0 112.168 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.9 mt -133.94 166.21 23.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.205 1.002 . . . . 20.0 111.599 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -82.67 -9.64 59.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.043 1.337 . . . . 20.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -109.27 2.76 21.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.931 1.692 . . . . 20.0 113.639 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -36.55 87.23 0.01 OUTLIER Glycine 0 CA--C 1.529 0.909 1 C-N-CA 130.987 4.137 . . . . 20.0 115.506 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.62 0.63 63.29 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.069 1.319 . . . . 20.0 113.963 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.7 m -66.54 173.48 3.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 20.0 111.728 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -86.63 -16.1 37.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.887 0.875 . . . . 20.0 111.923 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -132.16 -61.36 0.88 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.373 1.469 . . . . 20.0 110.302 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.5 m -152.18 153.01 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.967 1.307 . . . . 20.0 111.002 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.6 t -131.92 137.01 47.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.988 1.715 . . . . 20.0 109.251 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.3 m -137.21 156.35 48.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.715 1.206 . . . . 20.0 111.089 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.55 126.02 30.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.495 1.118 . . . . 20.0 112.571 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 125.836 1.655 . . . . 20.0 113.155 168.362 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 112.552 0.575 . . . . 20.0 112.552 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.36 -32.98 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.194 0.598 . . . . 20.0 111.394 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -67.35 -34.32 77.06 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.524 0.73 . . . . 20.0 111.794 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -9.51 58.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.362 1.065 . . . . 20.0 113.524 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.87 -2.4 84.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.757 1.17 . . . . 20.0 113.911 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -71.19 176.13 4.74 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.603 1.201 . . . . 20.0 110.852 168.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.14 -172.91 15.14 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 123.862 0.744 . . . . 20.0 112.818 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -117.68 82.01 1.76 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.447 1.499 . . . . 20.0 109.155 -173.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 151.8 81.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.185 0.994 . . . . 20.0 109.295 170.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.77 167.74 24.88 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.379 2.719 . . . . 20.0 111.598 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.24 -9.65 42.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.963 1.305 . . . . 20.0 113.272 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -95.63 -13.51 24.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.83 1.652 . . . . 20.0 113.548 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -137.55 20.17 2.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.059 1.344 . . . . 20.0 112.587 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 t -127.74 77.64 75.97 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.152 1.381 . . . . 20.0 109.354 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.34 171.11 18.68 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.068 3.179 . . . . 20.0 112.159 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -63.69 -13.35 42.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.799 1.64 . . . . 20.0 113.756 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.3 -25.98 25.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.75 1.22 . . . . 20.0 112.811 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.66 -8.21 14.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.3 1.44 . . . . 20.0 113.345 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -65.79 170.0 5.83 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.278 1.031 . . . . 20.0 111.789 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.8 mt -130.97 168.42 17.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 20.0 110.248 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -74.04 -19.93 60.46 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.237 1.015 . . . . 20.0 111.913 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -73.9 167.07 22.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.971 1.708 . . . . 20.0 111.675 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.12 87.31 0.12 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.923 0.773 . . . . 20.0 111.662 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.16 3.1 79.88 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.05 1.309 . . . . 20.0 114.172 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.0 m -131.93 -12.33 3.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.632 1.573 . . . . 20.0 114.762 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.3 p 64.79 6.8 3.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 130.889 3.676 . . . . 20.0 113.429 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.3 p -122.53 -57.18 1.76 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.78 1.232 . . . . 20.0 110.772 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.06 135.53 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 126.147 1.779 . . . . 20.0 109.402 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.4 t -145.42 121.71 10.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.839 1.656 . . . . 20.0 109.156 171.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 9.5 m -129.02 148.46 50.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.379 1.471 . . . . 20.0 110.414 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -73.26 107.64 5.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.797 1.239 . . . . 20.0 110.446 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 CA--C 1.536 0.407 0 C-N-CA 126.157 1.783 . . . . 20.0 112.367 170.98 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 112.87 0.692 . . . . 20.0 112.87 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.55 -37.41 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 124.131 0.972 . . . . 20.0 110.484 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.6 t -66.98 -30.53 70.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.257 1.023 . . . . 20.0 111.91 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.11 -2.07 46.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.138 1.375 . . . . 20.0 112.564 171.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.88 -5.01 84.95 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.903 1.716 . . . . 20.0 114.961 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -76.39 168.32 20.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.783 1.292 . . . . 20.0 112.14 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.14 170.93 32.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.639 1.114 . . . . 20.0 112.51 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.0 m -126.0 68.65 1.19 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.669 1.588 . . . . 20.0 107.936 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.66 161.47 65.77 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.999 1.72 . . . . 20.0 110.746 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.45 164.76 34.66 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.599 2.2 . . . . 20.0 111.329 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -66.94 -6.97 18.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.675 1.59 . . . . 20.0 113.738 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -121.05 -5.3 9.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.736 1.615 . . . . 20.0 113.964 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -105.58 -42.39 5.21 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.229 0.922 . . . . 20.0 112.026 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.6 115.46 27.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.39 1.076 . . . . 20.0 109.863 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.24 160.62 35.91 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.547 2.164 . . . . 20.0 110.381 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -63.9 -16.93 62.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.871 1.268 . . . . 20.0 112.643 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -70.6 -25.89 63.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.912 1.285 . . . . 20.0 112.669 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.79 2.74 10.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.858 1.663 . . . . 20.0 113.461 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.02 151.34 40.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.892 0.877 . . . . 20.0 109.821 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.6 mt -95.15 166.86 11.71 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.423 0.63 . . . . 20.0 110.214 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -74.15 -3.07 27.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.01 0.924 . . . . 20.0 112.32 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -143.78 169.11 18.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.687 1.995 . . . . 20.0 110.808 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.76 79.64 0.37 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 125.082 1.325 . . . . 20.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 -3.05 65.37 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.079 0.847 . . . . 20.0 114.247 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.1 m -85.08 -166.48 1.51 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.9 2.08 . . . . 20.0 110.314 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 t -91.62 -18.15 24.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.938 0.895 . . . . 20.0 112.479 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.7 p -134.22 -61.7 0.77 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.417 1.087 . . . . 20.0 110.622 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -150.09 157.92 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.301 1.84 . . . . 20.0 109.648 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.1 t -125.73 151.95 45.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.309 1.444 . . . . 20.0 110.176 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -137.78 125.96 23.03 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.653 0.781 . . . . 20.0 110.812 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 147.24 46.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.712 1.205 . . . . 20.0 110.052 169.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 41.8 mt . . . . . 0 CA--C 1.541 0.612 0 C-N-CA 125.263 1.425 . . . . 20.0 111.902 -176.024 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.5 m . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 109.997 -0.371 . . . . 20.0 109.997 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.8 -40.14 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.287 1.435 . . . . 20.0 111.171 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -62.32 -41.32 98.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.443 1.097 . . . . 20.0 111.756 -176.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -83.07 -7.31 59.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.331 1.052 . . . . 20.0 113.336 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.72 79.02 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.597 1.094 . . . . 20.0 114.955 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -65.37 164.74 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.043 1.422 . . . . 20.0 111.831 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.97 178.72 53.38 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 121.994 0.774 . . . . 20.0 112.103 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.6 t -150.34 76.81 1.28 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.118 -1.438 . . . . 20.0 107.118 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 157.44 86.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.841 1.257 . . . . 20.0 110.919 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.66 174.39 8.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.951 3.101 . . . . 20.0 111.352 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -60.11 -16.67 34.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.571 1.148 . . . . 20.0 113.124 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 m -89.11 -11.02 45.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.711 1.604 . . . . 20.0 113.862 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.11 -0.88 4.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.896 1.678 . . . . 20.0 113.199 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -120.33 77.51 26.07 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.921 1.288 . . . . 20.0 109.406 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.15 170.57 19.53 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.533 2.822 . . . . 20.0 110.963 175.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -60.56 -26.02 66.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.397 1.079 . . . . 20.0 112.753 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.63 -46.26 72.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.758 1.623 . . . . 20.0 111.859 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.78 -4.54 56.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.749 1.219 . . . . 20.0 113.929 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -60.4 145.3 48.54 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.321 1.049 . . . . 20.0 111.618 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.81 173.75 9.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.835 1.254 . . . . 20.0 111.51 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 t -65.02 -14.13 59.65 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.634 1.574 . . . . 20.0 112.737 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.18 168.12 20.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.419 2.287 . . . . 20.0 110.269 -174.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.67 85.18 0.17 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 124.465 1.031 . . . . 20.0 111.305 -170.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.67 -13.37 80.09 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.557 1.075 . . . . 20.0 115.01 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.4 m -80.82 -179.71 7.41 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.548 1.139 . . . . 20.0 111.294 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -93.78 -9.83 36.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.9 1.28 . . . . 20.0 111.987 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.5 p -133.13 -65.61 0.69 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.982 1.313 . . . . 20.0 109.736 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.84 156.14 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.363 1.465 . . . . 20.0 110.507 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -144.37 115.95 8.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.186 1.394 . . . . 20.0 109.35 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.84 136.73 51.83 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.215 1.006 . . . . 20.0 111.93 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.73 124.83 28.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.36 1.464 . . . . 20.0 109.464 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 125.685 1.594 . . . . 20.0 112.942 174.423 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 111.774 0.287 . . . . 20.0 111.774 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.6 t -73.74 -25.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.655 1.182 . . . . 20.0 111.16 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -67.9 -32.78 73.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.46 0.704 . . . . 20.0 111.916 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -67.94 -20.73 65.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.286 1.034 . . . . 20.0 112.711 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.69 -2.34 21.61 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.087 1.803 . . . . 20.0 114.132 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -77.8 175.99 9.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.583 1.192 . . . . 20.0 112.587 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -23.45 30.48 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.295 -0.725 . . . . 20.0 114.206 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.9 t 49.92 49.56 20.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.086 1.754 . . . . 20.0 112.523 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.08 155.21 84.8 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.532 1.133 . . . . 20.0 111.291 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.13 169.98 21.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.505 2.803 . . . . 20.0 112.306 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -69.34 8.7 0.56 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.465 1.906 . . . . 20.0 114.036 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.3 p -120.03 -6.31 9.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.337 1.855 . . . . 20.0 113.122 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -136.73 -17.76 1.44 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 113.842 1.053 . . . . 20.0 113.842 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -85.68 114.75 58.42 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.067 0.947 . . . . 20.0 109.616 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.21 162.9 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.772 2.315 . . . . 20.0 111.741 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -70.96 -6.42 38.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.363 1.465 . . . . 20.0 114.313 -173.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.42 -32.11 10.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.775 1.23 . . . . 20.0 111.848 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.16 -21.28 39.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 113.818 1.044 . . . . 20.0 113.818 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -63.4 157.47 23.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.011 0.924 . . . . 20.0 111.804 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.67 162.98 12.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.154 1.381 . . . . 20.0 110.408 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -83.22 -3.89 57.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.377 1.071 . . . . 20.0 111.677 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -148.93 176.19 10.63 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.733 2.013 . . . . 20.0 111.069 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.29 -166.29 30.04 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.133 0.873 . . . . 20.0 112.317 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.82 7.69 4.19 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.499 1.523 . . . . 20.0 114.047 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.9 173.53 5.27 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.801 1.24 . . . . 20.0 111.918 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.2 t -96.76 -5.43 38.59 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.119 1.367 . . . . 20.0 112.544 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.2 t -147.27 -49.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.278 1.031 . . . . 20.0 111.76 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -162.94 145.01 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.975 1.71 . . . . 20.0 108.164 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.1 t -114.27 151.76 32.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.285 1.034 . . . . 20.0 110.567 166.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.82 129.04 22.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.127 1.371 . . . . 20.0 109.574 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.16 137.44 33.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.156 0.982 . . . . 20.0 110.445 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.9 mt . . . . . 0 CA--C 1.538 0.5 0 C-N-CA 125.502 1.521 . . . . 20.0 112.633 -177.589 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 119.724 -0.179 . . . . 20.0 110.555 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.46 -32.24 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.589 1.156 . . . . 20.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.4 t -64.03 -39.79 94.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.503 1.121 . . . . 20.0 111.56 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -72.47 -6.0 40.67 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.689 1.196 . . . . 20.0 113.262 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.53 4.22 64.15 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.338 1.447 . . . . 20.0 114.625 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -77.45 171.22 15.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.55 1.14 . . . . 20.0 112.069 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.97 177.8 31.68 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.262 1.41 . . . . 20.0 113.136 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -133.6 69.17 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.84 1.656 . . . . 20.0 107.451 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.43 159.84 47.18 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.973 1.709 . . . . 20.0 110.914 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.54 166.0 30.95 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.846 2.364 . . . . 20.0 111.0 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -67.72 -19.71 65.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.87 1.268 . . . . 20.0 112.786 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -83.69 -16.97 42.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.992 1.317 . . . . 20.0 113.062 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -124.84 5.45 8.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.285 1.434 . . . . 20.0 113.157 -174.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -120.08 78.15 24.8 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.092 0.957 . . . . 20.0 110.43 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.82 172.68 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.536 2.824 . . . . 20.0 111.7 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -65.19 -13.36 58.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.516 1.127 . . . . 20.0 113.33 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.41 -32.56 20.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.042 1.337 . . . . 20.0 112.215 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 -18.33 22.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.28 1.032 . . . . 20.0 113.454 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -70.04 155.48 40.53 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 118.606 0.639 . . . . 20.0 110.6 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.11 177.45 6.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.051 0.94 . . . . 20.0 110.204 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -68.73 -21.93 64.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.333 0.653 . . . . 20.0 111.835 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.21 171.4 14.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.294 1.838 . . . . 20.0 111.66 -168.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.98 177.36 31.01 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.239 0.923 . . . . 20.0 112.812 175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.96 21.58 0.59 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.083 1.325 . . . . 20.0 113.367 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -63.13 176.87 0.68 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.374 1.469 . . . . 20.0 112.234 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -69.22 -29.63 67.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.724 1.209 . . . . 20.0 111.47 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 t -143.5 -41.31 0.29 Allowed 'General case' 0 C--N 1.344 0.354 0 CA-C-O 117.944 -1.027 . . . . 20.0 113.435 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -153.88 151.79 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.538 1.135 . . . . 20.0 109.68 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -118.93 135.17 54.73 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 125.474 1.51 . . . . 20.0 109.226 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -131.94 148.16 52.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.984 1.314 . . . . 20.0 110.039 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -74.73 166.28 23.85 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.611 -0.722 . . . . 20.0 111.476 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 125.407 1.483 . . . . 20.0 111.521 179.182 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 110.4 -0.222 . . . . 20.0 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.4 -39.92 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.048 1.339 . . . . 20.0 111.161 173.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -68.1 -32.05 72.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.267 1.027 . . . . 20.0 112.35 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -75.28 -9.95 59.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.63 1.572 . . . . 20.0 112.479 171.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.11 -2.96 69.39 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.254 1.407 . . . . 20.0 114.572 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -77.14 170.19 16.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.762 1.281 . . . . 20.0 111.72 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.54 160.13 23.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.907 0.765 . . . . 20.0 113.067 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.1 m -124.35 65.78 1.07 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.866 1.666 . . . . 20.0 109.189 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 mt -65.43 163.22 34.85 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.88 1.272 . . . . 20.0 111.512 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.62 170.93 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.036 2.491 . . . . 20.0 110.753 168.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -60.69 -27.05 67.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.429 1.092 . . . . 20.0 112.505 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -74.31 -10.6 59.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.861 1.264 . . . . 20.0 113.847 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.96 -5.27 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.044 1.338 . . . . 20.0 113.174 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.9 t -124.19 83.49 56.36 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.219 1.408 . . . . 20.0 109.809 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.89 173.48 14.43 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.966 3.11 . . . . 20.0 111.933 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -14.81 56.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 20.0 113.048 173.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.78 -29.26 50.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.138 . . . . 20.0 112.909 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.68 -8.68 14.92 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.457 1.103 . . . . 20.0 113.477 -170.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -70.22 159.63 33.65 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.522 0.729 . . . . 20.0 112.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.11 176.91 5.39 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.878 1.271 . . . . 20.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -70.58 -4.96 25.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.841 1.256 . . . . 20.0 113.187 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -139.98 176.29 8.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.152 1.781 . . . . 20.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.4 72.91 0.36 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.688 1.137 . . . . 20.0 111.96 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.42 -18.88 79.94 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.83 -0.983 . . . . 20.0 114.103 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.5 m -70.16 179.68 2.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.938 1.295 . . . . 20.0 112.52 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.2 m -86.09 -8.77 57.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.955 1.302 . . . . 20.0 112.264 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 t -148.53 -52.62 0.18 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.863 -1.065 . . . . 20.0 111.845 170.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.13 145.31 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.328 0.967 . . . . 20.0 112.012 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.6 t -122.85 112.28 17.69 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.959 2.103 . . . . 20.0 109.309 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -121.02 142.71 49.55 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.101 1.361 . . . . 20.0 111.726 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.73 137.99 31.92 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.182 1.393 . . . . 20.0 109.947 172.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.9 mt . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 127.19 2.196 . . . . 20.0 111.891 -169.939 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 119.827 -0.13 . . . . 20.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.06 -39.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.622 1.169 . . . . 20.0 111.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.6 t -67.73 -32.72 73.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 20.0 112.603 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -70.33 -13.02 61.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.153 1.381 . . . . 20.0 112.483 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.4 61.09 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.362 1.458 . . . . 20.0 114.163 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -79.04 171.64 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.671 1.235 . . . . 20.0 111.672 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.54 176.62 41.64 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.169 1.366 . . . . 20.0 112.259 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -141.16 56.45 1.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.906 -1.146 . . . . 20.0 107.906 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.24 157.5 12.12 Favored Pre-proline 0 C--N 1.345 0.375 0 C-N-CA 125.601 1.56 . . . . 20.0 111.666 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.36 167.51 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.822 2.348 . . . . 20.0 110.513 173.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -62.32 -22.12 65.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.558 0.743 . . . . 20.0 112.451 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p -84.41 -12.55 54.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.216 1.806 . . . . 20.0 114.441 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -4.41 11.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.189 1.395 . . . . 20.0 112.977 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 t -116.45 80.76 10.38 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.16 1.384 . . . . 20.0 108.824 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.07 170.73 18.26 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.654 2.903 . . . . 20.0 111.665 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -58.51 -28.78 65.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.708 1.603 . . . . 20.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.22 -40.43 64.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.832 1.253 . . . . 20.0 112.169 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.2 -5.66 57.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.934 1.087 . . . . 20.0 113.934 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -61.96 140.09 58.35 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.883 0.873 . . . . 20.0 110.957 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mt -75.86 173.04 11.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.115 0.96 . . . . 20.0 110.743 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -66.94 -12.62 60.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.373 1.069 . . . . 20.0 112.691 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.05 165.65 26.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.075 2.15 . . . . 20.0 110.869 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.65 86.79 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 125.798 1.666 . . . . 20.0 110.404 -172.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.5 1.37 60.18 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 118.448 -1.196 . . . . 20.0 115.575 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.1 m -97.42 174.35 6.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.643 1.177 . . . . 20.0 110.791 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -88.05 -5.13 58.65 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.403 1.081 . . . . 20.0 112.178 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 t -137.53 -61.26 0.64 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.676 1.591 . . . . 20.0 110.362 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -150.82 135.79 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.318 1.047 . . . . 20.0 110.952 -171.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.9 t -120.51 115.31 23.2 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.5 1.92 . . . . 20.0 109.146 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 m -126.12 146.7 49.83 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.776 1.63 . . . . 20.0 109.916 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.93 164.96 24.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.957 0.503 . . . . 20.0 111.82 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 125.364 1.466 . . . . 20.0 111.861 177.311 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 112.686 0.624 . . . . 20.0 112.686 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.83 -36.42 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.729 0.812 . . . . 20.0 109.62 173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.0 m -69.32 -13.46 62.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.631 1.173 . . . . 20.0 113.249 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -69.6 -10.04 56.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.347 1.059 . . . . 20.0 112.085 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.15 -3.06 56.74 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.558 1.551 . . . . 20.0 113.791 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.07 -96.59 0.11 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.296 1.048 . . . . 20.0 109.583 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.37 -155.06 25.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.303 1.43 . . . . 20.0 111.188 -170.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -149.89 145.11 26.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.749 1.22 . . . . 20.0 109.378 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.439 HD22 ' HB2' ' A' ' 32' ' ' CYS . 2.2 mp -123.55 160.58 50.19 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.581 . . . . 20.0 110.152 -177.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.82 171.79 16.75 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.163 3.242 . . . . 20.0 112.705 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -67.96 -2.13 6.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.855 2.462 . . . . 20.0 114.298 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.9 m -130.06 5.63 4.94 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.564 1.546 . . . . 20.0 112.933 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -136.04 9.59 3.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.552 1.141 . . . . 20.0 112.896 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.9 t -115.59 80.72 8.38 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 20.0 109.361 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.8 161.53 43.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.238 2.625 . . . . 20.0 110.705 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -58.77 -28.5 65.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.086 1.354 . . . . 20.0 113.106 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.8 -44.88 84.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.925 1.29 . . . . 20.0 111.789 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.28 -8.07 59.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.7 1.2 . . . . 20.0 113.848 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -62.74 141.9 58.38 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.338 0.972 . . . . 20.0 110.579 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.67 170.23 15.67 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.305 0.574 . . . . 20.0 110.874 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 t -66.89 -11.24 55.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.397 1.079 . . . . 20.0 112.381 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -144.68 165.65 27.45 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.575 2.35 . . . . 20.0 110.291 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.24 -169.67 15.05 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.481 1.515 . . . . 20.0 112.153 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.68 -7.22 0.33 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.891 1.234 . . . . 20.0 113.523 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 m -73.15 -179.1 3.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.457 1.503 . . . . 20.0 113.043 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -65.58 -30.14 70.83 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.49 1.516 . . . . 20.0 111.393 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -155.55 -38.28 0.09 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.152 0.981 . . . . 20.0 113.009 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m -140.5 139.85 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.328 0.967 . . . . 20.0 111.056 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 14.6 t -129.68 131.21 46.31 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.165 1.386 . . . . 20.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HB2' HD22 ' A' ' 11' ' ' LEU . 13.0 m -133.09 148.0 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.049 1.739 . . . . 20.0 109.601 176.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -70.39 148.77 48.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.051 0.94 . . . . 20.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 123.834 0.854 . . . . 20.0 112.279 172.659 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 108.936 -0.764 . . . . 20.0 108.936 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.21 -27.38 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.02 1.728 . . . . 20.0 112.15 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -60.0 -44.61 94.44 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.718 1.207 . . . . 20.0 111.695 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -85.88 -5.11 59.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.74 1.216 . . . . 20.0 113.423 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.96 -7.44 57.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.7 1.619 . . . . 20.0 114.918 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.11 171.03 6.04 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.339 1.456 . . . . 20.0 111.932 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.09 -167.09 13.18 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.658 1.123 . . . . 20.0 113.293 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.02 83.56 1.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.57 1.948 . . . . 20.0 107.874 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.42 HD13 HD22 ' A' ' 34' ' ' LEU . 5.3 mp -66.97 159.84 73.7 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.844 1.258 . . . . 20.0 110.233 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -69.47 162.75 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 20.0 110.977 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -69.72 3.92 2.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.742 1.617 . . . . 20.0 113.464 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.5 t -113.3 -0.68 14.48 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.997 2.119 . . . . 20.0 112.616 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.21 0.11 2.54 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.187 1.181 . . . . 20.0 114.187 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.5 t -111.39 110.22 55.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.171 0.989 . . . . 20.0 110.758 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.57 158.9 55.56 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.877 2.384 . . . . 20.0 111.119 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.21 -23.95 66.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.746 1.218 . . . . 20.0 113.534 -171.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -83.37 -30.97 26.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.324 1.45 . . . . 20.0 112.246 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.42 -11.97 58.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.723 1.209 . . . . 20.0 112.968 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -71.37 108.36 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.307 1.443 . . . . 20.0 109.219 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.91 159.63 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.957 0.903 . . . . 20.0 110.89 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -77.47 1.09 20.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.903 1.281 . . . . 20.0 113.165 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.2 170.0 18.81 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.752 1.621 . . . . 20.0 111.148 -172.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.82 171.56 21.71 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.29 0.947 . . . . 20.0 113.055 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.26 -16.18 38.68 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.681 1.134 . . . . 20.0 113.332 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.0 m -72.71 175.21 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.372 1.086 . . . . 20.0 110.587 168.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.2 t -126.82 8.63 6.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.003 1.321 . . . . 20.0 111.92 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -126.58 -64.28 1.03 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.298 1.439 . . . . 20.0 109.404 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.69 156.91 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.932 1.693 . . . . 20.0 110.151 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.5 t -142.12 82.72 1.81 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.257 2.223 . . . . 20.0 107.082 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 152.64 40.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.819 -0.628 . . . . 20.0 111.613 -173.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -102.18 104.61 15.2 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.734 1.214 . . . . 20.0 110.129 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 34' ' ' LEU . 1.1 pt? . . . . . 0 CA--C 1.54 0.596 0 C-N-CA 128.585 2.754 . . . . 20.0 112.153 169.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.227 -0.114 0 CA-C-O 118.888 -0.577 . . . . 20.0 112.236 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.0 t -67.04 -39.71 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.68 0.792 . . . . 20.0 110.741 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -62.72 -35.5 79.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.38 1.072 . . . . 20.0 111.662 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -81.1 -4.97 57.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.856 1.662 . . . . 20.0 113.302 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.54 85.53 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.784 1.183 . . . . 20.0 114.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -75.54 174.84 9.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.391 1.476 . . . . 20.0 111.487 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.63 173.09 16.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.973 0.797 . . . . 20.0 114.139 -174.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 75.8 m -126.28 72.15 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.711 . . . . 20.0 109.239 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.2 mt -68.33 162.02 64.61 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.873 1.269 . . . . 20.0 111.514 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.23 169.8 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.488 2.792 . . . . 20.0 110.665 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.95 -21.17 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.888 0.699 . . . . 20.0 112.888 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 t -65.26 -54.51 28.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.49 1.516 . . . . 20.0 111.21 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.51 -7.63 57.36 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.755 1.02 . . . . 20.0 113.755 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -115.86 81.07 9.31 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.82 1.248 . . . . 20.0 110.322 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.69 172.96 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.926 3.084 . . . . 20.0 112.477 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.03 -7.41 22.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.567 1.547 . . . . 20.0 113.52 174.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.24 -28.1 17.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.308 1.443 . . . . 20.0 112.209 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.08 -11.11 19.11 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 20.0 113.851 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -59.99 139.56 57.34 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.182 0.993 . . . . 20.0 111.291 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.35 165.65 17.08 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.339 0.59 . . . . 20.0 110.423 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.3 t -76.49 -7.61 55.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.834 0.854 . . . . 20.0 112.321 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.23 173.24 11.7 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.402 2.281 . . . . 20.0 110.488 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.67 171.1 32.41 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 121.559 0.533 . . . . 20.0 113.713 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.85 20.53 2.52 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.525 1.536 . . . . 20.0 112.847 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -68.17 179.21 1.61 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.706 1.202 . . . . 20.0 110.698 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.3 t -84.5 -21.74 30.48 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.034 0.534 . . . . 20.0 111.814 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -136.5 -60.35 0.71 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.72 1.208 . . . . 20.0 111.048 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.1 153.99 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.39 1.476 . . . . 20.0 110.476 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.12 132.08 41.26 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.213 1.405 . . . . 20.0 110.371 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.4 m -130.96 144.14 51.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.114 1.366 . . . . 20.0 110.37 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -74.19 103.96 4.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.16 0.984 . . . . 20.0 109.405 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.536 0.41 0 C-N-CA 126.092 1.757 . . . . 20.0 112.543 170.483 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 118.93 -0.557 . . . . 20.0 112.364 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.35 -38.26 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.864 0.866 . . . . 20.0 110.479 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -62.98 -35.51 80.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.038 0.935 . . . . 20.0 111.918 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -81.72 -4.68 56.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.502 1.521 . . . . 20.0 113.041 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.1 2.71 90.6 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.966 1.269 . . . . 20.0 114.948 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -71.53 174.11 7.1 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.802 1.301 . . . . 20.0 112.38 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.54 -177.96 51.86 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.097 1.332 . . . . 20.0 112.744 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.94 59.02 0.79 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.567 1.147 . . . . 20.0 110.006 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.57 153.38 95.76 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.039 0.536 . . . . 20.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.03 172.71 14.15 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.6 3.533 . . . . 20.0 111.475 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -62.28 -13.9 33.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.716 1.376 . . . . 20.0 114.716 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.7 m -95.28 -9.54 32.82 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.294 1.438 . . . . 20.0 113.476 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.83 -2.69 9.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.032 1.733 . . . . 20.0 112.354 175.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.98 85.71 40.95 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.539 1.535 . . . . 20.0 109.721 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.18 175.87 10.68 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.184 3.256 . . . . 20.0 112.326 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.69 -12.99 52.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.33 1.452 . . . . 20.0 113.42 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 -39.02 17.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.389 1.075 . . . . 20.0 112.04 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.72 -10.45 26.82 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.739 1.014 . . . . 20.0 113.739 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -63.37 149.78 45.02 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.92 0.782 . . . . 20.0 111.251 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.99 171.83 11.12 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.225 0.536 . . . . 20.0 110.528 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -67.71 -4.73 13.1 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.202 1.401 . . . . 20.0 112.907 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -148.97 162.21 40.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.316 1.846 . . . . 20.0 110.763 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.8 75.35 0.23 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 125.101 1.334 . . . . 20.0 111.022 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 7.7 61.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.986 1.279 . . . . 20.0 114.786 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 55.7 m -102.93 -172.72 2.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.23 1.812 . . . . 20.0 110.384 170.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -72.45 -27.16 62.13 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.586 1.154 . . . . 20.0 112.082 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 t -155.82 -32.81 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.44 0.904 . . . . 20.0 113.44 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -138.6 130.09 36.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 124.905 1.282 . . . . 20.0 110.732 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.78 141.46 48.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.724 1.61 . . . . 20.0 110.716 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -135.47 157.56 46.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.101 1.76 . . . . 20.0 110.495 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.24 160.34 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.175 0.59 . . . . 20.0 111.614 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 125.912 1.685 . . . . 20.0 113.341 171.768 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 111.742 0.275 . . . . 20.0 111.742 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.23 -37.87 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.1 . . . . 20.0 110.811 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -65.4 -34.69 78.89 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.2 1.0 . . . . 20.0 112.214 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -68.16 -17.67 64.4 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.778 1.231 . . . . 20.0 112.66 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.53 38.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.721 1.629 . . . . 20.0 114.245 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -68.79 168.5 13.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.908 1.354 . . . . 20.0 112.022 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.84 -160.94 27.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.406 1.479 . . . . 20.0 113.171 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 t -154.1 72.6 0.89 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.019 0.928 . . . . 20.0 108.793 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.56 162.36 43.51 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.3 1.44 . . . . 20.0 111.154 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.85 157.76 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.815 2.343 . . . . 20.0 110.766 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -63.37 -20.09 65.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.636 1.174 . . . . 20.0 113.112 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.9 m -87.79 -0.49 57.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.556 1.542 . . . . 20.0 113.715 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.53 -36.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.612 1.096 . . . . 20.0 113.362 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.79 113.2 38.33 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 20.0 109.182 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.78 168.33 23.75 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.99 2.46 . . . . 20.0 111.994 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.49 -4.79 32.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.937 1.295 . . . . 20.0 113.544 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -91.69 -34.55 14.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.634 1.174 . . . . 20.0 112.217 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.19 -18.11 35.07 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.636 1.174 . . . . 20.0 113.605 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -62.01 149.6 40.44 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.357 0.663 . . . . 20.0 112.205 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.62 172.09 8.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.202 1.401 . . . . 20.0 110.451 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -73.93 -7.22 51.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.689 1.196 . . . . 20.0 113.338 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -85.65 -179.63 6.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.712 1.605 . . . . 20.0 113.063 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.62 32.85 2.41 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.114 1.816 . . . . 20.0 112.852 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.22 1.9 54.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.221 1.391 . . . . 20.0 115.708 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.16 172.36 11.07 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.202 1.401 . . . . 20.0 110.197 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -92.25 -12.83 31.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.939 0.896 . . . . 20.0 112.353 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.6 p -130.18 -65.03 0.83 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.092 1.357 . . . . 20.0 109.574 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 m -151.36 159.32 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.451 1.1 . . . . 20.0 111.228 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -133.49 149.19 51.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.732 2.013 . . . . 20.0 108.507 172.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.11 149.37 52.42 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.313 1.045 . . . . 20.0 111.069 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -89.57 77.44 7.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.737 1.215 . . . . 20.0 113.398 -168.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 114.703 1.371 . . . . 20.0 114.703 178.418 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 121.623 0.725 . . . . 20.0 111.249 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -64.66 -42.58 95.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.401 1.48 . . . . 20.0 111.917 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.459 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 67.1 m -68.61 -39.06 81.03 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.38 1.072 . . . . 20.0 112.293 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.02 -40.33 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.124 0.97 . . . . 20.0 110.485 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.5 t -56.02 -48.0 76.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.286 1.034 . . . . 20.0 111.018 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -73.56 -3.84 30.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.228 1.811 . . . . 20.0 113.585 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.12 0.41 89.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.129 1.347 . . . . 20.0 115.058 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -72.01 165.42 24.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.672 1.236 . . . . 20.0 112.296 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.81 -158.41 30.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.111 1.815 . . . . 20.0 111.792 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.21 116.49 6.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.35 1.06 . . . . 20.0 108.811 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.52 159.13 33.36 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.516 1.527 . . . . 20.0 110.02 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.27 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.246 2.631 . . . . 20.0 111.719 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -68.25 -8.67 41.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.729 1.612 . . . . 20.0 113.7 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.7 p -107.24 -29.74 9.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.509 1.524 . . . . 20.0 113.577 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.26 -26.08 19.17 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.8 0.727 . . . . 20.0 112.406 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -85.1 110.49 28.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.463 1.505 . . . . 20.0 109.634 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.75 167.2 26.4 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.786 2.324 . . . . 20.0 111.487 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.42 -8.17 44.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.031 1.332 . . . . 20.0 113.327 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.53 -28.25 16.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.246 1.418 . . . . 20.0 111.792 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.16 -15.41 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.244 1.418 . . . . 20.0 113.513 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -60.05 139.37 57.51 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.728 0.811 . . . . 20.0 110.129 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.14 158.43 15.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.641 0.734 . . . . 20.0 110.823 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t -80.22 9.05 6.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.781 1.632 . . . . 20.0 112.88 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.86 168.97 9.25 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.044 1.338 . . . . 20.0 112.77 -168.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.13 32.1 7.54 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.325 1.917 . . . . 20.0 113.01 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA3' ' H ' ' A' ' 3' ' ' CYS . . . -76.6 -0.02 66.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.28 1.419 . . . . 20.0 115.749 -173.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m -125.08 -172.18 2.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.905 2.082 . . . . 20.0 110.22 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -105.89 -3.97 21.24 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 20.0 113.232 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.9 t -144.29 -55.63 0.35 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.268 1.027 . . . . 20.0 110.816 171.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -145.8 152.31 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.549 1.54 . . . . 20.0 109.151 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -121.84 144.23 48.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.682 1.193 . . . . 20.0 109.535 172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -135.23 149.64 49.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.865 1.266 . . . . 20.0 109.603 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -74.91 175.41 8.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.874 0.87 . . . . 20.0 111.876 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.3 mt -125.21 5.32 7.81 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.846 1.658 . . . . 20.0 112.117 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 t -67.4 -19.86 65.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.448 1.099 . . . . 20.0 113.475 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -68.03 -27.66 66.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.394 0.997 . . . . 20.0 112.349 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.2 mt -72.03 -39.97 68.74 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.667 1.187 . . . . 20.0 111.112 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -79.83 -12.86 59.74 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.772 1.229 . . . . 20.0 113.158 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.507 -1.718 . . . . 20.0 111.592 -179.451 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.133 -0.321 . . . . 20.0 110.133 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.12 -36.38 81.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.624 0.77 . . . . 20.0 111.369 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.74 -43.84 71.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.708 0.685 . . . . 20.0 111.867 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.75 -22.93 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.263 1.025 . . . . 20.0 111.227 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -58.73 -33.89 70.74 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.84 0.856 . . . . 20.0 113.161 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -79.16 -11.23 59.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.542 1.537 . . . . 20.0 113.342 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.95 -2.89 31.7 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.175 1.845 . . . . 20.0 114.329 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -72.42 -178.85 2.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.041 1.336 . . . . 20.0 112.154 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.3 168.62 21.48 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.887 1.232 . . . . 20.0 111.187 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 t -126.49 68.62 1.23 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 20.0 110.669 -160.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.3 mt -72.78 153.59 91.28 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.268 0.627 . . . . 20.0 111.882 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.65 173.97 11.76 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.724 3.616 . . . . 20.0 111.931 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.24 -38.2 73.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.686 1.195 . . . . 20.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.3 p -67.53 -17.32 64.62 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.153 1.381 . . . . 20.0 113.874 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.73 -12.27 10.27 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.028 1.731 . . . . 20.0 111.777 -174.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 t -122.83 89.46 50.29 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.373 1.469 . . . . 20.0 109.026 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.04 166.81 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.145 2.563 . . . . 20.0 110.753 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.94 -33.02 70.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.628 1.171 . . . . 20.0 112.907 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.94 -32.98 74.79 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.118 1.367 . . . . 20.0 112.429 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.37 -10.05 45.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.37 1.468 . . . . 20.0 113.156 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -65.05 143.91 57.61 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.005 0.922 . . . . 20.0 110.056 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.89 175.86 10.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 20.0 111.178 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -73.5 -7.64 52.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.303 0.641 . . . . 20.0 112.322 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -137.13 173.17 11.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.847 2.059 . . . . 20.0 110.625 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.17 -95.21 0.9 Allowed Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.281 0.943 . . . . 20.0 111.607 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 -32.15 4.72 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.56 2.029 . . . . 20.0 113.554 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m -82.5 -177.98 6.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.081 0.94 . . . . 20.0 110.574 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -74.86 -31.95 61.77 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.792 1.237 . . . . 20.0 110.255 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 p -136.11 -55.02 0.76 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.456 1.502 . . . . 20.0 111.341 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -145.23 137.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.678 1.591 . . . . 20.0 108.836 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.2 t -125.98 155.05 42.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.528 1.531 . . . . 20.0 109.905 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.8 160.51 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.835 1.254 . . . . 20.0 110.826 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.08 35.6 0.99 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.998 1.481 . . . . 20.0 114.998 -164.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.0 16.35 1.52 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.856 1.428 . . . . 20.0 114.856 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.7 t -54.16 -40.22 67.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.773 1.229 . . . . 20.0 111.795 167.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -65.95 -20.22 66.13 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.004 1.112 . . . . 20.0 114.004 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.16 -48.43 7.4 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.623 1.169 . . . . 20.0 110.256 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 m -66.02 -26.25 67.44 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.819 1.648 . . . . 20.0 112.312 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 C-N-CA 126.067 1.794 . . . . 20.0 113.815 173.821 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 110.517 -0.179 . . . . 20.0 110.517 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -67.16 -37.71 84.21 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.987 1.315 . . . . 20.0 111.958 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 t -61.99 -44.7 96.18 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.918 0.887 . . . . 20.0 110.702 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.97 -38.18 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.978 1.311 . . . . 20.0 111.471 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -67.36 -31.78 72.26 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.002 0.819 . . . . 20.0 112.666 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -73.45 -3.19 25.96 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.22 1.808 . . . . 20.0 113.426 171.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.77 -4.87 69.1 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.419 1.485 . . . . 20.0 114.542 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.97 -174.39 4.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.642 1.177 . . . . 20.0 111.155 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.13 -176.19 14.38 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.194 1.378 . . . . 20.0 111.499 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.3 m -134.56 88.77 2.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.989 1.315 . . . . 20.0 108.328 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.71 161.89 10.41 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.817 1.647 . . . . 20.0 111.367 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.7 165.1 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.471 2.114 . . . . 20.0 111.188 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.31 4.6 4.43 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.917 1.687 . . . . 20.0 113.287 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.0 p -115.7 -4.38 12.19 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.859 2.063 . . . . 20.0 113.711 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.18 -27.57 1.59 Allowed 'General case' 0 C--N 1.346 0.452 0 N-CA-C 114.081 1.141 . . . . 20.0 114.081 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 t -58.24 106.14 0.65 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 126.516 1.926 . . . . 20.0 110.508 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.75 155.9 35.14 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.601 2.2 . . . . 20.0 111.297 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -68.44 -17.84 64.29 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.631 0.604 . . . . 20.0 112.631 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -76.73 -33.5 58.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.847 1.259 . . . . 20.0 112.541 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.84 -5.82 59.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.015 1.116 . . . . 20.0 114.015 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -57.06 117.98 4.55 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.55 1.14 . . . . 20.0 110.529 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.9 mt -75.67 172.07 13.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.615 0.766 . . . . 20.0 110.717 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -70.2 -2.88 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.855 1.262 . . . . 20.0 113.289 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.55 163.3 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.965 1.706 . . . . 20.0 111.471 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.07 77.94 0.24 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.5 1.524 . . . . 20.0 110.663 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.23 6.4 76.12 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.699 1.142 . . . . 20.0 115.547 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 m -130.17 -175.73 3.72 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.883 2.073 . . . . 20.0 110.126 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.1 p -90.48 -7.37 53.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.026 1.33 . . . . 20.0 112.656 -171.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 p -131.85 -63.3 0.83 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.309 1.444 . . . . 20.0 109.971 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.55 152.58 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.734 1.213 . . . . 20.0 111.08 -171.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -133.74 67.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.239 1.816 . . . . 20.0 108.266 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.96 131.23 40.51 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 123.997 0.919 . . . . 20.0 109.451 167.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.77 159.78 21.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.208 0.603 . . . . 20.0 111.518 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 pp -133.79 -6.51 2.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.015 1.117 . . . . 20.0 114.015 164.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 t -65.96 -29.84 70.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.809 0.844 . . . . 20.0 111.707 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -89.41 -25.26 21.62 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.937 1.295 . . . . 20.0 111.289 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.5 mt -72.66 -38.45 67.63 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.62 1.168 . . . . 20.0 111.386 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 t -89.77 -6.42 55.99 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.917 1.287 . . . . 20.0 112.654 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.954 1.74 . . . . 20.0 111.336 -179.524 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.463 0.173 . . . . 20.0 110.614 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -68.17 -45.17 74.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.449 1.5 . . . . 20.0 112.255 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.0 t -66.76 -44.33 81.72 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.796 1.238 . . . . 20.0 111.786 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.94 -18.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.139 1.376 . . . . 20.0 111.935 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.8 t -58.23 -42.15 85.68 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.755 1.222 . . . . 20.0 112.081 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -21.83 64.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.763 1.625 . . . . 20.0 112.942 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.54 -3.36 36.85 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.016 1.769 . . . . 20.0 113.937 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -70.45 168.64 15.71 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.554 1.177 . . . . 20.0 112.252 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.01 -175.32 50.63 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.188 1.375 . . . . 20.0 112.417 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 t -151.93 49.56 0.79 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.452 1.101 . . . . 20.0 109.274 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.07 153.87 16.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.829 1.251 . . . . 20.0 111.721 -173.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.59 170.67 19.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.404 2.736 . . . . 20.0 112.447 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -65.21 -4.07 4.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.687 1.995 . . . . 20.0 114.449 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.5 t -115.65 -11.56 11.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.562 1.545 . . . . 20.0 113.066 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.09 -26.53 5.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.1 -0.952 . . . . 20.0 113.233 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 t -65.23 107.21 1.31 Allowed Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.36 1.864 . . . . 20.0 109.605 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.22 152.45 50.33 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.323 2.015 . . . . 20.0 110.035 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.31 -25.66 68.41 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.668 1.187 . . . . 20.0 112.64 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.16 -31.63 49.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.932 1.293 . . . . 20.0 112.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.39 58.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.794 1.035 . . . . 20.0 113.794 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -60.71 117.21 5.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.361 1.064 . . . . 20.0 108.723 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.3 176.39 3.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.676 1.191 . . . . 20.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 t -69.95 -3.9 18.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.058 0.943 . . . . 20.0 113.023 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -138.88 169.18 18.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.55 1.94 . . . . 20.0 110.586 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.91 71.69 0.49 Allowed Glycine 0 C--N 1.341 0.809 0 C-N-CA 125.013 1.292 . . . . 20.0 111.259 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.12 -19.66 76.82 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.845 0.736 . . . . 20.0 114.103 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.32 174.55 9.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.576 1.15 . . . . 20.0 111.148 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.6 m -86.59 -5.66 59.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.663 1.185 . . . . 20.0 111.987 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -149.56 -53.15 0.16 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.849 1.26 . . . . 20.0 111.681 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.21 122.46 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.568 1.147 . . . . 20.0 111.505 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.4 t -106.24 82.94 1.82 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.339 2.256 . . . . 20.0 108.944 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.26 142.94 27.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.87 1.268 . . . . 20.0 111.098 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.93 170.25 16.97 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.92 0.888 . . . . 20.0 112.207 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.37 -5.79 8.79 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.732 1.613 . . . . 20.0 112.117 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 t -70.58 -19.75 62.83 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.194 1.398 . . . . 20.0 112.614 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -62.53 -22.02 65.98 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.889 1.276 . . . . 20.0 113.652 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.84 -56.4 10.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.562 1.145 . . . . 20.0 110.343 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 t -72.16 -10.71 60.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.321 1.048 . . . . 20.0 113.193 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 CA-C-O 116.323 -2.376 . . . . 20.0 113.613 177.195 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 110.22 -0.289 . . . . 20.0 110.22 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.87 -42.65 99.32 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.185 0.994 . . . . 20.0 111.553 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.9 t -61.8 -45.82 92.21 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.069 0.947 . . . . 20.0 111.272 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -67.14 -34.85 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.885 1.274 . . . . 20.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.5 m -66.94 -36.94 83.35 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.185 0.994 . . . . 20.0 111.865 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -73.46 -5.73 41.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.718 1.207 . . . . 20.0 113.158 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.04 85.2 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.885 1.231 . . . . 20.0 113.878 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -84.26 168.7 15.45 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.163 1.385 . . . . 20.0 112.117 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.11 167.86 24.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.387 0.994 . . . . 20.0 113.234 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.9 m -126.81 74.09 1.46 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.701 1.6 . . . . 20.0 108.388 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.04 162.23 40.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.776 1.231 . . . . 20.0 110.824 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.44 173.4 14.54 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.365 2.71 . . . . 20.0 110.959 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -66.67 -0.46 2.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.221 1.809 . . . . 20.0 113.733 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.6 p -125.96 -8.08 6.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.941 1.696 . . . . 20.0 114.583 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -128.9 -6.4 5.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.355 0.979 . . . . 20.0 113.222 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.0 t -76.92 116.08 53.98 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.847 0.859 . . . . 20.0 108.741 163.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.87 159.18 48.78 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.733 2.289 . . . . 20.0 110.443 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -63.54 -24.59 67.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.029 0.932 . . . . 20.0 112.259 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.46 -30.66 64.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.959 1.304 . . . . 20.0 112.43 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 -18.71 41.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.052 1.13 . . . . 20.0 114.052 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -60.85 120.5 10.27 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.895 1.278 . . . . 20.0 111.313 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.9 mt -82.4 171.11 14.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.449 1.099 . . . . 20.0 112.015 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -69.49 -12.62 61.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.27 1.428 . . . . 20.0 112.445 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -132.6 168.97 17.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.939 2.095 . . . . 20.0 110.838 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.61 71.56 0.49 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.625 1.583 . . . . 20.0 110.806 -173.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.58 -7.9 87.87 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.336 0.969 . . . . 20.0 114.853 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m -81.63 -168.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.516 1.526 . . . . 20.0 109.778 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.0 p -103.12 -6.53 22.13 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.664 1.185 . . . . 20.0 111.987 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.3 p -127.92 -74.48 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.005 2.122 . . . . 20.0 109.247 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 m -150.5 120.48 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.76 1.624 . . . . 20.0 109.119 -172.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.45 108.74 19.82 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.465 1.106 . . . . 20.0 109.257 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -126.16 113.17 16.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.169 1.387 . . . . 20.0 109.015 -168.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.57 172.25 3.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.059 1.344 . . . . 20.0 112.873 -172.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 69.6 mt -126.36 7.93 7.1 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.122 1.369 . . . . 20.0 111.932 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -64.07 -25.66 68.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.336 1.054 . . . . 20.0 113.329 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -65.06 -31.87 73.3 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 124.254 1.021 . . . . 20.0 111.906 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.8 mt -72.74 -14.83 61.64 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.568 1.147 . . . . 20.0 113.315 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.0 t -123.29 6.52 9.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.376 1.87 . . . . 20.0 111.077 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 CA-C-O 117.184 -1.898 . . . . 20.0 111.425 -176.896 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 109.806 -0.442 . . . . 20.0 109.806 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.55 -46.1 80.8 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.788 -0.625 . . . . 20.0 111.494 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 1.0 OUTLIER -60.37 -32.6 71.45 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.765 0.654 . . . . 20.0 112.765 -177.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.44 -46.17 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.19 1.396 . . . . 20.0 110.39 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -65.32 -29.4 70.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.14 1.376 . . . . 20.0 112.665 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -71.51 -6.05 37.64 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.546 1.938 . . . . 20.0 112.669 171.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.41 6.32 89.33 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.599 -1.111 . . . . 20.0 114.491 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -74.87 167.69 21.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.616 1.208 . . . . 20.0 111.694 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.64 128.26 9.43 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.083 0.849 . . . . 20.0 112.555 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.9 m -82.41 75.0 9.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.913 0.885 . . . . 20.0 108.752 163.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.36 162.96 36.49 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 20.0 110.975 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.66 167.85 25.58 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.818 2.346 . . . . 20.0 110.849 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -74.42 5.85 4.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.621 1.569 . . . . 20.0 113.727 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 t -129.57 12.84 5.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.865 1.666 . . . . 20.0 112.323 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -133.04 -45.93 0.85 Allowed 'General case' 0 C--N 1.346 0.42 0 C-N-CA 124.442 1.097 . . . . 20.0 112.513 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.21 104.31 0.42 Allowed Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 127.336 2.254 . . . . 20.0 111.807 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.78 145.4 36.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.682 2.255 . . . . 20.0 110.96 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -59.91 -26.82 66.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.521 0.934 . . . . 20.0 113.521 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.01 -29.93 70.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.627 1.571 . . . . 20.0 112.647 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.69 24.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.829 1.252 . . . . 20.0 113.64 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -61.23 120.09 9.69 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.754 1.161 . . . . 20.0 110.409 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.09 172.94 10.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.704 1.202 . . . . 20.0 111.773 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -69.85 -10.5 58.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.744 1.218 . . . . 20.0 112.215 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -139.34 172.95 12.07 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.344 2.257 . . . . 20.0 110.591 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.6 76.05 0.21 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.789 -0.924 . . . . 20.0 110.789 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . -69.01 -13.33 66.59 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.841 1.21 . . . . 20.0 113.525 176.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.48 177.37 1.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.732 1.613 . . . . 20.0 111.244 167.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -93.65 -13.01 28.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.73 0.812 . . . . 20.0 112.798 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -135.39 -59.79 0.77 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.395 1.078 . . . . 20.0 110.819 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.9 m -148.22 153.62 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.652 1.581 . . . . 20.0 110.239 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.9 t -134.42 108.86 8.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.656 1.182 . . . . 20.0 109.502 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -102.46 137.22 41.0 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.133 0.973 . . . . 20.0 109.616 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.43 166.46 12.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.61 0.764 . . . . 20.0 111.618 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.17 7.7 9.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.004 1.722 . . . . 20.0 110.882 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 t -60.88 -28.55 68.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.882 2.073 . . . . 20.0 113.44 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.98 -14.92 63.34 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.404 1.261 . . . . 20.0 114.404 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.35 -60.58 2.47 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.153 0.981 . . . . 20.0 109.876 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 p -74.86 -10.49 59.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.935 1.294 . . . . 20.0 113.243 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.237 0 CA-C-O 116.818 -2.101 . . . . 20.0 111.89 -178.94 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 121.162 0.506 . . . . 20.0 111.657 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -67.09 -48.82 67.05 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.04 0.936 . . . . 20.0 111.561 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -61.98 -26.8 68.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.009 0.744 . . . . 20.0 113.009 -175.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.9 t -83.48 -41.19 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.436 1.495 . . . . 20.0 110.766 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -60.81 -35.2 75.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.704 1.202 . . . . 20.0 111.995 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -69.32 -14.16 62.78 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.887 2.075 . . . . 20.0 113.233 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 16.91 77.29 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.653 -1.082 . . . . 20.0 114.601 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -59.87 165.59 3.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.6 1.16 . . . . 20.0 112.567 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.51 -33.83 67.59 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.1 1.333 . . . . 20.0 113.986 -175.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 t 50.67 37.22 15.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.146 1.779 . . . . 20.0 112.008 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.49 154.12 56.66 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.934 1.294 . . . . 20.0 111.821 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.17 171.24 11.74 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.746 2.964 . . . . 20.0 111.342 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.65 -22.54 66.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.176 0.99 . . . . 20.0 112.475 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -80.99 -3.76 52.8 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.245 1.818 . . . . 20.0 114.161 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.5 -42.9 1.29 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.141 1.376 . . . . 20.0 112.918 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.86 109.78 5.36 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.218 1.807 . . . . 20.0 110.601 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.6 170.33 15.89 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.552 2.835 . . . . 20.0 112.199 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -66.77 -12.96 60.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.362 1.465 . . . . 20.0 113.411 173.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -96.32 -29.31 14.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.335 1.054 . . . . 20.0 112.82 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.68 -5.4 21.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.483 1.113 . . . . 20.0 113.633 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -60.43 136.2 57.97 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.774 0.716 . . . . 20.0 110.872 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.17 172.04 13.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.29 1.036 . . . . 20.0 111.186 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -72.46 -9.13 58.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.779 0.832 . . . . 20.0 112.318 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.22 172.22 13.33 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.781 2.032 . . . . 20.0 110.973 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.58 67.14 0.39 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.658 1.123 . . . . 20.0 111.654 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . -77.49 -7.42 87.09 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.128 1.347 . . . . 20.0 114.388 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.4 m -66.98 179.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.854 1.327 . . . . 20.0 111.378 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 t -68.62 -29.6 68.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.342 1.057 . . . . 20.0 111.543 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -158.85 -28.25 0.07 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 20.0 113.744 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 p -139.13 135.82 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.106 1.362 . . . . 20.0 110.241 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.2 t -133.64 139.28 46.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.063 1.345 . . . . 20.0 110.812 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.01 140.77 34.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.879 1.672 . . . . 20.0 109.2 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.06 166.78 18.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.209 0.604 . . . . 20.0 110.956 172.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.6 mt -128.99 0.42 5.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.715 1.606 . . . . 20.0 112.368 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 t -62.71 -25.03 67.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.948 1.299 . . . . 20.0 113.908 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 36' ' ' LYS . 10.7 mmpt? -67.3 -18.77 65.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.415 1.086 . . . . 20.0 113.144 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.86 -25.85 67.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.111 0.964 . . . . 20.0 112.823 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.3 p -119.19 1.59 11.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.225 1.81 . . . . 20.0 112.477 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.7 -1.611 . . . . 20.0 110.918 178.977 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.709 -0.478 . . . . 20.0 109.709 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -59.68 -41.41 90.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.126 1.37 . . . . 20.0 112.513 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -39.15 76.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.117 0.567 . . . . 20.0 111.743 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.36 -36.85 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.061 0.945 . . . . 20.0 110.685 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -65.49 -30.5 71.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.108 1.363 . . . . 20.0 112.056 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -80.32 -12.02 59.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.719 1.608 . . . . 20.0 113.026 171.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.0 12.85 56.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.742 1.163 . . . . 20.0 114.928 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -89.18 167.56 13.0 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.832 1.316 . . . . 20.0 112.781 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.7 -175.87 47.0 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.991 1.281 . . . . 20.0 113.363 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 t -138.28 65.52 1.46 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.119 1.367 . . . . 20.0 109.133 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.57 156.15 78.75 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.38 1.472 . . . . 20.0 110.81 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.46 164.37 35.49 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.178 2.586 . . . . 20.0 110.937 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -64.9 -22.84 67.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.654 0.782 . . . . 20.0 112.993 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.7 m -82.79 -3.76 57.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.909 1.284 . . . . 20.0 113.626 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -129.55 0.92 5.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.336 1.454 . . . . 20.0 112.574 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -128.65 80.93 71.72 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.944 1.297 . . . . 20.0 110.443 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.14 175.41 10.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.176 3.251 . . . . 20.0 112.159 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -67.39 -6.89 21.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.735 1.013 . . . . 20.0 113.735 172.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -86.19 -25.1 25.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.915 1.286 . . . . 20.0 112.396 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.27 -7.77 14.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.447 1.499 . . . . 20.0 113.43 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.56 165.34 8.16 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.352 1.061 . . . . 20.0 112.168 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.9 mt -133.94 166.21 23.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.205 1.002 . . . . 20.0 111.599 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -82.67 -9.64 59.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.043 1.337 . . . . 20.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -109.27 2.76 21.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.931 1.692 . . . . 20.0 113.639 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -36.55 87.23 0.01 OUTLIER Glycine 0 CA--C 1.529 0.909 1 C-N-CA 130.987 4.137 . . . . 20.0 115.506 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.62 0.63 63.29 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.069 1.319 . . . . 20.0 113.963 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.7 m -66.54 173.48 3.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 20.0 111.728 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -86.63 -16.1 37.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.887 0.875 . . . . 20.0 111.923 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -132.16 -61.36 0.88 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.373 1.469 . . . . 20.0 110.302 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.5 m -152.18 153.01 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.967 1.307 . . . . 20.0 111.002 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.6 t -131.92 137.01 47.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.988 1.715 . . . . 20.0 109.251 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.3 m -137.21 156.35 48.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.715 1.206 . . . . 20.0 111.089 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.55 126.02 30.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.495 1.118 . . . . 20.0 112.571 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.8 mt -117.87 8.88 12.73 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.836 1.655 . . . . 20.0 113.155 168.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -64.15 -19.21 65.14 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.498 1.045 . . . . 20.0 112.085 171.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -65.24 -14.72 61.37 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.194 1.398 . . . . 20.0 114.042 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.21 -45.13 74.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.972 0.806 . . . . 20.0 110.745 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 p -82.12 -7.52 59.62 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.239 1.416 . . . . 20.0 113.492 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.308 -1.829 . . . . 20.0 111.498 179.019 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.356 -0.238 . . . . 20.0 110.356 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.23 -63.25 1.32 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.719 0.808 . . . . 20.0 110.883 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.4 m -61.29 -45.6 93.8 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 123.593 0.757 . . . . 20.0 112.552 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.36 -32.98 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.194 0.598 . . . . 20.0 111.394 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -67.35 -34.32 77.06 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.524 0.73 . . . . 20.0 111.794 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -9.51 58.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.362 1.065 . . . . 20.0 113.524 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.87 -2.4 84.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.757 1.17 . . . . 20.0 113.911 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -71.19 176.13 4.74 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.603 1.201 . . . . 20.0 110.852 168.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.14 -172.91 15.14 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 123.862 0.744 . . . . 20.0 112.818 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -117.68 82.01 1.76 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.447 1.499 . . . . 20.0 109.155 -173.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 151.8 81.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.185 0.994 . . . . 20.0 109.295 170.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.77 167.74 24.88 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.379 2.719 . . . . 20.0 111.598 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.24 -9.65 42.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.963 1.305 . . . . 20.0 113.272 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -95.63 -13.51 24.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.83 1.652 . . . . 20.0 113.548 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -137.55 20.17 2.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.059 1.344 . . . . 20.0 112.587 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 t -127.74 77.64 75.97 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.152 1.381 . . . . 20.0 109.354 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.34 171.11 18.68 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.068 3.179 . . . . 20.0 112.159 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -63.69 -13.35 42.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.799 1.64 . . . . 20.0 113.756 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.3 -25.98 25.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.75 1.22 . . . . 20.0 112.811 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.66 -8.21 14.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.3 1.44 . . . . 20.0 113.345 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -65.79 170.0 5.83 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.278 1.031 . . . . 20.0 111.789 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.8 mt -130.97 168.42 17.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 20.0 110.248 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -74.04 -19.93 60.46 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.237 1.015 . . . . 20.0 111.913 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -73.9 167.07 22.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.971 1.708 . . . . 20.0 111.675 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.12 87.31 0.12 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.923 0.773 . . . . 20.0 111.662 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.16 3.1 79.88 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.05 1.309 . . . . 20.0 114.172 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.0 m -131.93 -12.33 3.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.632 1.573 . . . . 20.0 114.762 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.3 p 64.79 6.8 3.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 130.889 3.676 . . . . 20.0 113.429 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.3 p -122.53 -57.18 1.76 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.78 1.232 . . . . 20.0 110.772 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.06 135.53 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 126.147 1.779 . . . . 20.0 109.402 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.4 t -145.42 121.71 10.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.839 1.656 . . . . 20.0 109.156 171.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 9.5 m -129.02 148.46 50.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.379 1.471 . . . . 20.0 110.414 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -73.26 107.64 5.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.797 1.239 . . . . 20.0 110.446 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 pp -101.14 -16.07 17.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.157 1.783 . . . . 20.0 112.367 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 t -66.51 -19.54 65.81 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.008 1.323 . . . . 20.0 112.614 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -56.63 -19.59 17.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.372 1.869 . . . . 20.0 114.558 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -66.64 -31.75 72.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.739 1.216 . . . . 20.0 113.47 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.3 m -123.69 -43.43 2.14 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.541 1.536 . . . . 20.0 110.064 -172.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 117.297 -1.835 . . . . 20.0 110.284 179.353 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 120.641 0.257 . . . . 20.0 111.045 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -60.16 -58.07 10.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.69 1.596 . . . . 20.0 112.065 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -61.6 -36.46 80.76 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.87 0.692 . . . . 20.0 112.87 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.55 -37.41 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 124.131 0.972 . . . . 20.0 110.484 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.6 t -66.98 -30.53 70.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.257 1.023 . . . . 20.0 111.91 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.11 -2.07 46.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.138 1.375 . . . . 20.0 112.564 171.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.88 -5.01 84.95 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.903 1.716 . . . . 20.0 114.961 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -76.39 168.32 20.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.783 1.292 . . . . 20.0 112.14 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.14 170.93 32.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.639 1.114 . . . . 20.0 112.51 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.0 m -126.0 68.65 1.19 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.669 1.588 . . . . 20.0 107.936 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.66 161.47 65.77 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.999 1.72 . . . . 20.0 110.746 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.45 164.76 34.66 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.599 2.2 . . . . 20.0 111.329 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -66.94 -6.97 18.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.675 1.59 . . . . 20.0 113.738 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -121.05 -5.3 9.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.736 1.615 . . . . 20.0 113.964 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -105.58 -42.39 5.21 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.229 0.922 . . . . 20.0 112.026 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.6 115.46 27.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.39 1.076 . . . . 20.0 109.863 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.24 160.62 35.91 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.547 2.164 . . . . 20.0 110.381 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -63.9 -16.93 62.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.871 1.268 . . . . 20.0 112.643 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -70.6 -25.89 63.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.912 1.285 . . . . 20.0 112.669 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.79 2.74 10.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.858 1.663 . . . . 20.0 113.461 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.02 151.34 40.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.892 0.877 . . . . 20.0 109.821 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.6 mt -95.15 166.86 11.71 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.423 0.63 . . . . 20.0 110.214 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -74.15 -3.07 27.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.01 0.924 . . . . 20.0 112.32 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -143.78 169.11 18.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.687 1.995 . . . . 20.0 110.808 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.76 79.64 0.37 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 125.082 1.325 . . . . 20.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 -3.05 65.37 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.079 0.847 . . . . 20.0 114.247 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.1 m -85.08 -166.48 1.51 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.9 2.08 . . . . 20.0 110.314 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 t -91.62 -18.15 24.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.938 0.895 . . . . 20.0 112.479 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.7 p -134.22 -61.7 0.77 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.417 1.087 . . . . 20.0 110.622 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -150.09 157.92 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.301 1.84 . . . . 20.0 109.648 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.1 t -125.73 151.95 45.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.309 1.444 . . . . 20.0 110.176 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -137.78 125.96 23.03 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.653 0.781 . . . . 20.0 110.812 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 147.24 46.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.712 1.205 . . . . 20.0 110.052 169.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 41.8 mt -126.38 -3.92 6.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.263 1.425 . . . . 20.0 111.902 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.2 t -69.57 -18.72 63.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.528 1.131 . . . . 20.0 113.089 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -21.88 66.6 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.343 1.057 . . . . 20.0 112.994 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.41 -17.66 61.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.765 1.226 . . . . 20.0 113.242 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.5 t -117.85 4.01 12.21 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.706 1.602 . . . . 20.0 111.804 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 117.853 -1.526 . . . . 20.0 110.859 177.27 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.477 -0.194 . . . . 20.0 110.477 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.15 -33.22 74.08 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.677 1.191 . . . . 20.0 112.399 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.5 m -58.25 -52.1 67.0 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.018 1.327 . . . . 20.0 109.997 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.8 -40.14 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.287 1.435 . . . . 20.0 111.171 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -62.32 -41.32 98.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.443 1.097 . . . . 20.0 111.756 -176.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -83.07 -7.31 59.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.331 1.052 . . . . 20.0 113.336 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.72 79.02 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.597 1.094 . . . . 20.0 114.955 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -65.37 164.74 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.043 1.422 . . . . 20.0 111.831 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.97 178.72 53.38 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 121.994 0.774 . . . . 20.0 112.103 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.6 t -150.34 76.81 1.28 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.118 -1.438 . . . . 20.0 107.118 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 157.44 86.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.841 1.257 . . . . 20.0 110.919 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.66 174.39 8.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.951 3.101 . . . . 20.0 111.352 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -60.11 -16.67 34.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.571 1.148 . . . . 20.0 113.124 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 m -89.11 -11.02 45.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.711 1.604 . . . . 20.0 113.862 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.11 -0.88 4.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.896 1.678 . . . . 20.0 113.199 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -120.33 77.51 26.07 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.921 1.288 . . . . 20.0 109.406 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.15 170.57 19.53 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.533 2.822 . . . . 20.0 110.963 175.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -60.56 -26.02 66.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.397 1.079 . . . . 20.0 112.753 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.63 -46.26 72.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.758 1.623 . . . . 20.0 111.859 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.78 -4.54 56.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.749 1.219 . . . . 20.0 113.929 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -60.4 145.3 48.54 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.321 1.049 . . . . 20.0 111.618 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.81 173.75 9.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.835 1.254 . . . . 20.0 111.51 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 t -65.02 -14.13 59.65 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.634 1.574 . . . . 20.0 112.737 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.18 168.12 20.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.419 2.287 . . . . 20.0 110.269 -174.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.67 85.18 0.17 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 124.465 1.031 . . . . 20.0 111.305 -170.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.67 -13.37 80.09 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.557 1.075 . . . . 20.0 115.01 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.4 m -80.82 -179.71 7.41 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.548 1.139 . . . . 20.0 111.294 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -93.78 -9.83 36.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.9 1.28 . . . . 20.0 111.987 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.5 p -133.13 -65.61 0.69 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.982 1.313 . . . . 20.0 109.736 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.84 156.14 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.363 1.465 . . . . 20.0 110.507 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -144.37 115.95 8.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.186 1.394 . . . . 20.0 109.35 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.84 136.73 51.83 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.215 1.006 . . . . 20.0 111.93 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.73 124.83 28.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.36 1.464 . . . . 20.0 109.464 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.82 -8.05 10.38 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.685 1.594 . . . . 20.0 112.942 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.0 t -70.56 -15.51 62.78 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.598 1.559 . . . . 20.0 112.489 174.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -60.55 -21.05 62.13 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.377 1.071 . . . . 20.0 112.908 167.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.31 -56.18 2.36 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.93 1.692 . . . . 20.0 109.396 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.9 p -87.14 68.99 10.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.622 1.569 . . . . 20.0 110.123 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.389 -1.784 . . . . 20.0 110.955 177.674 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.483 0.182 . . . . 20.0 111.058 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -125.23 -51.09 1.65 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.358 1.463 . . . . 20.0 111.21 -172.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.0 t -66.71 -26.82 67.19 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.407 0.549 . . . . 20.0 111.774 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.6 t -73.74 -25.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.655 1.182 . . . . 20.0 111.16 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -67.9 -32.78 73.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.46 0.704 . . . . 20.0 111.916 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -67.94 -20.73 65.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.286 1.034 . . . . 20.0 112.711 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.69 -2.34 21.61 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.087 1.803 . . . . 20.0 114.132 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -77.8 175.99 9.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.583 1.192 . . . . 20.0 112.587 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -23.45 30.48 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.295 -0.725 . . . . 20.0 114.206 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.9 t 49.92 49.56 20.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.086 1.754 . . . . 20.0 112.523 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.08 155.21 84.8 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.532 1.133 . . . . 20.0 111.291 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.13 169.98 21.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.505 2.803 . . . . 20.0 112.306 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -69.34 8.7 0.56 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.465 1.906 . . . . 20.0 114.036 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.3 p -120.03 -6.31 9.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.337 1.855 . . . . 20.0 113.122 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -136.73 -17.76 1.44 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 113.842 1.053 . . . . 20.0 113.842 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -85.68 114.75 58.42 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.067 0.947 . . . . 20.0 109.616 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.21 162.9 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.772 2.315 . . . . 20.0 111.741 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -70.96 -6.42 38.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.363 1.465 . . . . 20.0 114.313 -173.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.42 -32.11 10.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.775 1.23 . . . . 20.0 111.848 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.16 -21.28 39.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 113.818 1.044 . . . . 20.0 113.818 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -63.4 157.47 23.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.011 0.924 . . . . 20.0 111.804 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.67 162.98 12.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.154 1.381 . . . . 20.0 110.408 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -83.22 -3.89 57.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.377 1.071 . . . . 20.0 111.677 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -148.93 176.19 10.63 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.733 2.013 . . . . 20.0 111.069 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.29 -166.29 30.04 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.133 0.873 . . . . 20.0 112.317 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.82 7.69 4.19 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.499 1.523 . . . . 20.0 114.047 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.9 173.53 5.27 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.801 1.24 . . . . 20.0 111.918 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.2 t -96.76 -5.43 38.59 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.119 1.367 . . . . 20.0 112.544 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.2 t -147.27 -49.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.278 1.031 . . . . 20.0 111.76 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -162.94 145.01 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.975 1.71 . . . . 20.0 108.164 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.1 t -114.27 151.76 32.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.285 1.034 . . . . 20.0 110.567 166.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.82 129.04 22.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.127 1.371 . . . . 20.0 109.574 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.16 137.44 33.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.156 0.982 . . . . 20.0 110.445 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.9 mt -111.16 0.68 16.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.502 1.521 . . . . 20.0 112.633 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -60.15 -32.08 70.7 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.075 0.95 . . . . 20.0 111.917 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -68.44 -31.3 70.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.227 1.411 . . . . 20.0 112.284 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.1 mt -70.42 -48.85 54.08 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.142 0.977 . . . . 20.0 111.054 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 t -75.07 -4.68 39.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.55 1.14 . . . . 20.0 113.06 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 117.695 -1.614 . . . . 20.0 110.602 174.528 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.511 -0.551 . . . . 20.0 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -62.14 -30.96 71.4 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.985 0.914 . . . . 20.0 112.741 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -50.46 53.59 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.359 0.664 . . . . 20.0 110.555 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.46 -32.24 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.589 1.156 . . . . 20.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.4 t -64.03 -39.79 94.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.503 1.121 . . . . 20.0 111.56 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -72.47 -6.0 40.67 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.689 1.196 . . . . 20.0 113.262 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.53 4.22 64.15 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.338 1.447 . . . . 20.0 114.625 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -77.45 171.22 15.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.55 1.14 . . . . 20.0 112.069 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.97 177.8 31.68 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.262 1.41 . . . . 20.0 113.136 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -133.6 69.17 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.84 1.656 . . . . 20.0 107.451 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.43 159.84 47.18 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.973 1.709 . . . . 20.0 110.914 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.54 166.0 30.95 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.846 2.364 . . . . 20.0 111.0 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -67.72 -19.71 65.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.87 1.268 . . . . 20.0 112.786 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -83.69 -16.97 42.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.992 1.317 . . . . 20.0 113.062 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -124.84 5.45 8.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.285 1.434 . . . . 20.0 113.157 -174.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -120.08 78.15 24.8 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.092 0.957 . . . . 20.0 110.43 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.82 172.68 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.536 2.824 . . . . 20.0 111.7 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -65.19 -13.36 58.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.516 1.127 . . . . 20.0 113.33 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.41 -32.56 20.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.042 1.337 . . . . 20.0 112.215 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 -18.33 22.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.28 1.032 . . . . 20.0 113.454 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -70.04 155.48 40.53 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 118.606 0.639 . . . . 20.0 110.6 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.11 177.45 6.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.051 0.94 . . . . 20.0 110.204 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -68.73 -21.93 64.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.333 0.653 . . . . 20.0 111.835 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.21 171.4 14.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.294 1.838 . . . . 20.0 111.66 -168.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.98 177.36 31.01 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.239 0.923 . . . . 20.0 112.812 175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.96 21.58 0.59 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.083 1.325 . . . . 20.0 113.367 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -63.13 176.87 0.68 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.374 1.469 . . . . 20.0 112.234 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -69.22 -29.63 67.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.724 1.209 . . . . 20.0 111.47 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 t -143.5 -41.31 0.29 Allowed 'General case' 0 C--N 1.344 0.354 0 CA-C-O 117.944 -1.027 . . . . 20.0 113.435 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -153.88 151.79 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.538 1.135 . . . . 20.0 109.68 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -118.93 135.17 54.73 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 125.474 1.51 . . . . 20.0 109.226 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -131.94 148.16 52.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.984 1.314 . . . . 20.0 110.039 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -74.73 166.28 23.85 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.611 -0.722 . . . . 20.0 111.476 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt -124.43 11.49 8.66 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.407 1.483 . . . . 20.0 111.521 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.0 t -63.9 -19.7 65.29 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.815 1.646 . . . . 20.0 113.449 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -63.13 -24.93 68.12 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.628 1.171 . . . . 20.0 113.498 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.4 mt -77.48 -43.46 32.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.323 1.049 . . . . 20.0 110.882 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -82.66 70.53 9.65 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.015 1.726 . . . . 20.0 110.255 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.145 -1.919 . . . . 20.0 111.204 176.636 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.47 HD21 ' HA ' ' A' ' 27' ' ' CYS . 19.1 t-20 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.636 -0.505 . . . . 20.0 109.636 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -66.64 -32.92 74.55 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.706 0.803 . . . . 20.0 112.756 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t -70.59 -43.4 69.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.392 0.277 . . . . 20.0 110.4 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.4 -39.92 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.048 1.339 . . . . 20.0 111.161 173.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -68.1 -32.05 72.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.267 1.027 . . . . 20.0 112.35 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -75.28 -9.95 59.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.63 1.572 . . . . 20.0 112.479 171.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.11 -2.96 69.39 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.254 1.407 . . . . 20.0 114.572 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -77.14 170.19 16.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.762 1.281 . . . . 20.0 111.72 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.54 160.13 23.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.907 0.765 . . . . 20.0 113.067 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.1 m -124.35 65.78 1.07 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.866 1.666 . . . . 20.0 109.189 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 mt -65.43 163.22 34.85 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.88 1.272 . . . . 20.0 111.512 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.62 170.93 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.036 2.491 . . . . 20.0 110.753 168.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -60.69 -27.05 67.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.429 1.092 . . . . 20.0 112.505 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -74.31 -10.6 59.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.861 1.264 . . . . 20.0 113.847 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.96 -5.27 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.044 1.338 . . . . 20.0 113.174 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.9 t -124.19 83.49 56.36 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.219 1.408 . . . . 20.0 109.809 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.89 173.48 14.43 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.966 3.11 . . . . 20.0 111.933 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -14.81 56.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 20.0 113.048 173.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.78 -29.26 50.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.138 . . . . 20.0 112.909 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.68 -8.68 14.92 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.457 1.103 . . . . 20.0 113.477 -170.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -70.22 159.63 33.65 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.522 0.729 . . . . 20.0 112.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.11 176.91 5.39 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.878 1.271 . . . . 20.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -70.58 -4.96 25.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.841 1.256 . . . . 20.0 113.187 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -139.98 176.29 8.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.152 1.781 . . . . 20.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.4 72.91 0.36 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.688 1.137 . . . . 20.0 111.96 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.42 -18.88 79.94 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.83 -0.983 . . . . 20.0 114.103 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.47 ' HA ' HD21 ' A' ' 1' ' ' ASN . 83.5 m -70.16 179.68 2.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.938 1.295 . . . . 20.0 112.52 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.2 m -86.09 -8.77 57.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.955 1.302 . . . . 20.0 112.264 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 t -148.53 -52.62 0.18 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.863 -1.065 . . . . 20.0 111.845 170.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.13 145.31 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.328 0.967 . . . . 20.0 112.012 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.6 t -122.85 112.28 17.69 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.959 2.103 . . . . 20.0 109.309 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -121.02 142.71 49.55 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.101 1.361 . . . . 20.0 111.726 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.73 137.99 31.92 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.182 1.393 . . . . 20.0 109.947 172.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.9 mt -124.84 14.43 8.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.19 2.196 . . . . 20.0 111.891 -169.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.7 t -59.94 -17.63 39.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.791 2.036 . . . . 20.0 114.961 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -63.84 -22.12 66.77 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.473 1.033 . . . . 20.0 112.706 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.6 mt -117.14 -72.39 0.69 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.811 2.045 . . . . 20.0 109.096 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.1 p -86.08 68.3 10.25 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.979 1.712 . . . . 20.0 109.687 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.212 -1.882 . . . . 20.0 110.395 176.717 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 110.132 -0.321 . . . . 20.0 110.132 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -59.54 -46.75 87.97 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 121.889 -0.507 . . . . 20.0 112.288 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t -56.28 -48.07 77.36 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.605 1.162 . . . . 20.0 111.212 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.06 -39.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.622 1.169 . . . . 20.0 111.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.6 t -67.73 -32.72 73.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 20.0 112.603 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -70.33 -13.02 61.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.153 1.381 . . . . 20.0 112.483 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.4 61.09 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.362 1.458 . . . . 20.0 114.163 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -79.04 171.64 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.671 1.235 . . . . 20.0 111.672 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.54 176.62 41.64 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.169 1.366 . . . . 20.0 112.259 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -141.16 56.45 1.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.906 -1.146 . . . . 20.0 107.906 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.24 157.5 12.12 Favored Pre-proline 0 C--N 1.345 0.375 0 C-N-CA 125.601 1.56 . . . . 20.0 111.666 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.36 167.51 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.822 2.348 . . . . 20.0 110.513 173.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -62.32 -22.12 65.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.558 0.743 . . . . 20.0 112.451 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p -84.41 -12.55 54.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.216 1.806 . . . . 20.0 114.441 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -4.41 11.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.189 1.395 . . . . 20.0 112.977 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 t -116.45 80.76 10.38 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.16 1.384 . . . . 20.0 108.824 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.07 170.73 18.26 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.654 2.903 . . . . 20.0 111.665 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -58.51 -28.78 65.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.708 1.603 . . . . 20.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.22 -40.43 64.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.832 1.253 . . . . 20.0 112.169 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.2 -5.66 57.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.934 1.087 . . . . 20.0 113.934 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -61.96 140.09 58.35 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.883 0.873 . . . . 20.0 110.957 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mt -75.86 173.04 11.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.115 0.96 . . . . 20.0 110.743 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -66.94 -12.62 60.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.373 1.069 . . . . 20.0 112.691 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.05 165.65 26.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.075 2.15 . . . . 20.0 110.869 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.65 86.79 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 125.798 1.666 . . . . 20.0 110.404 -172.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.5 1.37 60.18 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 118.448 -1.196 . . . . 20.0 115.575 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.1 m -97.42 174.35 6.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.643 1.177 . . . . 20.0 110.791 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -88.05 -5.13 58.65 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.403 1.081 . . . . 20.0 112.178 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 t -137.53 -61.26 0.64 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.676 1.591 . . . . 20.0 110.362 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -150.82 135.79 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.318 1.047 . . . . 20.0 110.952 -171.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.9 t -120.51 115.31 23.2 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.5 1.92 . . . . 20.0 109.146 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 m -126.12 146.7 49.83 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.776 1.63 . . . . 20.0 109.916 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.93 164.96 24.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.957 0.503 . . . . 20.0 111.82 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.45 6.04 10.63 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.364 1.466 . . . . 20.0 111.861 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.8 t -71.03 -9.79 58.64 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.551 0.945 . . . . 20.0 113.551 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -69.01 -27.64 65.86 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 119.166 0.894 . . . . 20.0 112.134 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.67 -45.16 83.93 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.687 0.795 . . . . 20.0 110.759 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.3 p -78.19 -12.73 60.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.928 1.291 . . . . 20.0 112.856 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.299 0 CA-C-O 117.8 -1.555 . . . . 20.0 112.334 174.705 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.573 0.225 . . . . 20.0 111.134 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -73.02 -46.02 54.4 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.122 0.969 . . . . 20.0 112.539 -175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.9 t -72.02 -25.5 61.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.389 0.676 . . . . 20.0 112.686 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.83 -36.42 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.729 0.812 . . . . 20.0 109.62 173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.0 m -69.32 -13.46 62.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.631 1.173 . . . . 20.0 113.249 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -69.6 -10.04 56.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.347 1.059 . . . . 20.0 112.085 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.15 -3.06 56.74 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.558 1.551 . . . . 20.0 113.791 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.07 -96.59 0.11 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.296 1.048 . . . . 20.0 109.583 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.37 -155.06 25.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.303 1.43 . . . . 20.0 111.188 -170.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -149.89 145.11 26.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.749 1.22 . . . . 20.0 109.378 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.439 HD22 ' HB2' ' A' ' 32' ' ' CYS . 2.2 mp -123.55 160.58 50.19 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.581 . . . . 20.0 110.152 -177.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.82 171.79 16.75 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.163 3.242 . . . . 20.0 112.705 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -67.96 -2.13 6.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.855 2.462 . . . . 20.0 114.298 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.9 m -130.06 5.63 4.94 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.564 1.546 . . . . 20.0 112.933 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -136.04 9.59 3.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.552 1.141 . . . . 20.0 112.896 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.9 t -115.59 80.72 8.38 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 20.0 109.361 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.8 161.53 43.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.238 2.625 . . . . 20.0 110.705 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -58.77 -28.5 65.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.086 1.354 . . . . 20.0 113.106 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.8 -44.88 84.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.925 1.29 . . . . 20.0 111.789 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.28 -8.07 59.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.7 1.2 . . . . 20.0 113.848 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -62.74 141.9 58.38 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.338 0.972 . . . . 20.0 110.579 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.67 170.23 15.67 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.305 0.574 . . . . 20.0 110.874 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 t -66.89 -11.24 55.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.397 1.079 . . . . 20.0 112.381 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -144.68 165.65 27.45 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.575 2.35 . . . . 20.0 110.291 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.24 -169.67 15.05 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.481 1.515 . . . . 20.0 112.153 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.68 -7.22 0.33 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.891 1.234 . . . . 20.0 113.523 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 m -73.15 -179.1 3.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.457 1.503 . . . . 20.0 113.043 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -65.58 -30.14 70.83 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.49 1.516 . . . . 20.0 111.393 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -155.55 -38.28 0.09 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.152 0.981 . . . . 20.0 113.009 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m -140.5 139.85 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.328 0.967 . . . . 20.0 111.056 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 14.6 t -129.68 131.21 46.31 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.165 1.386 . . . . 20.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HB2' HD22 ' A' ' 11' ' ' LEU . 13.0 m -133.09 148.0 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.049 1.739 . . . . 20.0 109.601 176.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -70.39 148.77 48.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.051 0.94 . . . . 20.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -102.19 -6.21 23.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.834 0.854 . . . . 20.0 112.279 172.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 t -64.55 -29.88 70.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.269 1.028 . . . . 20.0 111.941 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -62.4 -32.55 73.4 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.159 1.384 . . . . 20.0 112.958 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.02 -44.41 65.91 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.486 1.114 . . . . 20.0 111.013 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 p -77.72 -20.36 53.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.016 1.327 . . . . 20.0 113.015 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 116.98 -2.011 . . . . 20.0 113.542 173.196 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.712 -0.477 . . . . 20.0 109.712 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 5.0 tp10 -64.12 -26.53 68.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.25 1.02 . . . . 20.0 112.833 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -60.03 -62.46 1.85 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.38 1.072 . . . . 20.0 108.936 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.21 -27.38 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.02 1.728 . . . . 20.0 112.15 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -60.0 -44.61 94.44 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.718 1.207 . . . . 20.0 111.695 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -85.88 -5.11 59.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.74 1.216 . . . . 20.0 113.423 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.96 -7.44 57.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.7 1.619 . . . . 20.0 114.918 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.11 171.03 6.04 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.339 1.456 . . . . 20.0 111.932 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.09 -167.09 13.18 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.658 1.123 . . . . 20.0 113.293 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.02 83.56 1.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.57 1.948 . . . . 20.0 107.874 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.42 HD13 HD22 ' A' ' 34' ' ' LEU . 5.3 mp -66.97 159.84 73.7 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.844 1.258 . . . . 20.0 110.233 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -69.47 162.75 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 20.0 110.977 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -69.72 3.92 2.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.742 1.617 . . . . 20.0 113.464 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.5 t -113.3 -0.68 14.48 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.997 2.119 . . . . 20.0 112.616 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.21 0.11 2.54 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.187 1.181 . . . . 20.0 114.187 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.5 t -111.39 110.22 55.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.171 0.989 . . . . 20.0 110.758 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.57 158.9 55.56 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.877 2.384 . . . . 20.0 111.119 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.21 -23.95 66.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.746 1.218 . . . . 20.0 113.534 -171.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -83.37 -30.97 26.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.324 1.45 . . . . 20.0 112.246 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.42 -11.97 58.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.723 1.209 . . . . 20.0 112.968 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -71.37 108.36 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.307 1.443 . . . . 20.0 109.219 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.91 159.63 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.957 0.903 . . . . 20.0 110.89 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -77.47 1.09 20.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.903 1.281 . . . . 20.0 113.165 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.2 170.0 18.81 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.752 1.621 . . . . 20.0 111.148 -172.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.82 171.56 21.71 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.29 0.947 . . . . 20.0 113.055 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.404 ' HA3' ' H ' ' A' ' 2' ' ' GLU . . . -96.26 -16.18 38.68 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.681 1.134 . . . . 20.0 113.332 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.0 m -72.71 175.21 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.372 1.086 . . . . 20.0 110.587 168.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.2 t -126.82 8.63 6.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.003 1.321 . . . . 20.0 111.92 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -126.58 -64.28 1.03 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.298 1.439 . . . . 20.0 109.404 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.69 156.91 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.932 1.693 . . . . 20.0 110.151 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.5 t -142.12 82.72 1.81 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.257 2.223 . . . . 20.0 107.082 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 152.64 40.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.819 -0.628 . . . . 20.0 111.613 -173.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -102.18 104.61 15.2 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.734 1.214 . . . . 20.0 110.129 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 34' ' ' LEU . 1.1 pt? -114.89 3.77 14.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.585 2.754 . . . . 20.0 112.153 169.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.7 t -63.6 -24.44 67.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.247 1.019 . . . . 20.0 111.072 165.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -71.37 -21.26 62.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.062 1.345 . . . . 20.0 113.082 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.0 mt -91.2 -41.51 10.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.849 1.26 . . . . 20.0 112.113 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.2 t -143.59 -22.23 0.59 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.251 1.021 . . . . 20.0 113.638 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 116.516 -2.269 . . . . 20.0 112.676 -177.774 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.607 -0.146 . . . . 20.0 110.607 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -65.87 -53.16 43.37 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.515 0.726 . . . . 20.0 111.6 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 m -63.87 -38.2 90.22 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 118.888 -0.577 . . . . 20.0 112.236 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.0 t -67.04 -39.71 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.68 0.792 . . . . 20.0 110.741 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -62.72 -35.5 79.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.38 1.072 . . . . 20.0 111.662 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -81.1 -4.97 57.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.856 1.662 . . . . 20.0 113.302 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.54 85.53 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.784 1.183 . . . . 20.0 114.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -75.54 174.84 9.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.391 1.476 . . . . 20.0 111.487 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.63 173.09 16.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.973 0.797 . . . . 20.0 114.139 -174.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 75.8 m -126.28 72.15 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.711 . . . . 20.0 109.239 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.2 mt -68.33 162.02 64.61 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.873 1.269 . . . . 20.0 111.514 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.23 169.8 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.488 2.792 . . . . 20.0 110.665 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.95 -21.17 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.888 0.699 . . . . 20.0 112.888 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 t -65.26 -54.51 28.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.49 1.516 . . . . 20.0 111.21 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.51 -7.63 57.36 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.755 1.02 . . . . 20.0 113.755 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -115.86 81.07 9.31 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.82 1.248 . . . . 20.0 110.322 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.69 172.96 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.926 3.084 . . . . 20.0 112.477 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.03 -7.41 22.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.567 1.547 . . . . 20.0 113.52 174.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.24 -28.1 17.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.308 1.443 . . . . 20.0 112.209 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.08 -11.11 19.11 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 20.0 113.851 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -59.99 139.56 57.34 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.182 0.993 . . . . 20.0 111.291 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.35 165.65 17.08 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.339 0.59 . . . . 20.0 110.423 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.3 t -76.49 -7.61 55.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.834 0.854 . . . . 20.0 112.321 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.23 173.24 11.7 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.402 2.281 . . . . 20.0 110.488 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.67 171.1 32.41 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 121.559 0.533 . . . . 20.0 113.713 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.85 20.53 2.52 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.525 1.536 . . . . 20.0 112.847 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -68.17 179.21 1.61 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.706 1.202 . . . . 20.0 110.698 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.3 t -84.5 -21.74 30.48 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.034 0.534 . . . . 20.0 111.814 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -136.5 -60.35 0.71 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.72 1.208 . . . . 20.0 111.048 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.1 153.99 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.39 1.476 . . . . 20.0 110.476 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.12 132.08 41.26 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.213 1.405 . . . . 20.0 110.371 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.4 m -130.96 144.14 51.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.114 1.366 . . . . 20.0 110.37 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -74.19 103.96 4.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.16 0.984 . . . . 20.0 109.405 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.4 pp -113.05 0.44 15.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.092 1.757 . . . . 20.0 112.543 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -61.65 -23.23 65.93 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.288 1.835 . . . . 20.0 113.376 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -62.42 -48.2 80.74 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.322 1.049 . . . . 20.0 111.511 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.6 mt -78.15 -55.32 5.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.275 1.43 . . . . 20.0 110.437 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . 0.258 12.5 t 41.47 44.11 2.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.218 2.607 . . . . 20.0 113.951 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 C-N-CA 124.97 1.271 . . . . 20.0 113.392 -175.993 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 109.857 -0.423 . . . . 20.0 109.857 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.0 -35.87 79.04 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.741 0.817 . . . . 20.0 111.997 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -64.62 -36.11 83.19 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.653 0.781 . . . . 20.0 112.364 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.35 -38.26 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.864 0.866 . . . . 20.0 110.479 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -62.98 -35.51 80.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.038 0.935 . . . . 20.0 111.918 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -81.72 -4.68 56.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.502 1.521 . . . . 20.0 113.041 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.1 2.71 90.6 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.966 1.269 . . . . 20.0 114.948 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -71.53 174.11 7.1 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.802 1.301 . . . . 20.0 112.38 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.54 -177.96 51.86 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.097 1.332 . . . . 20.0 112.744 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.94 59.02 0.79 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.567 1.147 . . . . 20.0 110.006 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.57 153.38 95.76 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.039 0.536 . . . . 20.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.03 172.71 14.15 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.6 3.533 . . . . 20.0 111.475 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -62.28 -13.9 33.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.716 1.376 . . . . 20.0 114.716 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.7 m -95.28 -9.54 32.82 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.294 1.438 . . . . 20.0 113.476 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.83 -2.69 9.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.032 1.733 . . . . 20.0 112.354 175.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.98 85.71 40.95 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.539 1.535 . . . . 20.0 109.721 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.18 175.87 10.68 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.184 3.256 . . . . 20.0 112.326 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.69 -12.99 52.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.33 1.452 . . . . 20.0 113.42 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 -39.02 17.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.389 1.075 . . . . 20.0 112.04 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.72 -10.45 26.82 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.739 1.014 . . . . 20.0 113.739 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -63.37 149.78 45.02 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.92 0.782 . . . . 20.0 111.251 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.99 171.83 11.12 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.225 0.536 . . . . 20.0 110.528 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -67.71 -4.73 13.1 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.202 1.401 . . . . 20.0 112.907 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -148.97 162.21 40.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.316 1.846 . . . . 20.0 110.763 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.8 75.35 0.23 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 125.101 1.334 . . . . 20.0 111.022 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 7.7 61.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.986 1.279 . . . . 20.0 114.786 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 55.7 m -102.93 -172.72 2.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.23 1.812 . . . . 20.0 110.384 170.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -72.45 -27.16 62.13 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.586 1.154 . . . . 20.0 112.082 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 t -155.82 -32.81 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.44 0.904 . . . . 20.0 113.44 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -138.6 130.09 36.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 124.905 1.282 . . . . 20.0 110.732 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.78 141.46 48.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.724 1.61 . . . . 20.0 110.716 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -135.47 157.56 46.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.101 1.76 . . . . 20.0 110.495 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.24 160.34 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.175 0.59 . . . . 20.0 111.614 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pp -123.85 6.48 8.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.912 1.685 . . . . 20.0 113.341 171.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.5 t -60.39 -26.09 66.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.079 1.352 . . . . 20.0 112.562 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -73.32 -35.88 66.13 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.53 1.132 . . . . 20.0 112.287 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.72 -42.98 73.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.256 1.022 . . . . 20.0 111.251 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.7 p -75.33 -9.53 58.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.315 1.446 . . . . 20.0 112.914 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.591 -1.672 . . . . 20.0 111.331 178.265 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.8 p30 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.075 0.464 . . . . 20.0 111.724 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.5 -48.27 70.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.326 1.05 . . . . 20.0 111.347 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.24 -41.77 97.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.392 1.077 . . . . 20.0 111.742 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.23 -37.87 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.1 . . . . 20.0 110.811 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -65.4 -34.69 78.89 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.2 1.0 . . . . 20.0 112.214 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -68.16 -17.67 64.4 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.778 1.231 . . . . 20.0 112.66 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.53 38.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.721 1.629 . . . . 20.0 114.245 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -68.79 168.5 13.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.908 1.354 . . . . 20.0 112.022 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.84 -160.94 27.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.406 1.479 . . . . 20.0 113.171 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 t -154.1 72.6 0.89 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.019 0.928 . . . . 20.0 108.793 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.56 162.36 43.51 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.3 1.44 . . . . 20.0 111.154 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.85 157.76 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.815 2.343 . . . . 20.0 110.766 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -63.37 -20.09 65.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.636 1.174 . . . . 20.0 113.112 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.9 m -87.79 -0.49 57.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.556 1.542 . . . . 20.0 113.715 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.53 -36.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.612 1.096 . . . . 20.0 113.362 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.79 113.2 38.33 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 20.0 109.182 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.78 168.33 23.75 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.99 2.46 . . . . 20.0 111.994 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.49 -4.79 32.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.937 1.295 . . . . 20.0 113.544 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -91.69 -34.55 14.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.634 1.174 . . . . 20.0 112.217 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.19 -18.11 35.07 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.636 1.174 . . . . 20.0 113.605 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -62.01 149.6 40.44 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.357 0.663 . . . . 20.0 112.205 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.62 172.09 8.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.202 1.401 . . . . 20.0 110.451 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -73.93 -7.22 51.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.689 1.196 . . . . 20.0 113.338 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -85.65 -179.63 6.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.712 1.605 . . . . 20.0 113.063 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.62 32.85 2.41 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.114 1.816 . . . . 20.0 112.852 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.22 1.9 54.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.221 1.391 . . . . 20.0 115.708 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.16 172.36 11.07 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.202 1.401 . . . . 20.0 110.197 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -92.25 -12.83 31.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.939 0.896 . . . . 20.0 112.353 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.6 p -130.18 -65.03 0.83 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.092 1.357 . . . . 20.0 109.574 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 m -151.36 159.32 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.451 1.1 . . . . 20.0 111.228 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -133.49 149.19 51.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.732 2.013 . . . . 20.0 108.507 172.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.11 149.37 52.42 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.313 1.045 . . . . 20.0 111.069 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -89.57 77.44 7.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.737 1.215 . . . . 20.0 113.398 -168.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.48 -3.37 17.52 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.703 1.371 . . . . 20.0 114.703 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -64.32 -15.97 61.31 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.944 1.298 . . . . 20.0 113.222 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -64.13 -24.98 67.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.948 1.299 . . . . 20.0 112.511 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.45 -17.11 63.6 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.919 1.288 . . . . 20.0 113.395 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -119.66 5.13 11.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.667 1.587 . . . . 20.0 111.891 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 117.228 -1.873 . . . . 20.0 110.305 179.126 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 67.1 m . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 118.898 -0.572 . . . . 20.0 112.293 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.02 -40.33 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.124 0.97 . . . . 20.0 110.485 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.5 t -56.02 -48.0 76.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.286 1.034 . . . . 20.0 111.018 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -73.56 -3.84 30.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.228 1.811 . . . . 20.0 113.585 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.12 0.41 89.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.129 1.347 . . . . 20.0 115.058 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -72.01 165.42 24.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.672 1.236 . . . . 20.0 112.296 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.81 -158.41 30.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.111 1.815 . . . . 20.0 111.792 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.21 116.49 6.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.35 1.06 . . . . 20.0 108.811 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.52 159.13 33.36 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.516 1.527 . . . . 20.0 110.02 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.27 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.246 2.631 . . . . 20.0 111.719 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -68.25 -8.67 41.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.729 1.612 . . . . 20.0 113.7 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.7 p -107.24 -29.74 9.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.509 1.524 . . . . 20.0 113.577 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.26 -26.08 19.17 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.8 0.727 . . . . 20.0 112.406 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -85.1 110.49 28.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.463 1.505 . . . . 20.0 109.634 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.75 167.2 26.4 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.786 2.324 . . . . 20.0 111.487 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.42 -8.17 44.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.031 1.332 . . . . 20.0 113.327 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.53 -28.25 16.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.246 1.418 . . . . 20.0 111.792 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.16 -15.41 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.244 1.418 . . . . 20.0 113.513 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -60.05 139.37 57.51 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.728 0.811 . . . . 20.0 110.129 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.14 158.43 15.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.641 0.734 . . . . 20.0 110.823 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t -80.22 9.05 6.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.781 1.632 . . . . 20.0 112.88 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.86 168.97 9.25 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.044 1.338 . . . . 20.0 112.77 -168.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.13 32.1 7.54 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.325 1.917 . . . . 20.0 113.01 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.6 -0.02 66.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.28 1.419 . . . . 20.0 115.749 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m -125.08 -172.18 2.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.905 2.082 . . . . 20.0 110.22 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -105.89 -3.97 21.24 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 20.0 113.232 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.9 t -144.29 -55.63 0.35 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.268 1.027 . . . . 20.0 110.816 171.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -145.8 152.31 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.549 1.54 . . . . 20.0 109.151 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -121.84 144.23 48.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.682 1.193 . . . . 20.0 109.535 172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -135.23 149.64 49.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.865 1.266 . . . . 20.0 109.603 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -74.91 175.41 8.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.874 0.87 . . . . 20.0 111.876 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 125.846 1.658 . . . . 20.0 112.117 175.237 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 111.867 0.321 . . . . 20.0 111.867 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.75 -22.93 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.263 1.025 . . . . 20.0 111.227 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -58.73 -33.89 70.74 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.84 0.856 . . . . 20.0 113.161 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -79.16 -11.23 59.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.542 1.537 . . . . 20.0 113.342 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.95 -2.89 31.7 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.175 1.845 . . . . 20.0 114.329 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -72.42 -178.85 2.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.041 1.336 . . . . 20.0 112.154 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.3 168.62 21.48 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.887 1.232 . . . . 20.0 111.187 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 t -126.49 68.62 1.23 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 20.0 110.669 -160.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.3 mt -72.78 153.59 91.28 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.268 0.627 . . . . 20.0 111.882 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.65 173.97 11.76 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.724 3.616 . . . . 20.0 111.931 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.24 -38.2 73.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.686 1.195 . . . . 20.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.3 p -67.53 -17.32 64.62 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.153 1.381 . . . . 20.0 113.874 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.73 -12.27 10.27 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.028 1.731 . . . . 20.0 111.777 -174.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 t -122.83 89.46 50.29 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.373 1.469 . . . . 20.0 109.026 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.04 166.81 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.145 2.563 . . . . 20.0 110.753 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.94 -33.02 70.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.628 1.171 . . . . 20.0 112.907 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.94 -32.98 74.79 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.118 1.367 . . . . 20.0 112.429 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.37 -10.05 45.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.37 1.468 . . . . 20.0 113.156 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -65.05 143.91 57.61 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.005 0.922 . . . . 20.0 110.056 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.89 175.86 10.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 20.0 111.178 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -73.5 -7.64 52.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.303 0.641 . . . . 20.0 112.322 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -137.13 173.17 11.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.847 2.059 . . . . 20.0 110.625 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.17 -95.21 0.9 Allowed Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.281 0.943 . . . . 20.0 111.607 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 -32.15 4.72 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.56 2.029 . . . . 20.0 113.554 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m -82.5 -177.98 6.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.081 0.94 . . . . 20.0 110.574 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -74.86 -31.95 61.77 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.792 1.237 . . . . 20.0 110.255 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 p -136.11 -55.02 0.76 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.456 1.502 . . . . 20.0 111.341 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -145.23 137.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.678 1.591 . . . . 20.0 108.836 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.2 t -125.98 155.05 42.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.528 1.531 . . . . 20.0 109.905 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.8 160.51 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.835 1.254 . . . . 20.0 110.826 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.08 35.6 0.99 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.998 1.481 . . . . 20.0 114.998 -164.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 114.856 1.428 . . . . 20.0 114.856 -174.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 t . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 110.702 -0.11 . . . . 20.0 110.702 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.97 -38.18 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.978 1.311 . . . . 20.0 111.471 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -67.36 -31.78 72.26 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.002 0.819 . . . . 20.0 112.666 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -73.45 -3.19 25.96 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.22 1.808 . . . . 20.0 113.426 171.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.77 -4.87 69.1 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.419 1.485 . . . . 20.0 114.542 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.97 -174.39 4.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.642 1.177 . . . . 20.0 111.155 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.13 -176.19 14.38 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.194 1.378 . . . . 20.0 111.499 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.3 m -134.56 88.77 2.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.989 1.315 . . . . 20.0 108.328 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.71 161.89 10.41 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.817 1.647 . . . . 20.0 111.367 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.7 165.1 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.471 2.114 . . . . 20.0 111.188 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.31 4.6 4.43 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.917 1.687 . . . . 20.0 113.287 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.0 p -115.7 -4.38 12.19 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.859 2.063 . . . . 20.0 113.711 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.18 -27.57 1.59 Allowed 'General case' 0 C--N 1.346 0.452 0 N-CA-C 114.081 1.141 . . . . 20.0 114.081 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 t -58.24 106.14 0.65 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 126.516 1.926 . . . . 20.0 110.508 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.75 155.9 35.14 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.601 2.2 . . . . 20.0 111.297 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -68.44 -17.84 64.29 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.631 0.604 . . . . 20.0 112.631 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -76.73 -33.5 58.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.847 1.259 . . . . 20.0 112.541 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.84 -5.82 59.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.015 1.116 . . . . 20.0 114.015 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -57.06 117.98 4.55 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.55 1.14 . . . . 20.0 110.529 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.9 mt -75.67 172.07 13.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.615 0.766 . . . . 20.0 110.717 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -70.2 -2.88 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.855 1.262 . . . . 20.0 113.289 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.55 163.3 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.965 1.706 . . . . 20.0 111.471 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.07 77.94 0.24 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.5 1.524 . . . . 20.0 110.663 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.23 6.4 76.12 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.699 1.142 . . . . 20.0 115.547 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 m -130.17 -175.73 3.72 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.883 2.073 . . . . 20.0 110.126 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.1 p -90.48 -7.37 53.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.026 1.33 . . . . 20.0 112.656 -171.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 p -131.85 -63.3 0.83 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.309 1.444 . . . . 20.0 109.971 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.55 152.58 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.734 1.213 . . . . 20.0 111.08 -171.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -133.74 67.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.239 1.816 . . . . 20.0 108.266 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.96 131.23 40.51 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 123.997 0.919 . . . . 20.0 109.451 167.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.77 159.78 21.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.208 0.603 . . . . 20.0 111.518 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 114.015 1.117 . . . . 20.0 114.015 164.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 111.786 0.291 . . . . 20.0 111.786 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.94 -18.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.139 1.376 . . . . 20.0 111.935 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.8 t -58.23 -42.15 85.68 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.755 1.222 . . . . 20.0 112.081 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -21.83 64.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.763 1.625 . . . . 20.0 112.942 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.54 -3.36 36.85 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.016 1.769 . . . . 20.0 113.937 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -70.45 168.64 15.71 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.554 1.177 . . . . 20.0 112.252 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.01 -175.32 50.63 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.188 1.375 . . . . 20.0 112.417 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 t -151.93 49.56 0.79 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.452 1.101 . . . . 20.0 109.274 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.07 153.87 16.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.829 1.251 . . . . 20.0 111.721 -173.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.59 170.67 19.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.404 2.736 . . . . 20.0 112.447 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -65.21 -4.07 4.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.687 1.995 . . . . 20.0 114.449 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.5 t -115.65 -11.56 11.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.562 1.545 . . . . 20.0 113.066 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.09 -26.53 5.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.1 -0.952 . . . . 20.0 113.233 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 t -65.23 107.21 1.31 Allowed Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.36 1.864 . . . . 20.0 109.605 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.22 152.45 50.33 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.323 2.015 . . . . 20.0 110.035 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.31 -25.66 68.41 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.668 1.187 . . . . 20.0 112.64 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.16 -31.63 49.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.932 1.293 . . . . 20.0 112.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.39 58.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.794 1.035 . . . . 20.0 113.794 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -60.71 117.21 5.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.361 1.064 . . . . 20.0 108.723 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.3 176.39 3.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.676 1.191 . . . . 20.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 t -69.95 -3.9 18.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.058 0.943 . . . . 20.0 113.023 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -138.88 169.18 18.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.55 1.94 . . . . 20.0 110.586 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.91 71.69 0.49 Allowed Glycine 0 C--N 1.341 0.809 0 C-N-CA 125.013 1.292 . . . . 20.0 111.259 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.12 -19.66 76.82 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.845 0.736 . . . . 20.0 114.103 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.32 174.55 9.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.576 1.15 . . . . 20.0 111.148 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.6 m -86.59 -5.66 59.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.663 1.185 . . . . 20.0 111.987 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -149.56 -53.15 0.16 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.849 1.26 . . . . 20.0 111.681 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.21 122.46 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.568 1.147 . . . . 20.0 111.505 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.4 t -106.24 82.94 1.82 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.339 2.256 . . . . 20.0 108.944 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.26 142.94 27.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.87 1.268 . . . . 20.0 111.098 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.93 170.25 16.97 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.92 0.888 . . . . 20.0 112.207 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 125.732 1.613 . . . . 20.0 112.117 177.266 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 119.747 -0.168 . . . . 20.0 111.272 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -67.14 -34.85 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.885 1.274 . . . . 20.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.5 m -66.94 -36.94 83.35 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.185 0.994 . . . . 20.0 111.865 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -73.46 -5.73 41.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.718 1.207 . . . . 20.0 113.158 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.04 85.2 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.885 1.231 . . . . 20.0 113.878 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -84.26 168.7 15.45 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.163 1.385 . . . . 20.0 112.117 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.11 167.86 24.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.387 0.994 . . . . 20.0 113.234 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.9 m -126.81 74.09 1.46 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.701 1.6 . . . . 20.0 108.388 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.04 162.23 40.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.776 1.231 . . . . 20.0 110.824 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.44 173.4 14.54 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.365 2.71 . . . . 20.0 110.959 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -66.67 -0.46 2.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.221 1.809 . . . . 20.0 113.733 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.6 p -125.96 -8.08 6.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.941 1.696 . . . . 20.0 114.583 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -128.9 -6.4 5.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.355 0.979 . . . . 20.0 113.222 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.0 t -76.92 116.08 53.98 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.847 0.859 . . . . 20.0 108.741 163.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.87 159.18 48.78 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.733 2.289 . . . . 20.0 110.443 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -63.54 -24.59 67.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.029 0.932 . . . . 20.0 112.259 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.46 -30.66 64.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.959 1.304 . . . . 20.0 112.43 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 -18.71 41.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.052 1.13 . . . . 20.0 114.052 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -60.85 120.5 10.27 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.895 1.278 . . . . 20.0 111.313 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.9 mt -82.4 171.11 14.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.449 1.099 . . . . 20.0 112.015 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -69.49 -12.62 61.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.27 1.428 . . . . 20.0 112.445 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -132.6 168.97 17.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.939 2.095 . . . . 20.0 110.838 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.61 71.56 0.49 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.625 1.583 . . . . 20.0 110.806 -173.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.58 -7.9 87.87 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.336 0.969 . . . . 20.0 114.853 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m -81.63 -168.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.516 1.526 . . . . 20.0 109.778 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.0 p -103.12 -6.53 22.13 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.664 1.185 . . . . 20.0 111.987 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.3 p -127.92 -74.48 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.005 2.122 . . . . 20.0 109.247 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 m -150.5 120.48 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.76 1.624 . . . . 20.0 109.119 -172.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.45 108.74 19.82 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.465 1.106 . . . . 20.0 109.257 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -126.16 113.17 16.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.169 1.387 . . . . 20.0 109.015 -168.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.57 172.25 3.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.059 1.344 . . . . 20.0 112.873 -172.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 69.6 mt . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 125.122 1.369 . . . . 20.0 111.932 -174.223 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.595 0 N-CA-C 112.765 0.654 . . . . 20.0 112.765 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.44 -46.17 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.19 1.396 . . . . 20.0 110.39 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -65.32 -29.4 70.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.14 1.376 . . . . 20.0 112.665 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -71.51 -6.05 37.64 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.546 1.938 . . . . 20.0 112.669 171.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.41 6.32 89.33 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.599 -1.111 . . . . 20.0 114.491 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -74.87 167.69 21.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.616 1.208 . . . . 20.0 111.694 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.64 128.26 9.43 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.083 0.849 . . . . 20.0 112.555 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.9 m -82.41 75.0 9.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.913 0.885 . . . . 20.0 108.752 163.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.36 162.96 36.49 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 20.0 110.975 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.66 167.85 25.58 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.818 2.346 . . . . 20.0 110.849 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -74.42 5.85 4.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.621 1.569 . . . . 20.0 113.727 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 t -129.57 12.84 5.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.865 1.666 . . . . 20.0 112.323 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -133.04 -45.93 0.85 Allowed 'General case' 0 C--N 1.346 0.42 0 C-N-CA 124.442 1.097 . . . . 20.0 112.513 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.21 104.31 0.42 Allowed Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 127.336 2.254 . . . . 20.0 111.807 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.78 145.4 36.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.682 2.255 . . . . 20.0 110.96 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -59.91 -26.82 66.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.521 0.934 . . . . 20.0 113.521 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.01 -29.93 70.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.627 1.571 . . . . 20.0 112.647 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.69 24.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.829 1.252 . . . . 20.0 113.64 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -61.23 120.09 9.69 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.754 1.161 . . . . 20.0 110.409 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.09 172.94 10.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.704 1.202 . . . . 20.0 111.773 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -69.85 -10.5 58.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.744 1.218 . . . . 20.0 112.215 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -139.34 172.95 12.07 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.344 2.257 . . . . 20.0 110.591 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.6 76.05 0.21 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.789 -0.924 . . . . 20.0 110.789 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . -69.01 -13.33 66.59 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.841 1.21 . . . . 20.0 113.525 176.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.48 177.37 1.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.732 1.613 . . . . 20.0 111.244 167.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -93.65 -13.01 28.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.73 0.812 . . . . 20.0 112.798 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -135.39 -59.79 0.77 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.395 1.078 . . . . 20.0 110.819 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.9 m -148.22 153.62 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.652 1.581 . . . . 20.0 110.239 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.9 t -134.42 108.86 8.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.656 1.182 . . . . 20.0 109.502 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -102.46 137.22 41.0 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.133 0.973 . . . . 20.0 109.616 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.43 166.46 12.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.61 0.764 . . . . 20.0 111.618 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt . . . . . 0 CA--C 1.539 0.545 0 C-N-CA 126.004 1.722 . . . . 20.0 110.882 177.343 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 113.009 0.744 . . . . 20.0 113.009 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.9 t -83.48 -41.19 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.436 1.495 . . . . 20.0 110.766 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -60.81 -35.2 75.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.704 1.202 . . . . 20.0 111.995 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -69.32 -14.16 62.78 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.887 2.075 . . . . 20.0 113.233 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 16.91 77.29 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.653 -1.082 . . . . 20.0 114.601 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -59.87 165.59 3.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.6 1.16 . . . . 20.0 112.567 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.51 -33.83 67.59 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.1 1.333 . . . . 20.0 113.986 -175.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 t 50.67 37.22 15.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.146 1.779 . . . . 20.0 112.008 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.49 154.12 56.66 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.934 1.294 . . . . 20.0 111.821 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.17 171.24 11.74 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.746 2.964 . . . . 20.0 111.342 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.65 -22.54 66.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.176 0.99 . . . . 20.0 112.475 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -80.99 -3.76 52.8 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.245 1.818 . . . . 20.0 114.161 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.5 -42.9 1.29 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.141 1.376 . . . . 20.0 112.918 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.86 109.78 5.36 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.218 1.807 . . . . 20.0 110.601 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.6 170.33 15.89 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.552 2.835 . . . . 20.0 112.199 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -66.77 -12.96 60.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.362 1.465 . . . . 20.0 113.411 173.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -96.32 -29.31 14.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.335 1.054 . . . . 20.0 112.82 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.68 -5.4 21.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.483 1.113 . . . . 20.0 113.633 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -60.43 136.2 57.97 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.774 0.716 . . . . 20.0 110.872 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.17 172.04 13.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.29 1.036 . . . . 20.0 111.186 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -72.46 -9.13 58.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.779 0.832 . . . . 20.0 112.318 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.22 172.22 13.33 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.781 2.032 . . . . 20.0 110.973 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.58 67.14 0.39 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.658 1.123 . . . . 20.0 111.654 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . -77.49 -7.42 87.09 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.128 1.347 . . . . 20.0 114.388 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.4 m -66.98 179.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.854 1.327 . . . . 20.0 111.378 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 t -68.62 -29.6 68.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.342 1.057 . . . . 20.0 111.543 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -158.85 -28.25 0.07 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 20.0 113.744 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 p -139.13 135.82 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.106 1.362 . . . . 20.0 110.241 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.2 t -133.64 139.28 46.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.063 1.345 . . . . 20.0 110.812 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.01 140.77 34.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.879 1.672 . . . . 20.0 109.2 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.06 166.78 18.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.209 0.604 . . . . 20.0 110.956 172.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.472 0.638 0 C-N-CA 125.715 1.606 . . . . 20.0 112.368 178.383 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 119.318 -0.373 . . . . 20.0 111.743 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.36 -36.85 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.061 0.945 . . . . 20.0 110.685 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -65.49 -30.5 71.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.108 1.363 . . . . 20.0 112.056 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -80.32 -12.02 59.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.719 1.608 . . . . 20.0 113.026 171.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.0 12.85 56.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.742 1.163 . . . . 20.0 114.928 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -89.18 167.56 13.0 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.832 1.316 . . . . 20.0 112.781 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.7 -175.87 47.0 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.991 1.281 . . . . 20.0 113.363 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 t -138.28 65.52 1.46 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.119 1.367 . . . . 20.0 109.133 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.57 156.15 78.75 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.38 1.472 . . . . 20.0 110.81 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.46 164.37 35.49 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.178 2.586 . . . . 20.0 110.937 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -64.9 -22.84 67.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.654 0.782 . . . . 20.0 112.993 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.7 m -82.79 -3.76 57.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.909 1.284 . . . . 20.0 113.626 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -129.55 0.92 5.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.336 1.454 . . . . 20.0 112.574 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -128.65 80.93 71.72 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.944 1.297 . . . . 20.0 110.443 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.14 175.41 10.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.176 3.251 . . . . 20.0 112.159 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -67.39 -6.89 21.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.735 1.013 . . . . 20.0 113.735 172.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -86.19 -25.1 25.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.915 1.286 . . . . 20.0 112.396 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.27 -7.77 14.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.447 1.499 . . . . 20.0 113.43 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.56 165.34 8.16 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.352 1.061 . . . . 20.0 112.168 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.9 mt -133.94 166.21 23.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.205 1.002 . . . . 20.0 111.599 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -82.67 -9.64 59.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.043 1.337 . . . . 20.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -109.27 2.76 21.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.931 1.692 . . . . 20.0 113.639 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -36.55 87.23 0.01 OUTLIER Glycine 0 CA--C 1.529 0.909 1 C-N-CA 130.987 4.137 . . . . 20.0 115.506 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.62 0.63 63.29 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.069 1.319 . . . . 20.0 113.963 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.7 m -66.54 173.48 3.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 20.0 111.728 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -86.63 -16.1 37.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.887 0.875 . . . . 20.0 111.923 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -132.16 -61.36 0.88 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.373 1.469 . . . . 20.0 110.302 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.5 m -152.18 153.01 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.967 1.307 . . . . 20.0 111.002 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.6 t -131.92 137.01 47.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.988 1.715 . . . . 20.0 109.251 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.3 m -137.21 156.35 48.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.715 1.206 . . . . 20.0 111.089 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.55 126.02 30.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.495 1.118 . . . . 20.0 112.571 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.8 mt . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 125.836 1.655 . . . . 20.0 113.155 168.362 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.464 0.266 0 N-CA-C 112.552 0.575 . . . . 20.0 112.552 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.36 -32.98 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.194 0.598 . . . . 20.0 111.394 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -67.35 -34.32 77.06 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.524 0.73 . . . . 20.0 111.794 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -9.51 58.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.362 1.065 . . . . 20.0 113.524 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.87 -2.4 84.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.757 1.17 . . . . 20.0 113.911 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -71.19 176.13 4.74 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.603 1.201 . . . . 20.0 110.852 168.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.14 -172.91 15.14 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 123.862 0.744 . . . . 20.0 112.818 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -117.68 82.01 1.76 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.447 1.499 . . . . 20.0 109.155 -173.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 151.8 81.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.185 0.994 . . . . 20.0 109.295 170.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.77 167.74 24.88 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.379 2.719 . . . . 20.0 111.598 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.24 -9.65 42.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.963 1.305 . . . . 20.0 113.272 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -95.63 -13.51 24.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.83 1.652 . . . . 20.0 113.548 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -137.55 20.17 2.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.059 1.344 . . . . 20.0 112.587 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 t -127.74 77.64 75.97 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.152 1.381 . . . . 20.0 109.354 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.34 171.11 18.68 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.068 3.179 . . . . 20.0 112.159 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -63.69 -13.35 42.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.799 1.64 . . . . 20.0 113.756 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.3 -25.98 25.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.75 1.22 . . . . 20.0 112.811 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.66 -8.21 14.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.3 1.44 . . . . 20.0 113.345 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -65.79 170.0 5.83 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.278 1.031 . . . . 20.0 111.789 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.8 mt -130.97 168.42 17.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 20.0 110.248 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -74.04 -19.93 60.46 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.237 1.015 . . . . 20.0 111.913 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -73.9 167.07 22.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.971 1.708 . . . . 20.0 111.675 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.12 87.31 0.12 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.923 0.773 . . . . 20.0 111.662 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.16 3.1 79.88 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.05 1.309 . . . . 20.0 114.172 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.0 m -131.93 -12.33 3.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.632 1.573 . . . . 20.0 114.762 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.3 p 64.79 6.8 3.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 130.889 3.676 . . . . 20.0 113.429 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.3 p -122.53 -57.18 1.76 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.78 1.232 . . . . 20.0 110.772 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.06 135.53 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 126.147 1.779 . . . . 20.0 109.402 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.4 t -145.42 121.71 10.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.839 1.656 . . . . 20.0 109.156 171.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 9.5 m -129.02 148.46 50.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.379 1.471 . . . . 20.0 110.414 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -73.26 107.64 5.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.797 1.239 . . . . 20.0 110.446 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 CA--C 1.536 0.407 0 C-N-CA 126.157 1.783 . . . . 20.0 112.367 170.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 112.87 0.692 . . . . 20.0 112.87 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.55 -37.41 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 124.131 0.972 . . . . 20.0 110.484 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.6 t -66.98 -30.53 70.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.257 1.023 . . . . 20.0 111.91 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.11 -2.07 46.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.138 1.375 . . . . 20.0 112.564 171.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.88 -5.01 84.95 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.903 1.716 . . . . 20.0 114.961 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -76.39 168.32 20.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.783 1.292 . . . . 20.0 112.14 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.14 170.93 32.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.639 1.114 . . . . 20.0 112.51 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.0 m -126.0 68.65 1.19 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.669 1.588 . . . . 20.0 107.936 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.66 161.47 65.77 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.999 1.72 . . . . 20.0 110.746 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.45 164.76 34.66 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.599 2.2 . . . . 20.0 111.329 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -66.94 -6.97 18.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.675 1.59 . . . . 20.0 113.738 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -121.05 -5.3 9.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.736 1.615 . . . . 20.0 113.964 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -105.58 -42.39 5.21 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.229 0.922 . . . . 20.0 112.026 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.6 115.46 27.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.39 1.076 . . . . 20.0 109.863 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.24 160.62 35.91 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.547 2.164 . . . . 20.0 110.381 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -63.9 -16.93 62.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.871 1.268 . . . . 20.0 112.643 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -70.6 -25.89 63.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.912 1.285 . . . . 20.0 112.669 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.79 2.74 10.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.858 1.663 . . . . 20.0 113.461 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.02 151.34 40.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.892 0.877 . . . . 20.0 109.821 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.6 mt -95.15 166.86 11.71 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.423 0.63 . . . . 20.0 110.214 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -74.15 -3.07 27.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.01 0.924 . . . . 20.0 112.32 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -143.78 169.11 18.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.687 1.995 . . . . 20.0 110.808 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.76 79.64 0.37 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 125.082 1.325 . . . . 20.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 -3.05 65.37 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.079 0.847 . . . . 20.0 114.247 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.1 m -85.08 -166.48 1.51 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.9 2.08 . . . . 20.0 110.314 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 t -91.62 -18.15 24.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.938 0.895 . . . . 20.0 112.479 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.7 p -134.22 -61.7 0.77 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.417 1.087 . . . . 20.0 110.622 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -150.09 157.92 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.301 1.84 . . . . 20.0 109.648 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.1 t -125.73 151.95 45.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.309 1.444 . . . . 20.0 110.176 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -137.78 125.96 23.03 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.653 0.781 . . . . 20.0 110.812 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 147.24 46.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.712 1.205 . . . . 20.0 110.052 169.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 41.8 mt . . . . . 0 CA--C 1.541 0.612 0 C-N-CA 125.263 1.425 . . . . 20.0 111.902 -176.024 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.5 m . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 109.997 -0.371 . . . . 20.0 109.997 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.8 -40.14 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.287 1.435 . . . . 20.0 111.171 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -62.32 -41.32 98.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.443 1.097 . . . . 20.0 111.756 -176.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -83.07 -7.31 59.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.331 1.052 . . . . 20.0 113.336 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.72 79.02 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.597 1.094 . . . . 20.0 114.955 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -65.37 164.74 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.043 1.422 . . . . 20.0 111.831 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.97 178.72 53.38 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 121.994 0.774 . . . . 20.0 112.103 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.6 t -150.34 76.81 1.28 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.118 -1.438 . . . . 20.0 107.118 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 157.44 86.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.841 1.257 . . . . 20.0 110.919 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.66 174.39 8.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.951 3.101 . . . . 20.0 111.352 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -16.67 34.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.571 1.148 . . . . 20.0 113.124 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 m -89.11 -11.02 45.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.711 1.604 . . . . 20.0 113.862 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.11 -0.88 4.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.896 1.678 . . . . 20.0 113.199 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -120.33 77.51 26.07 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.921 1.288 . . . . 20.0 109.406 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.15 170.57 19.53 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.533 2.822 . . . . 20.0 110.963 175.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -60.56 -26.02 66.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.397 1.079 . . . . 20.0 112.753 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.63 -46.26 72.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.758 1.623 . . . . 20.0 111.859 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.78 -4.54 56.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.749 1.219 . . . . 20.0 113.929 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -60.4 145.3 48.54 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.321 1.049 . . . . 20.0 111.618 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.81 173.75 9.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.835 1.254 . . . . 20.0 111.51 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 t -65.02 -14.13 59.65 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.634 1.574 . . . . 20.0 112.737 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.18 168.12 20.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.419 2.287 . . . . 20.0 110.269 -174.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.67 85.18 0.17 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 124.465 1.031 . . . . 20.0 111.305 -170.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.67 -13.37 80.09 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.557 1.075 . . . . 20.0 115.01 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.4 m -80.82 -179.71 7.41 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.548 1.139 . . . . 20.0 111.294 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -93.78 -9.83 36.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.9 1.28 . . . . 20.0 111.987 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.5 p -133.13 -65.61 0.69 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.982 1.313 . . . . 20.0 109.736 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.84 156.14 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.363 1.465 . . . . 20.0 110.507 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -144.37 115.95 8.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.186 1.394 . . . . 20.0 109.35 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.84 136.73 51.83 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.215 1.006 . . . . 20.0 111.93 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.73 124.83 28.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.36 1.464 . . . . 20.0 109.464 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 125.685 1.594 . . . . 20.0 112.942 174.423 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 111.774 0.287 . . . . 20.0 111.774 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.6 t -73.74 -25.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.655 1.182 . . . . 20.0 111.16 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -67.9 -32.78 73.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.46 0.704 . . . . 20.0 111.916 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -67.94 -20.73 65.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.286 1.034 . . . . 20.0 112.711 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.69 -2.34 21.61 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.087 1.803 . . . . 20.0 114.132 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -77.8 175.99 9.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.583 1.192 . . . . 20.0 112.587 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -23.45 30.48 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.295 -0.725 . . . . 20.0 114.206 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.9 t 49.92 49.56 20.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.086 1.754 . . . . 20.0 112.523 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.08 155.21 84.8 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.532 1.133 . . . . 20.0 111.291 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.13 169.98 21.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.505 2.803 . . . . 20.0 112.306 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -69.34 8.7 0.56 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.465 1.906 . . . . 20.0 114.036 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.3 p -120.03 -6.31 9.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.337 1.855 . . . . 20.0 113.122 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -136.73 -17.76 1.44 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 113.842 1.053 . . . . 20.0 113.842 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -85.68 114.75 58.42 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.067 0.947 . . . . 20.0 109.616 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.21 162.9 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.772 2.315 . . . . 20.0 111.741 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -70.96 -6.42 38.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.363 1.465 . . . . 20.0 114.313 -173.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.42 -32.11 10.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.775 1.23 . . . . 20.0 111.848 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.16 -21.28 39.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 113.818 1.044 . . . . 20.0 113.818 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -63.4 157.47 23.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.011 0.924 . . . . 20.0 111.804 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.67 162.98 12.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.154 1.381 . . . . 20.0 110.408 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -83.22 -3.89 57.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.377 1.071 . . . . 20.0 111.677 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -148.93 176.19 10.63 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.733 2.013 . . . . 20.0 111.069 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.29 -166.29 30.04 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.133 0.873 . . . . 20.0 112.317 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.82 7.69 4.19 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.499 1.523 . . . . 20.0 114.047 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.9 173.53 5.27 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.801 1.24 . . . . 20.0 111.918 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.2 t -96.76 -5.43 38.59 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.119 1.367 . . . . 20.0 112.544 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.2 t -147.27 -49.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.278 1.031 . . . . 20.0 111.76 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -162.94 145.01 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.975 1.71 . . . . 20.0 108.164 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.1 t -114.27 151.76 32.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.285 1.034 . . . . 20.0 110.567 166.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.82 129.04 22.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.127 1.371 . . . . 20.0 109.574 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.16 137.44 33.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.156 0.982 . . . . 20.0 110.445 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.9 mt . . . . . 0 CA--C 1.538 0.5 0 C-N-CA 125.502 1.521 . . . . 20.0 112.633 -177.589 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 119.724 -0.179 . . . . 20.0 110.555 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.46 -32.24 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.589 1.156 . . . . 20.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.4 t -64.03 -39.79 94.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.503 1.121 . . . . 20.0 111.56 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -72.47 -6.0 40.67 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.689 1.196 . . . . 20.0 113.262 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.53 4.22 64.15 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.338 1.447 . . . . 20.0 114.625 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -77.45 171.22 15.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.55 1.14 . . . . 20.0 112.069 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.97 177.8 31.68 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.262 1.41 . . . . 20.0 113.136 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -133.6 69.17 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.84 1.656 . . . . 20.0 107.451 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.43 159.84 47.18 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.973 1.709 . . . . 20.0 110.914 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.54 166.0 30.95 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.846 2.364 . . . . 20.0 111.0 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -67.72 -19.71 65.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.87 1.268 . . . . 20.0 112.786 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -83.69 -16.97 42.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.992 1.317 . . . . 20.0 113.062 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -124.84 5.45 8.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.285 1.434 . . . . 20.0 113.157 -174.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -120.08 78.15 24.8 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.092 0.957 . . . . 20.0 110.43 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.82 172.68 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.536 2.824 . . . . 20.0 111.7 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -65.19 -13.36 58.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.516 1.127 . . . . 20.0 113.33 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.41 -32.56 20.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.042 1.337 . . . . 20.0 112.215 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 -18.33 22.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.28 1.032 . . . . 20.0 113.454 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -70.04 155.48 40.53 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 118.606 0.639 . . . . 20.0 110.6 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.11 177.45 6.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.051 0.94 . . . . 20.0 110.204 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -68.73 -21.93 64.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.333 0.653 . . . . 20.0 111.835 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.21 171.4 14.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.294 1.838 . . . . 20.0 111.66 -168.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.98 177.36 31.01 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.239 0.923 . . . . 20.0 112.812 175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.96 21.58 0.59 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.083 1.325 . . . . 20.0 113.367 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -63.13 176.87 0.68 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.374 1.469 . . . . 20.0 112.234 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -69.22 -29.63 67.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.724 1.209 . . . . 20.0 111.47 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 t -143.5 -41.31 0.29 Allowed 'General case' 0 C--N 1.344 0.354 0 CA-C-O 117.944 -1.027 . . . . 20.0 113.435 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -153.88 151.79 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.538 1.135 . . . . 20.0 109.68 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -118.93 135.17 54.73 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 125.474 1.51 . . . . 20.0 109.226 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -131.94 148.16 52.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.984 1.314 . . . . 20.0 110.039 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -74.73 166.28 23.85 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.611 -0.722 . . . . 20.0 111.476 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 CA--C 1.542 0.667 0 C-N-CA 125.407 1.483 . . . . 20.0 111.521 179.182 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 110.4 -0.222 . . . . 20.0 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.4 -39.92 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.048 1.339 . . . . 20.0 111.161 173.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -68.1 -32.05 72.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.267 1.027 . . . . 20.0 112.35 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -75.28 -9.95 59.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.63 1.572 . . . . 20.0 112.479 171.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.11 -2.96 69.39 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.254 1.407 . . . . 20.0 114.572 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -77.14 170.19 16.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.762 1.281 . . . . 20.0 111.72 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.54 160.13 23.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.907 0.765 . . . . 20.0 113.067 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.1 m -124.35 65.78 1.07 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.866 1.666 . . . . 20.0 109.189 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 mt -65.43 163.22 34.85 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.88 1.272 . . . . 20.0 111.512 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.62 170.93 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.036 2.491 . . . . 20.0 110.753 168.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -60.69 -27.05 67.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.429 1.092 . . . . 20.0 112.505 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -74.31 -10.6 59.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.861 1.264 . . . . 20.0 113.847 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.96 -5.27 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.044 1.338 . . . . 20.0 113.174 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.9 t -124.19 83.49 56.36 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.219 1.408 . . . . 20.0 109.809 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.89 173.48 14.43 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.966 3.11 . . . . 20.0 111.933 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -14.81 56.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 20.0 113.048 173.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.78 -29.26 50.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.138 . . . . 20.0 112.909 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.68 -8.68 14.92 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.457 1.103 . . . . 20.0 113.477 -170.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -70.22 159.63 33.65 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.522 0.729 . . . . 20.0 112.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.11 176.91 5.39 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.878 1.271 . . . . 20.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -70.58 -4.96 25.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.841 1.256 . . . . 20.0 113.187 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -139.98 176.29 8.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.152 1.781 . . . . 20.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.4 72.91 0.36 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.688 1.137 . . . . 20.0 111.96 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.42 -18.88 79.94 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.83 -0.983 . . . . 20.0 114.103 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.5 m -70.16 179.68 2.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.938 1.295 . . . . 20.0 112.52 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.2 m -86.09 -8.77 57.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.955 1.302 . . . . 20.0 112.264 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 t -148.53 -52.62 0.18 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.863 -1.065 . . . . 20.0 111.845 170.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.13 145.31 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.328 0.967 . . . . 20.0 112.012 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.6 t -122.85 112.28 17.69 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.959 2.103 . . . . 20.0 109.309 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -121.02 142.71 49.55 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.101 1.361 . . . . 20.0 111.726 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.73 137.99 31.92 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.182 1.393 . . . . 20.0 109.947 172.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.9 mt . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 127.19 2.196 . . . . 20.0 111.891 -169.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 119.827 -0.13 . . . . 20.0 111.212 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.06 -39.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.622 1.169 . . . . 20.0 111.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.6 t -67.73 -32.72 73.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 20.0 112.603 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -70.33 -13.02 61.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.153 1.381 . . . . 20.0 112.483 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.4 61.09 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.362 1.458 . . . . 20.0 114.163 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -79.04 171.64 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.671 1.235 . . . . 20.0 111.672 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.54 176.62 41.64 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.169 1.366 . . . . 20.0 112.259 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -141.16 56.45 1.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.906 -1.146 . . . . 20.0 107.906 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.24 157.5 12.12 Favored Pre-proline 0 C--N 1.345 0.375 0 C-N-CA 125.601 1.56 . . . . 20.0 111.666 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.36 167.51 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.822 2.348 . . . . 20.0 110.513 173.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -62.32 -22.12 65.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.558 0.743 . . . . 20.0 112.451 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p -84.41 -12.55 54.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.216 1.806 . . . . 20.0 114.441 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -4.41 11.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.189 1.395 . . . . 20.0 112.977 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 t -116.45 80.76 10.38 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.16 1.384 . . . . 20.0 108.824 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.07 170.73 18.26 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.654 2.903 . . . . 20.0 111.665 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -58.51 -28.78 65.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.708 1.603 . . . . 20.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.22 -40.43 64.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.832 1.253 . . . . 20.0 112.169 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.2 -5.66 57.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.934 1.087 . . . . 20.0 113.934 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -61.96 140.09 58.35 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.883 0.873 . . . . 20.0 110.957 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mt -75.86 173.04 11.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.115 0.96 . . . . 20.0 110.743 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -66.94 -12.62 60.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.373 1.069 . . . . 20.0 112.691 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.05 165.65 26.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.075 2.15 . . . . 20.0 110.869 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.65 86.79 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 125.798 1.666 . . . . 20.0 110.404 -172.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.5 1.37 60.18 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 118.448 -1.196 . . . . 20.0 115.575 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.1 m -97.42 174.35 6.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.643 1.177 . . . . 20.0 110.791 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -88.05 -5.13 58.65 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.403 1.081 . . . . 20.0 112.178 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 t -137.53 -61.26 0.64 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.676 1.591 . . . . 20.0 110.362 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -150.82 135.79 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.318 1.047 . . . . 20.0 110.952 -171.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.9 t -120.51 115.31 23.2 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.5 1.92 . . . . 20.0 109.146 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 m -126.12 146.7 49.83 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.776 1.63 . . . . 20.0 109.916 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.93 164.96 24.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.957 0.503 . . . . 20.0 111.82 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 125.364 1.466 . . . . 20.0 111.861 177.311 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 112.686 0.624 . . . . 20.0 112.686 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.83 -36.42 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.729 0.812 . . . . 20.0 109.62 173.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.0 m -69.32 -13.46 62.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.631 1.173 . . . . 20.0 113.249 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -69.6 -10.04 56.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.347 1.059 . . . . 20.0 112.085 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.15 -3.06 56.74 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.558 1.551 . . . . 20.0 113.791 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.07 -96.59 0.11 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.296 1.048 . . . . 20.0 109.583 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.37 -155.06 25.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.303 1.43 . . . . 20.0 111.188 -170.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -149.89 145.11 26.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.749 1.22 . . . . 20.0 109.378 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.439 HD22 ' HB2' ' A' ' 32' ' ' CYS . 2.2 mp -123.55 160.58 50.19 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.581 . . . . 20.0 110.152 -177.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.82 171.79 16.75 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.163 3.242 . . . . 20.0 112.705 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -67.96 -2.13 6.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.855 2.462 . . . . 20.0 114.298 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.9 m -130.06 5.63 4.94 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.564 1.546 . . . . 20.0 112.933 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -136.04 9.59 3.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.552 1.141 . . . . 20.0 112.896 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.9 t -115.59 80.72 8.38 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 20.0 109.361 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.8 161.53 43.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.238 2.625 . . . . 20.0 110.705 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -58.77 -28.5 65.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.086 1.354 . . . . 20.0 113.106 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.8 -44.88 84.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.925 1.29 . . . . 20.0 111.789 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.28 -8.07 59.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.7 1.2 . . . . 20.0 113.848 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -62.74 141.9 58.38 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.338 0.972 . . . . 20.0 110.579 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.67 170.23 15.67 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.305 0.574 . . . . 20.0 110.874 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 t -66.89 -11.24 55.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.397 1.079 . . . . 20.0 112.381 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -144.68 165.65 27.45 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.575 2.35 . . . . 20.0 110.291 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.24 -169.67 15.05 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.481 1.515 . . . . 20.0 112.153 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.68 -7.22 0.33 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.891 1.234 . . . . 20.0 113.523 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 m -73.15 -179.1 3.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.457 1.503 . . . . 20.0 113.043 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -65.58 -30.14 70.83 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.49 1.516 . . . . 20.0 111.393 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -155.55 -38.28 0.09 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.152 0.981 . . . . 20.0 113.009 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m -140.5 139.85 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.328 0.967 . . . . 20.0 111.056 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 14.6 t -129.68 131.21 46.31 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.165 1.386 . . . . 20.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HB2' HD22 ' A' ' 11' ' ' LEU . 13.0 m -133.09 148.0 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.049 1.739 . . . . 20.0 109.601 176.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -70.39 148.77 48.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.051 0.94 . . . . 20.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 123.834 0.854 . . . . 20.0 112.279 172.659 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 108.936 -0.764 . . . . 20.0 108.936 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.21 -27.38 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.02 1.728 . . . . 20.0 112.15 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -60.0 -44.61 94.44 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.718 1.207 . . . . 20.0 111.695 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -85.88 -5.11 59.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.74 1.216 . . . . 20.0 113.423 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.96 -7.44 57.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.7 1.619 . . . . 20.0 114.918 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.11 171.03 6.04 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.339 1.456 . . . . 20.0 111.932 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.09 -167.09 13.18 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.658 1.123 . . . . 20.0 113.293 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.02 83.56 1.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.57 1.948 . . . . 20.0 107.874 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.42 HD13 HD22 ' A' ' 34' ' ' LEU . 5.3 mp -66.97 159.84 73.7 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.844 1.258 . . . . 20.0 110.233 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -69.47 162.75 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 20.0 110.977 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -69.72 3.92 2.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.742 1.617 . . . . 20.0 113.464 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.5 t -113.3 -0.68 14.48 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.997 2.119 . . . . 20.0 112.616 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.21 0.11 2.54 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.187 1.181 . . . . 20.0 114.187 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.5 t -111.39 110.22 55.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.171 0.989 . . . . 20.0 110.758 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.57 158.9 55.56 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.877 2.384 . . . . 20.0 111.119 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.21 -23.95 66.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.746 1.218 . . . . 20.0 113.534 -171.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -83.37 -30.97 26.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.324 1.45 . . . . 20.0 112.246 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.42 -11.97 58.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.723 1.209 . . . . 20.0 112.968 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -71.37 108.36 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.307 1.443 . . . . 20.0 109.219 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.91 159.63 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.957 0.903 . . . . 20.0 110.89 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -77.47 1.09 20.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.903 1.281 . . . . 20.0 113.165 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.2 170.0 18.81 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.752 1.621 . . . . 20.0 111.148 -172.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.82 171.56 21.71 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.29 0.947 . . . . 20.0 113.055 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -96.26 -16.18 38.68 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.681 1.134 . . . . 20.0 113.332 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.0 m -72.71 175.21 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.372 1.086 . . . . 20.0 110.587 168.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.2 t -126.82 8.63 6.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.003 1.321 . . . . 20.0 111.92 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -126.58 -64.28 1.03 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.298 1.439 . . . . 20.0 109.404 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.69 156.91 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.932 1.693 . . . . 20.0 110.151 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.5 t -142.12 82.72 1.81 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.257 2.223 . . . . 20.0 107.082 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 152.64 40.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.819 -0.628 . . . . 20.0 111.613 -173.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -102.18 104.61 15.2 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.734 1.214 . . . . 20.0 110.129 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.1 pt? . . . . . 0 CA--C 1.54 0.596 0 C-N-CA 128.585 2.754 . . . . 20.0 112.153 169.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.227 -0.114 0 CA-C-O 118.888 -0.577 . . . . 20.0 112.236 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.0 t -67.04 -39.71 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.68 0.792 . . . . 20.0 110.741 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -62.72 -35.5 79.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.38 1.072 . . . . 20.0 111.662 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -81.1 -4.97 57.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.856 1.662 . . . . 20.0 113.302 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.54 85.53 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.784 1.183 . . . . 20.0 114.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -75.54 174.84 9.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.391 1.476 . . . . 20.0 111.487 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.63 173.09 16.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.973 0.797 . . . . 20.0 114.139 -174.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 75.8 m -126.28 72.15 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.711 . . . . 20.0 109.239 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.2 mt -68.33 162.02 64.61 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.873 1.269 . . . . 20.0 111.514 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.23 169.8 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.488 2.792 . . . . 20.0 110.665 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.95 -21.17 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.888 0.699 . . . . 20.0 112.888 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 t -65.26 -54.51 28.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.49 1.516 . . . . 20.0 111.21 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.51 -7.63 57.36 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.755 1.02 . . . . 20.0 113.755 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -115.86 81.07 9.31 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.82 1.248 . . . . 20.0 110.322 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.69 172.96 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.926 3.084 . . . . 20.0 112.477 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.03 -7.41 22.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.567 1.547 . . . . 20.0 113.52 174.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.24 -28.1 17.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.308 1.443 . . . . 20.0 112.209 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.08 -11.11 19.11 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 20.0 113.851 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -59.99 139.56 57.34 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.182 0.993 . . . . 20.0 111.291 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.35 165.65 17.08 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.339 0.59 . . . . 20.0 110.423 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.3 t -76.49 -7.61 55.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.834 0.854 . . . . 20.0 112.321 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.23 173.24 11.7 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.402 2.281 . . . . 20.0 110.488 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.67 171.1 32.41 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 121.559 0.533 . . . . 20.0 113.713 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.85 20.53 2.52 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.525 1.536 . . . . 20.0 112.847 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -68.17 179.21 1.61 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.706 1.202 . . . . 20.0 110.698 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.3 t -84.5 -21.74 30.48 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.034 0.534 . . . . 20.0 111.814 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -136.5 -60.35 0.71 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.72 1.208 . . . . 20.0 111.048 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.1 153.99 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.39 1.476 . . . . 20.0 110.476 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.12 132.08 41.26 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.213 1.405 . . . . 20.0 110.371 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.4 m -130.96 144.14 51.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.114 1.366 . . . . 20.0 110.37 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -74.19 103.96 4.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.16 0.984 . . . . 20.0 109.405 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.536 0.41 0 C-N-CA 126.092 1.757 . . . . 20.0 112.543 170.483 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 118.93 -0.557 . . . . 20.0 112.364 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.35 -38.26 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.864 0.866 . . . . 20.0 110.479 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -62.98 -35.51 80.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.038 0.935 . . . . 20.0 111.918 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -81.72 -4.68 56.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.502 1.521 . . . . 20.0 113.041 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.1 2.71 90.6 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.966 1.269 . . . . 20.0 114.948 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -71.53 174.11 7.1 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.802 1.301 . . . . 20.0 112.38 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.54 -177.96 51.86 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.097 1.332 . . . . 20.0 112.744 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.94 59.02 0.79 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.567 1.147 . . . . 20.0 110.006 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.57 153.38 95.76 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.039 0.536 . . . . 20.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.03 172.71 14.15 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.6 3.533 . . . . 20.0 111.475 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -62.28 -13.9 33.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.716 1.376 . . . . 20.0 114.716 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.7 m -95.28 -9.54 32.82 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.294 1.438 . . . . 20.0 113.476 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.83 -2.69 9.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.032 1.733 . . . . 20.0 112.354 175.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.98 85.71 40.95 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.539 1.535 . . . . 20.0 109.721 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.18 175.87 10.68 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.184 3.256 . . . . 20.0 112.326 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.69 -12.99 52.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.33 1.452 . . . . 20.0 113.42 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 -39.02 17.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.389 1.075 . . . . 20.0 112.04 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.72 -10.45 26.82 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.739 1.014 . . . . 20.0 113.739 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -63.37 149.78 45.02 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.92 0.782 . . . . 20.0 111.251 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.99 171.83 11.12 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.225 0.536 . . . . 20.0 110.528 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -67.71 -4.73 13.1 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.202 1.401 . . . . 20.0 112.907 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -148.97 162.21 40.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.316 1.846 . . . . 20.0 110.763 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.8 75.35 0.23 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 125.101 1.334 . . . . 20.0 111.022 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 7.7 61.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.986 1.279 . . . . 20.0 114.786 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 55.7 m -102.93 -172.72 2.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.23 1.812 . . . . 20.0 110.384 170.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -72.45 -27.16 62.13 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.586 1.154 . . . . 20.0 112.082 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 t -155.82 -32.81 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.44 0.904 . . . . 20.0 113.44 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -138.6 130.09 36.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 124.905 1.282 . . . . 20.0 110.732 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.78 141.46 48.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.724 1.61 . . . . 20.0 110.716 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -135.47 157.56 46.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.101 1.76 . . . . 20.0 110.495 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.24 160.34 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.175 0.59 . . . . 20.0 111.614 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 125.912 1.685 . . . . 20.0 113.341 171.768 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 111.742 0.275 . . . . 20.0 111.742 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.23 -37.87 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.1 . . . . 20.0 110.811 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -65.4 -34.69 78.89 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.2 1.0 . . . . 20.0 112.214 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -68.16 -17.67 64.4 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.778 1.231 . . . . 20.0 112.66 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.53 38.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.721 1.629 . . . . 20.0 114.245 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -68.79 168.5 13.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.908 1.354 . . . . 20.0 112.022 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.84 -160.94 27.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.406 1.479 . . . . 20.0 113.171 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 t -154.1 72.6 0.89 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.019 0.928 . . . . 20.0 108.793 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.56 162.36 43.51 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.3 1.44 . . . . 20.0 111.154 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.85 157.76 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.815 2.343 . . . . 20.0 110.766 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -63.37 -20.09 65.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.636 1.174 . . . . 20.0 113.112 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.9 m -87.79 -0.49 57.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.556 1.542 . . . . 20.0 113.715 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.53 -36.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.612 1.096 . . . . 20.0 113.362 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.79 113.2 38.33 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 20.0 109.182 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.78 168.33 23.75 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.99 2.46 . . . . 20.0 111.994 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.49 -4.79 32.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.937 1.295 . . . . 20.0 113.544 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -91.69 -34.55 14.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.634 1.174 . . . . 20.0 112.217 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.19 -18.11 35.07 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.636 1.174 . . . . 20.0 113.605 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -62.01 149.6 40.44 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.357 0.663 . . . . 20.0 112.205 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.62 172.09 8.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.202 1.401 . . . . 20.0 110.451 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -73.93 -7.22 51.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.689 1.196 . . . . 20.0 113.338 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -85.65 -179.63 6.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.712 1.605 . . . . 20.0 113.063 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.62 32.85 2.41 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.114 1.816 . . . . 20.0 112.852 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.22 1.9 54.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.221 1.391 . . . . 20.0 115.708 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.16 172.36 11.07 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.202 1.401 . . . . 20.0 110.197 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -92.25 -12.83 31.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.939 0.896 . . . . 20.0 112.353 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.6 p -130.18 -65.03 0.83 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.092 1.357 . . . . 20.0 109.574 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 m -151.36 159.32 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.451 1.1 . . . . 20.0 111.228 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -133.49 149.19 51.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.732 2.013 . . . . 20.0 108.507 172.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.11 149.37 52.42 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.313 1.045 . . . . 20.0 111.069 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -89.57 77.44 7.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.737 1.215 . . . . 20.0 113.398 -168.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 114.703 1.371 . . . . 20.0 114.703 178.418 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 121.623 0.725 . . . . 20.0 111.249 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -64.66 -42.58 95.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.401 1.48 . . . . 20.0 111.917 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.459 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 67.1 m -68.61 -39.06 81.03 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.38 1.072 . . . . 20.0 112.293 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.02 -40.33 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.124 0.97 . . . . 20.0 110.485 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.5 t -56.02 -48.0 76.76 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.286 1.034 . . . . 20.0 111.018 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -73.56 -3.84 30.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.228 1.811 . . . . 20.0 113.585 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.12 0.41 89.58 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.129 1.347 . . . . 20.0 115.058 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -72.01 165.42 24.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.672 1.236 . . . . 20.0 112.296 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.81 -158.41 30.44 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.111 1.815 . . . . 20.0 111.792 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -147.21 116.49 6.96 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.35 1.06 . . . . 20.0 108.811 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.52 159.13 33.36 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.516 1.527 . . . . 20.0 110.02 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.27 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.246 2.631 . . . . 20.0 111.719 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -68.25 -8.67 41.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.729 1.612 . . . . 20.0 113.7 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.7 p -107.24 -29.74 9.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.509 1.524 . . . . 20.0 113.577 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.26 -26.08 19.17 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 118.8 0.727 . . . . 20.0 112.406 -173.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -85.1 110.49 28.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.463 1.505 . . . . 20.0 109.634 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.75 167.2 26.4 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.786 2.324 . . . . 20.0 111.487 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -69.42 -8.17 44.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.031 1.332 . . . . 20.0 113.327 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -92.53 -28.25 16.89 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.246 1.418 . . . . 20.0 111.792 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.16 -15.41 20.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.244 1.418 . . . . 20.0 113.513 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -60.05 139.37 57.51 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.728 0.811 . . . . 20.0 110.129 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -94.14 158.43 15.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.641 0.734 . . . . 20.0 110.823 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.2 t -80.22 9.05 6.15 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.781 1.632 . . . . 20.0 112.88 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -112.86 168.97 9.25 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.044 1.338 . . . . 20.0 112.77 -168.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -107.13 32.1 7.54 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.325 1.917 . . . . 20.0 113.01 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA3' ' H ' ' A' ' 3' ' ' CYS . . . -76.6 -0.02 66.45 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.28 1.419 . . . . 20.0 115.749 -173.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.1 m -125.08 -172.18 2.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.905 2.082 . . . . 20.0 110.22 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -105.89 -3.97 21.24 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.384 1.474 . . . . 20.0 113.232 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.9 t -144.29 -55.63 0.35 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.268 1.027 . . . . 20.0 110.816 171.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -145.8 152.31 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.549 1.54 . . . . 20.0 109.151 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.1 t -121.84 144.23 48.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.682 1.193 . . . . 20.0 109.535 172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -135.23 149.64 49.91 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.865 1.266 . . . . 20.0 109.603 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -74.91 175.41 8.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.874 0.87 . . . . 20.0 111.876 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.3 mt -125.21 5.32 7.81 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.846 1.658 . . . . 20.0 112.117 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 t -67.4 -19.86 65.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.448 1.099 . . . . 20.0 113.475 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -68.03 -27.66 66.73 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.394 0.997 . . . . 20.0 112.349 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 50.2 mt -72.03 -39.97 68.74 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.667 1.187 . . . . 20.0 111.112 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -79.83 -12.86 59.74 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.772 1.229 . . . . 20.0 113.158 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.507 -1.718 . . . . 20.0 111.592 -179.451 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.133 -0.321 . . . . 20.0 110.133 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -67.12 -36.38 81.8 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.624 0.77 . . . . 20.0 111.369 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.74 -43.84 71.48 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.708 0.685 . . . . 20.0 111.867 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.75 -22.93 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.263 1.025 . . . . 20.0 111.227 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.9 t -58.73 -33.89 70.74 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.84 0.856 . . . . 20.0 113.161 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -79.16 -11.23 59.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.542 1.537 . . . . 20.0 113.342 173.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.95 -2.89 31.7 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.175 1.845 . . . . 20.0 114.329 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -72.42 -178.85 2.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.041 1.336 . . . . 20.0 112.154 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.3 168.62 21.48 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.887 1.232 . . . . 20.0 111.187 174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 t -126.49 68.62 1.23 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 20.0 110.669 -160.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 31.3 mt -72.78 153.59 91.28 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.268 0.627 . . . . 20.0 111.882 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.65 173.97 11.76 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.724 3.616 . . . . 20.0 111.931 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -57.24 -38.2 73.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.686 1.195 . . . . 20.0 112.499 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.3 p -67.53 -17.32 64.62 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.153 1.381 . . . . 20.0 113.874 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.73 -12.27 10.27 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.028 1.731 . . . . 20.0 111.777 -174.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.3 t -122.83 89.46 50.29 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.373 1.469 . . . . 20.0 109.026 -176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.04 166.81 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.145 2.563 . . . . 20.0 110.753 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.94 -33.02 70.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.628 1.171 . . . . 20.0 112.907 -173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.94 -32.98 74.79 Favored 'General case' 0 C--N 1.344 0.342 0 C-N-CA 125.118 1.367 . . . . 20.0 112.429 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.37 -10.05 45.4 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.37 1.468 . . . . 20.0 113.156 -174.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -65.05 143.91 57.61 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.005 0.922 . . . . 20.0 110.056 171.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.6 mt -78.89 175.86 10.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.393 0.677 . . . . 20.0 111.178 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -73.5 -7.64 52.64 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.303 0.641 . . . . 20.0 112.322 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -137.13 173.17 11.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.847 2.059 . . . . 20.0 110.625 178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.17 -95.21 0.9 Allowed Glycine 0 C--N 1.338 0.661 0 C-N-CA 124.281 0.943 . . . . 20.0 111.607 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.95 -32.15 4.72 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 126.56 2.029 . . . . 20.0 113.554 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.8 m -82.5 -177.98 6.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.081 0.94 . . . . 20.0 110.574 169.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -74.86 -31.95 61.77 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.792 1.237 . . . . 20.0 110.255 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 p -136.11 -55.02 0.76 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.456 1.502 . . . . 20.0 111.341 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.3 t -145.23 137.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 125.678 1.591 . . . . 20.0 108.836 -169.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.2 t -125.98 155.05 42.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.528 1.531 . . . . 20.0 109.905 169.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.8 160.51 35.38 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.835 1.254 . . . . 20.0 110.826 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.08 35.6 0.99 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.998 1.481 . . . . 20.0 114.998 -164.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.0 16.35 1.52 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.856 1.428 . . . . 20.0 114.856 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.7 t -54.16 -40.22 67.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.773 1.229 . . . . 20.0 111.795 167.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -65.95 -20.22 66.13 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.004 1.112 . . . . 20.0 114.004 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.16 -48.43 7.4 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.623 1.169 . . . . 20.0 110.256 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 m -66.02 -26.25 67.44 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.819 1.648 . . . . 20.0 112.312 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 C-N-CA 126.067 1.794 . . . . 20.0 113.815 173.821 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 110.517 -0.179 . . . . 20.0 110.517 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -67.16 -37.71 84.21 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.987 1.315 . . . . 20.0 111.958 177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.7 t -61.99 -44.7 96.18 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.918 0.887 . . . . 20.0 110.702 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.97 -38.18 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.978 1.311 . . . . 20.0 111.471 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.1 p -67.36 -31.78 72.26 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.002 0.819 . . . . 20.0 112.666 -178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -73.45 -3.19 25.96 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.22 1.808 . . . . 20.0 113.426 171.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.77 -4.87 69.1 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.419 1.485 . . . . 20.0 114.542 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -78.97 -174.39 4.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.642 1.177 . . . . 20.0 111.155 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -127.13 -176.19 14.38 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.194 1.378 . . . . 20.0 111.499 171.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.3 m -134.56 88.77 2.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.989 1.315 . . . . 20.0 108.328 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.71 161.89 10.41 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 125.817 1.647 . . . . 20.0 111.367 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.7 165.1 33.68 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.471 2.114 . . . . 20.0 111.188 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -73.31 4.6 4.43 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.917 1.687 . . . . 20.0 113.287 -174.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.0 p -115.7 -4.38 12.19 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.859 2.063 . . . . 20.0 113.711 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.18 -27.57 1.59 Allowed 'General case' 0 C--N 1.346 0.452 0 N-CA-C 114.081 1.141 . . . . 20.0 114.081 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.3 t -58.24 106.14 0.65 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 126.516 1.926 . . . . 20.0 110.508 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.75 155.9 35.14 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.601 2.2 . . . . 20.0 111.297 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -68.44 -17.84 64.29 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.631 0.604 . . . . 20.0 112.631 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -76.73 -33.5 58.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.847 1.259 . . . . 20.0 112.541 177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.84 -5.82 59.34 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.015 1.116 . . . . 20.0 114.015 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 mtm105 -57.06 117.98 4.55 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.55 1.14 . . . . 20.0 110.529 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.9 mt -75.67 172.07 13.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.615 0.766 . . . . 20.0 110.717 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -70.2 -2.88 14.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.855 1.262 . . . . 20.0 113.289 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.55 163.3 34.29 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.965 1.706 . . . . 20.0 111.471 -173.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.07 77.94 0.24 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.5 1.524 . . . . 20.0 110.663 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.23 6.4 76.12 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.699 1.142 . . . . 20.0 115.547 -174.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 m -130.17 -175.73 3.72 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.883 2.073 . . . . 20.0 110.126 171.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 89.1 p -90.48 -7.37 53.18 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.026 1.33 . . . . 20.0 112.656 -171.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.2 p -131.85 -63.3 0.83 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.309 1.444 . . . . 20.0 109.971 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.55 152.58 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 124.734 1.213 . . . . 20.0 111.08 -171.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.8 t -133.74 67.8 1.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.239 1.816 . . . . 20.0 108.266 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.96 131.23 40.51 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 123.997 0.919 . . . . 20.0 109.451 167.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.77 159.78 21.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.208 0.603 . . . . 20.0 111.518 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 pp -133.79 -6.51 2.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.015 1.117 . . . . 20.0 114.015 164.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.5 t -65.96 -29.84 70.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.809 0.844 . . . . 20.0 111.707 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -89.41 -25.26 21.62 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.937 1.295 . . . . 20.0 111.289 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.5 mt -72.66 -38.45 67.63 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.62 1.168 . . . . 20.0 111.386 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 t -89.77 -6.42 55.99 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.917 1.287 . . . . 20.0 112.654 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.954 1.74 . . . . 20.0 111.336 -179.524 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.463 0.173 . . . . 20.0 110.614 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -68.17 -45.17 74.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.449 1.5 . . . . 20.0 112.255 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.0 t -66.76 -44.33 81.72 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.796 1.238 . . . . 20.0 111.786 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.94 -18.13 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.139 1.376 . . . . 20.0 111.935 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.8 t -58.23 -42.15 85.68 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.755 1.222 . . . . 20.0 112.081 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -21.83 64.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.763 1.625 . . . . 20.0 112.942 174.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.54 -3.36 36.85 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.016 1.769 . . . . 20.0 113.937 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -70.45 168.64 15.71 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.554 1.177 . . . . 20.0 112.252 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.01 -175.32 50.63 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.188 1.375 . . . . 20.0 112.417 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 t -151.93 49.56 0.79 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.452 1.101 . . . . 20.0 109.274 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.07 153.87 16.7 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 124.829 1.251 . . . . 20.0 111.721 -173.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.59 170.67 19.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.404 2.736 . . . . 20.0 112.447 -175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -65.21 -4.07 4.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.687 1.995 . . . . 20.0 114.449 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.5 t -115.65 -11.56 11.68 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.562 1.545 . . . . 20.0 113.066 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.09 -26.53 5.1 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.1 -0.952 . . . . 20.0 113.233 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 t -65.23 107.21 1.31 Allowed Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.36 1.864 . . . . 20.0 109.605 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.22 152.45 50.33 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.323 2.015 . . . . 20.0 110.035 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -63.31 -25.66 68.41 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.668 1.187 . . . . 20.0 112.64 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -78.16 -31.63 49.76 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.932 1.293 . . . . 20.0 112.92 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.44 -8.39 58.98 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.794 1.035 . . . . 20.0 113.794 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -60.71 117.21 5.09 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.361 1.064 . . . . 20.0 108.723 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.3 176.39 3.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.676 1.191 . . . . 20.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 t -69.95 -3.9 18.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.058 0.943 . . . . 20.0 113.023 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -138.88 169.18 18.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.55 1.94 . . . . 20.0 110.586 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.91 71.69 0.49 Allowed Glycine 0 C--N 1.341 0.809 0 C-N-CA 125.013 1.292 . . . . 20.0 111.259 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.12 -19.66 76.82 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 123.845 0.736 . . . . 20.0 114.103 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.32 174.55 9.39 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.576 1.15 . . . . 20.0 111.148 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.6 m -86.59 -5.66 59.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.663 1.185 . . . . 20.0 111.987 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -149.56 -53.15 0.16 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.849 1.26 . . . . 20.0 111.681 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.21 122.46 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.568 1.147 . . . . 20.0 111.505 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.4 t -106.24 82.94 1.82 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 127.339 2.256 . . . . 20.0 108.944 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.26 142.94 27.23 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.87 1.268 . . . . 20.0 111.098 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.93 170.25 16.97 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.92 0.888 . . . . 20.0 112.207 177.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.37 -5.79 8.79 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.732 1.613 . . . . 20.0 112.117 177.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 t -70.58 -19.75 62.83 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.194 1.398 . . . . 20.0 112.614 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -62.53 -22.02 65.98 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.889 1.276 . . . . 20.0 113.652 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.6 mt -66.84 -56.4 10.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.562 1.145 . . . . 20.0 110.343 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 t -72.16 -10.71 60.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.321 1.048 . . . . 20.0 113.193 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 CA-C-O 116.323 -2.376 . . . . 20.0 113.613 177.195 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 110.22 -0.289 . . . . 20.0 110.22 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -61.87 -42.65 99.32 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.185 0.994 . . . . 20.0 111.553 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.9 t -61.8 -45.82 92.21 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.069 0.947 . . . . 20.0 111.272 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.5 t -67.14 -34.85 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.885 1.274 . . . . 20.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.5 m -66.94 -36.94 83.35 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.185 0.994 . . . . 20.0 111.865 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -73.46 -5.73 41.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.718 1.207 . . . . 20.0 113.158 171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.85 4.04 85.2 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.885 1.231 . . . . 20.0 113.878 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -84.26 168.7 15.45 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.163 1.385 . . . . 20.0 112.117 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.11 167.86 24.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.387 0.994 . . . . 20.0 113.234 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.9 m -126.81 74.09 1.46 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.701 1.6 . . . . 20.0 108.388 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.04 162.23 40.65 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.776 1.231 . . . . 20.0 110.824 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.44 173.4 14.54 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.365 2.71 . . . . 20.0 110.959 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -66.67 -0.46 2.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.221 1.809 . . . . 20.0 113.733 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.6 p -125.96 -8.08 6.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.941 1.696 . . . . 20.0 114.583 -173.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -128.9 -6.4 5.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.355 0.979 . . . . 20.0 113.222 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.0 t -76.92 116.08 53.98 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.847 0.859 . . . . 20.0 108.741 163.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -72.87 159.18 48.78 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.733 2.289 . . . . 20.0 110.443 172.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -63.54 -24.59 67.88 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.029 0.932 . . . . 20.0 112.259 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -72.46 -30.66 64.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.959 1.304 . . . . 20.0 112.43 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.39 -18.71 41.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.052 1.13 . . . . 20.0 114.052 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -60.85 120.5 10.27 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.895 1.278 . . . . 20.0 111.313 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.9 mt -82.4 171.11 14.54 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.449 1.099 . . . . 20.0 112.015 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -69.49 -12.62 61.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.27 1.428 . . . . 20.0 112.445 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -132.6 168.97 17.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.939 2.095 . . . . 20.0 110.838 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.61 71.56 0.49 Allowed Glycine 0 C--N 1.339 0.737 0 C-N-CA 125.625 1.583 . . . . 20.0 110.806 -173.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.58 -7.9 87.87 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.336 0.969 . . . . 20.0 114.853 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.7 m -81.63 -168.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.516 1.526 . . . . 20.0 109.778 167.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.0 p -103.12 -6.53 22.13 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.664 1.185 . . . . 20.0 111.987 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.3 p -127.92 -74.48 0.58 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.005 2.122 . . . . 20.0 109.247 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 m -150.5 120.48 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.76 1.624 . . . . 20.0 109.119 -172.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.45 108.74 19.82 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.465 1.106 . . . . 20.0 109.257 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -126.16 113.17 16.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.169 1.387 . . . . 20.0 109.015 -168.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.57 172.25 3.51 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.059 1.344 . . . . 20.0 112.873 -172.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 69.6 mt -126.36 7.93 7.1 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.122 1.369 . . . . 20.0 111.932 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.0 t -64.07 -25.66 68.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.336 1.054 . . . . 20.0 113.329 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -65.06 -31.87 73.3 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 124.254 1.021 . . . . 20.0 111.906 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.8 mt -72.74 -14.83 61.64 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.568 1.147 . . . . 20.0 113.315 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.0 t -123.29 6.52 9.08 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.376 1.87 . . . . 20.0 111.077 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 CA-C-O 117.184 -1.898 . . . . 20.0 111.425 -176.896 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 109.806 -0.442 . . . . 20.0 109.806 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.55 -46.1 80.8 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.788 -0.625 . . . . 20.0 111.494 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.44 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 1.0 OUTLIER -60.37 -32.6 71.45 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.765 0.654 . . . . 20.0 112.765 -177.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.44 -46.17 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.19 1.396 . . . . 20.0 110.39 174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.1 t -65.32 -29.4 70.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.14 1.376 . . . . 20.0 112.665 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -71.51 -6.05 37.64 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.546 1.938 . . . . 20.0 112.669 171.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.41 6.32 89.33 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.599 -1.111 . . . . 20.0 114.491 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -74.87 167.69 21.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.616 1.208 . . . . 20.0 111.694 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.64 128.26 9.43 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.083 0.849 . . . . 20.0 112.555 -171.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 74.9 m -82.41 75.0 9.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.913 0.885 . . . . 20.0 108.752 163.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.36 162.96 36.49 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 20.0 110.975 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.66 167.85 25.58 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.818 2.346 . . . . 20.0 110.849 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -74.42 5.85 4.26 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.621 1.569 . . . . 20.0 113.727 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.5 t -129.57 12.84 5.93 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.865 1.666 . . . . 20.0 112.323 -175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -133.04 -45.93 0.85 Allowed 'General case' 0 C--N 1.346 0.42 0 C-N-CA 124.442 1.097 . . . . 20.0 112.513 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -52.21 104.31 0.42 Allowed Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 127.336 2.254 . . . . 20.0 111.807 -175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.78 145.4 36.49 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.682 2.255 . . . . 20.0 110.96 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -59.91 -26.82 66.23 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.521 0.934 . . . . 20.0 113.521 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -65.01 -29.93 70.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.627 1.571 . . . . 20.0 112.647 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.33 -7.69 24.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.829 1.252 . . . . 20.0 113.64 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -61.23 120.09 9.69 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.754 1.161 . . . . 20.0 110.409 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.09 172.94 10.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.704 1.202 . . . . 20.0 111.773 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -69.85 -10.5 58.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.744 1.218 . . . . 20.0 112.215 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -139.34 172.95 12.07 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.344 2.257 . . . . 20.0 110.591 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.6 76.05 0.21 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.789 -0.924 . . . . 20.0 110.789 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . -69.01 -13.33 66.59 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.841 1.21 . . . . 20.0 113.525 176.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -66.48 177.37 1.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.732 1.613 . . . . 20.0 111.244 167.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 97.5 p -93.65 -13.01 28.08 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.73 0.812 . . . . 20.0 112.798 -174.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -135.39 -59.79 0.77 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.395 1.078 . . . . 20.0 110.819 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.9 m -148.22 153.62 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.652 1.581 . . . . 20.0 110.239 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.9 t -134.42 108.86 8.39 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.656 1.182 . . . . 20.0 109.502 173.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 m -102.46 137.22 41.0 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.133 0.973 . . . . 20.0 109.616 171.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -66.43 166.46 12.39 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.61 0.764 . . . . 20.0 111.618 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.9 mt -122.17 7.7 9.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.004 1.722 . . . . 20.0 110.882 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 t -60.88 -28.55 68.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.882 2.073 . . . . 20.0 113.44 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.98 -14.92 63.34 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.404 1.261 . . . . 20.0 114.404 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.35 -60.58 2.47 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 124.153 0.981 . . . . 20.0 109.876 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 p -74.86 -10.49 59.55 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.935 1.294 . . . . 20.0 113.243 174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.237 0 CA-C-O 116.818 -2.101 . . . . 20.0 111.89 -178.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 121.162 0.506 . . . . 20.0 111.657 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -67.09 -48.82 67.05 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.04 0.936 . . . . 20.0 111.561 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 26' ' ' GLY . 0.1 OUTLIER -61.98 -26.8 68.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.009 0.744 . . . . 20.0 113.009 -175.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 65.9 t -83.48 -41.19 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.436 1.495 . . . . 20.0 110.766 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -60.81 -35.2 75.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.704 1.202 . . . . 20.0 111.995 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -69.32 -14.16 62.78 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.887 2.075 . . . . 20.0 113.233 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 16.91 77.29 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.653 -1.082 . . . . 20.0 114.601 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -59.87 165.59 3.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.6 1.16 . . . . 20.0 112.567 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.51 -33.83 67.59 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.1 1.333 . . . . 20.0 113.986 -175.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 t 50.67 37.22 15.94 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.146 1.779 . . . . 20.0 112.008 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.49 154.12 56.66 Favored Pre-proline 0 C--N 1.345 0.387 0 C-N-CA 124.934 1.294 . . . . 20.0 111.821 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -67.17 171.24 11.74 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.746 2.964 . . . . 20.0 111.342 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.65 -22.54 66.52 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.176 0.99 . . . . 20.0 112.475 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.7 p -80.99 -3.76 52.8 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.245 1.818 . . . . 20.0 114.161 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.5 -42.9 1.29 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.141 1.376 . . . . 20.0 112.918 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.86 109.78 5.36 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.218 1.807 . . . . 20.0 110.601 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -80.6 170.33 15.89 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.552 2.835 . . . . 20.0 112.199 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -66.77 -12.96 60.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.362 1.465 . . . . 20.0 113.411 173.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -96.32 -29.31 14.06 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.335 1.054 . . . . 20.0 112.82 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.68 -5.4 21.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.483 1.113 . . . . 20.0 113.633 -176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -60.43 136.2 57.97 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 118.774 0.716 . . . . 20.0 110.872 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.17 172.04 13.88 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.29 1.036 . . . . 20.0 111.186 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.2 t -72.46 -9.13 58.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.779 0.832 . . . . 20.0 112.318 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.22 172.22 13.33 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.781 2.032 . . . . 20.0 110.973 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -147.58 67.14 0.39 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.658 1.123 . . . . 20.0 111.654 -174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . -77.49 -7.42 87.09 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.128 1.347 . . . . 20.0 114.388 178.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.4 m -66.98 179.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.854 1.327 . . . . 20.0 111.378 166.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 t -68.62 -29.6 68.14 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.342 1.057 . . . . 20.0 111.543 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -158.85 -28.25 0.07 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.744 1.016 . . . . 20.0 113.744 173.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 p -139.13 135.82 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.106 1.362 . . . . 20.0 110.241 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.2 t -133.64 139.28 46.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.063 1.345 . . . . 20.0 110.812 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.01 140.77 34.37 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.879 1.672 . . . . 20.0 109.2 174.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.06 166.78 18.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.209 0.604 . . . . 20.0 110.956 172.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.6 mt -128.99 0.42 5.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.715 1.606 . . . . 20.0 112.368 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.0 t -62.71 -25.03 67.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.948 1.299 . . . . 20.0 113.908 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 36' ' ' LYS . 10.7 mmpt? -67.3 -18.77 65.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.415 1.086 . . . . 20.0 113.144 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.86 -25.85 67.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.111 0.964 . . . . 20.0 112.823 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.3 p -119.19 1.59 11.35 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.225 1.81 . . . . 20.0 112.477 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.7 -1.611 . . . . 20.0 110.918 178.977 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.709 -0.478 . . . . 20.0 109.709 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -59.68 -41.41 90.64 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.126 1.37 . . . . 20.0 112.513 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -39.15 76.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.117 0.567 . . . . 20.0 111.743 -178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.0 t -70.36 -36.85 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.061 0.945 . . . . 20.0 110.685 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -65.49 -30.5 71.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.108 1.363 . . . . 20.0 112.056 175.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -80.32 -12.02 59.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.719 1.608 . . . . 20.0 113.026 171.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.0 12.85 56.03 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.742 1.163 . . . . 20.0 114.928 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -89.18 167.56 13.0 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.832 1.316 . . . . 20.0 112.781 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.7 -175.87 47.0 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.991 1.281 . . . . 20.0 113.363 173.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 t -138.28 65.52 1.46 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.119 1.367 . . . . 20.0 109.133 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -64.57 156.15 78.75 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.38 1.472 . . . . 20.0 110.81 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.46 164.37 35.49 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 123.178 2.586 . . . . 20.0 110.937 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -64.9 -22.84 67.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.654 0.782 . . . . 20.0 112.993 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.7 m -82.79 -3.76 57.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.909 1.284 . . . . 20.0 113.626 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -129.55 0.92 5.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.336 1.454 . . . . 20.0 112.574 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -128.65 80.93 71.72 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.944 1.297 . . . . 20.0 110.443 -175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.14 175.41 10.94 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.176 3.251 . . . . 20.0 112.159 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -67.39 -6.89 21.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.735 1.013 . . . . 20.0 113.735 172.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -86.19 -25.1 25.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.915 1.286 . . . . 20.0 112.396 174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.27 -7.77 14.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.447 1.499 . . . . 20.0 113.43 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.4 ptt85 -63.56 165.34 8.16 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 124.352 1.061 . . . . 20.0 112.168 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 68.9 mt -133.94 166.21 23.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.205 1.002 . . . . 20.0 111.599 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.5 t -82.67 -9.64 59.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.043 1.337 . . . . 20.0 113.694 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -109.27 2.76 21.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.931 1.692 . . . . 20.0 113.639 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -36.55 87.23 0.01 OUTLIER Glycine 0 CA--C 1.529 0.909 1 C-N-CA 130.987 4.137 . . . . 20.0 115.506 -174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -95.62 0.63 63.29 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.069 1.319 . . . . 20.0 113.963 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 96.7 m -66.54 173.48 3.35 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.934 1.294 . . . . 20.0 111.728 171.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.6 m -86.63 -16.1 37.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.887 0.875 . . . . 20.0 111.923 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -132.16 -61.36 0.88 Allowed 'General case' 0 C--N 1.343 0.293 0 C-N-CA 125.373 1.469 . . . . 20.0 110.302 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.5 m -152.18 153.01 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.967 1.307 . . . . 20.0 111.002 -173.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.6 t -131.92 137.01 47.81 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.988 1.715 . . . . 20.0 109.251 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.3 m -137.21 156.35 48.41 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.715 1.206 . . . . 20.0 111.089 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -75.55 126.02 30.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.495 1.118 . . . . 20.0 112.571 -171.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.8 mt -117.87 8.88 12.73 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.836 1.655 . . . . 20.0 113.155 168.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.9 t -64.15 -19.21 65.14 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.498 1.045 . . . . 20.0 112.085 171.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -65.24 -14.72 61.37 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.194 1.398 . . . . 20.0 114.042 174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.21 -45.13 74.18 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.972 0.806 . . . . 20.0 110.745 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 p -82.12 -7.52 59.62 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.239 1.416 . . . . 20.0 113.492 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.308 -1.829 . . . . 20.0 111.498 179.019 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.356 -0.238 . . . . 20.0 110.356 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.23 -63.25 1.32 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.719 0.808 . . . . 20.0 110.883 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.4 m -61.29 -45.6 93.8 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 123.593 0.757 . . . . 20.0 112.552 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.36 -32.98 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.194 0.598 . . . . 20.0 111.394 -175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -67.35 -34.32 77.06 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.524 0.73 . . . . 20.0 111.794 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.18 -9.51 58.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.362 1.065 . . . . 20.0 113.524 173.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.87 -2.4 84.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.757 1.17 . . . . 20.0 113.911 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -71.19 176.13 4.74 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.603 1.201 . . . . 20.0 110.852 168.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.14 -172.91 15.14 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 123.862 0.744 . . . . 20.0 112.818 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -117.68 82.01 1.76 Allowed 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.447 1.499 . . . . 20.0 109.155 -173.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.46 151.8 81.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.185 0.994 . . . . 20.0 109.295 170.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -70.77 167.74 24.88 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.379 2.719 . . . . 20.0 111.598 -173.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -67.24 -9.65 42.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.963 1.305 . . . . 20.0 113.272 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -95.63 -13.51 24.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.83 1.652 . . . . 20.0 113.548 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -137.55 20.17 2.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.059 1.344 . . . . 20.0 112.587 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 t -127.74 77.64 75.97 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.152 1.381 . . . . 20.0 109.354 174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.34 171.11 18.68 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.068 3.179 . . . . 20.0 112.159 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -63.69 -13.35 42.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.799 1.64 . . . . 20.0 113.756 176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.3 -25.98 25.17 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.75 1.22 . . . . 20.0 112.811 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.66 -8.21 14.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.3 1.44 . . . . 20.0 113.345 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -65.79 170.0 5.83 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.278 1.031 . . . . 20.0 111.789 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.8 mt -130.97 168.42 17.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.558 1.143 . . . . 20.0 110.248 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.4 t -74.04 -19.93 60.46 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.237 1.015 . . . . 20.0 111.913 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -73.9 167.07 22.21 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.971 1.708 . . . . 20.0 111.675 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -156.12 87.31 0.12 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.923 0.773 . . . . 20.0 111.662 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.16 3.1 79.88 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.05 1.309 . . . . 20.0 114.172 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 34.0 m -131.93 -12.33 3.3 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.632 1.573 . . . . 20.0 114.762 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.3 p 64.79 6.8 3.49 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 130.889 3.676 . . . . 20.0 113.429 -175.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.3 p -122.53 -57.18 1.76 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.78 1.232 . . . . 20.0 110.772 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -153.06 135.53 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 126.147 1.779 . . . . 20.0 109.402 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 39.4 t -145.42 121.71 10.9 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.839 1.656 . . . . 20.0 109.156 171.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 9.5 m -129.02 148.46 50.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.379 1.471 . . . . 20.0 110.414 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -73.26 107.64 5.69 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.797 1.239 . . . . 20.0 110.446 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 pp -101.14 -16.07 17.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.157 1.783 . . . . 20.0 112.367 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 t -66.51 -19.54 65.81 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.008 1.323 . . . . 20.0 112.614 -176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -56.63 -19.59 17.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.372 1.869 . . . . 20.0 114.558 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.5 mt -66.64 -31.75 72.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.739 1.216 . . . . 20.0 113.47 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.3 m -123.69 -43.43 2.14 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.541 1.536 . . . . 20.0 110.064 -172.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 117.297 -1.835 . . . . 20.0 110.284 179.353 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 120.641 0.257 . . . . 20.0 111.045 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -60.16 -58.07 10.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.69 1.596 . . . . 20.0 112.065 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -61.6 -36.46 80.76 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.87 0.692 . . . . 20.0 112.87 -177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.5 t -70.55 -37.41 69.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 124.131 0.972 . . . . 20.0 110.484 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.6 t -66.98 -30.53 70.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.257 1.023 . . . . 20.0 111.91 174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.11 -2.07 46.87 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.138 1.375 . . . . 20.0 112.564 171.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.88 -5.01 84.95 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.903 1.716 . . . . 20.0 114.961 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -76.39 168.32 20.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.783 1.292 . . . . 20.0 112.14 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -93.14 170.93 32.08 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.639 1.114 . . . . 20.0 112.51 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.0 m -126.0 68.65 1.19 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.669 1.588 . . . . 20.0 107.936 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.66 161.47 65.77 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.999 1.72 . . . . 20.0 110.746 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.45 164.76 34.66 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.599 2.2 . . . . 20.0 111.329 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -66.94 -6.97 18.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.675 1.59 . . . . 20.0 113.738 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -121.05 -5.3 9.53 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.736 1.615 . . . . 20.0 113.964 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -105.58 -42.39 5.21 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.229 0.922 . . . . 20.0 112.026 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.6 115.46 27.35 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.39 1.076 . . . . 20.0 109.863 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.24 160.62 35.91 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.547 2.164 . . . . 20.0 110.381 174.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -63.9 -16.93 62.61 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.871 1.268 . . . . 20.0 112.643 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -70.6 -25.89 63.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.912 1.285 . . . . 20.0 112.669 173.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.79 2.74 10.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.858 1.663 . . . . 20.0 113.461 -174.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.02 151.34 40.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.892 0.877 . . . . 20.0 109.821 172.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.6 mt -95.15 166.86 11.71 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.423 0.63 . . . . 20.0 110.214 171.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -74.15 -3.07 27.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.01 0.924 . . . . 20.0 112.32 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -143.78 169.11 18.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.687 1.995 . . . . 20.0 110.808 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.76 79.64 0.37 Allowed Glycine 0 C--N 1.338 0.678 0 C-N-CA 125.082 1.325 . . . . 20.0 110.497 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.52 -3.05 65.37 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.079 0.847 . . . . 20.0 114.247 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 75.1 m -85.08 -166.48 1.51 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.9 2.08 . . . . 20.0 110.314 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 t -91.62 -18.15 24.47 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.938 0.895 . . . . 20.0 112.479 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 48.7 p -134.22 -61.7 0.77 Allowed 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.417 1.087 . . . . 20.0 110.622 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -150.09 157.92 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.301 1.84 . . . . 20.0 109.648 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 35.1 t -125.73 151.95 45.98 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.309 1.444 . . . . 20.0 110.176 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -137.78 125.96 23.03 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 123.653 0.781 . . . . 20.0 110.812 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 147.24 46.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.712 1.205 . . . . 20.0 110.052 169.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 41.8 mt -126.38 -3.92 6.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.263 1.425 . . . . 20.0 111.902 -176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.2 t -69.57 -18.72 63.66 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.528 1.131 . . . . 20.0 113.089 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -21.88 66.6 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.343 1.057 . . . . 20.0 112.994 173.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.6 mt -73.41 -17.66 61.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.765 1.226 . . . . 20.0 113.242 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.5 t -117.85 4.01 12.21 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.706 1.602 . . . . 20.0 111.804 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 117.853 -1.526 . . . . 20.0 110.859 177.27 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.477 -0.194 . . . . 20.0 110.477 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.15 -33.22 74.08 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.677 1.191 . . . . 20.0 112.399 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 28.5 m -58.25 -52.1 67.0 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 125.018 1.327 . . . . 20.0 109.997 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.8 -40.14 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 125.287 1.435 . . . . 20.0 111.171 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -62.32 -41.32 98.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.443 1.097 . . . . 20.0 111.756 -176.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -83.07 -7.31 59.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.331 1.052 . . . . 20.0 113.336 174.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.15 -0.72 79.02 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.597 1.094 . . . . 20.0 114.955 174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -65.37 164.74 13.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.043 1.422 . . . . 20.0 111.831 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.97 178.72 53.38 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 121.994 0.774 . . . . 20.0 112.103 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.6 t -150.34 76.81 1.28 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.118 -1.438 . . . . 20.0 107.118 175.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 157.44 86.99 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.841 1.257 . . . . 20.0 110.919 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.66 174.39 8.58 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.951 3.101 . . . . 20.0 111.352 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.11 -16.67 34.1 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.571 1.148 . . . . 20.0 113.124 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 m -89.11 -11.02 45.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.711 1.604 . . . . 20.0 113.862 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -131.11 -0.88 4.1 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.896 1.678 . . . . 20.0 113.199 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -120.33 77.51 26.07 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.921 1.288 . . . . 20.0 109.406 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.15 170.57 19.53 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.533 2.822 . . . . 20.0 110.963 175.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -60.56 -26.02 66.61 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.397 1.079 . . . . 20.0 112.753 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.63 -46.26 72.99 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.758 1.623 . . . . 20.0 111.859 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.78 -4.54 56.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.749 1.219 . . . . 20.0 113.929 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 -60.4 145.3 48.54 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.321 1.049 . . . . 20.0 111.618 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.0 mt -85.81 173.75 9.81 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.835 1.254 . . . . 20.0 111.51 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 t -65.02 -14.13 59.65 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.634 1.574 . . . . 20.0 112.737 173.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.18 168.12 20.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.419 2.287 . . . . 20.0 110.269 -174.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.67 85.18 0.17 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 124.465 1.031 . . . . 20.0 111.305 -170.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.67 -13.37 80.09 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.557 1.075 . . . . 20.0 115.01 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.4 m -80.82 -179.71 7.41 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.548 1.139 . . . . 20.0 111.294 171.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -93.78 -9.83 36.22 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.9 1.28 . . . . 20.0 111.987 -172.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.5 p -133.13 -65.61 0.69 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.982 1.313 . . . . 20.0 109.736 -176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.84 156.14 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.363 1.465 . . . . 20.0 110.507 -173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.3 t -144.37 115.95 8.14 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.186 1.394 . . . . 20.0 109.35 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.84 136.73 51.83 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.215 1.006 . . . . 20.0 111.93 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.73 124.83 28.26 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.36 1.464 . . . . 20.0 109.464 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 pp -118.82 -8.05 10.38 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.685 1.594 . . . . 20.0 112.942 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.0 t -70.56 -15.51 62.78 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.598 1.559 . . . . 20.0 112.489 174.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -60.55 -21.05 62.13 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.377 1.071 . . . . 20.0 112.908 167.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.8 mt -101.31 -56.18 2.36 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.93 1.692 . . . . 20.0 109.396 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.9 p -87.14 68.99 10.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.622 1.569 . . . . 20.0 110.123 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.389 -1.784 . . . . 20.0 110.955 177.674 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.483 0.182 . . . . 20.0 111.058 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -125.23 -51.09 1.65 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.358 1.463 . . . . 20.0 111.21 -172.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.0 t -66.71 -26.82 67.19 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.407 0.549 . . . . 20.0 111.774 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.6 t -73.74 -25.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.655 1.182 . . . . 20.0 111.16 175.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -67.9 -32.78 73.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.46 0.704 . . . . 20.0 111.916 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -67.94 -20.73 65.1 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.286 1.034 . . . . 20.0 112.711 168.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.69 -2.34 21.61 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.087 1.803 . . . . 20.0 114.132 175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -77.8 175.99 9.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.583 1.192 . . . . 20.0 112.587 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.79 -23.45 30.48 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 119.295 -0.725 . . . . 20.0 114.206 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.9 t 49.92 49.56 20.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.086 1.754 . . . . 20.0 112.523 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.08 155.21 84.8 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.532 1.133 . . . . 20.0 111.291 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.13 169.98 21.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.505 2.803 . . . . 20.0 112.306 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -69.34 8.7 0.56 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.465 1.906 . . . . 20.0 114.036 174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.3 p -120.03 -6.31 9.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.337 1.855 . . . . 20.0 113.122 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -136.73 -17.76 1.44 Allowed 'General case' 0 C--N 1.346 0.437 0 N-CA-C 113.842 1.053 . . . . 20.0 113.842 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.2 t -85.68 114.75 58.42 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.067 0.947 . . . . 20.0 109.616 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.21 162.9 39.44 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.772 2.315 . . . . 20.0 111.741 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -70.96 -6.42 38.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.363 1.465 . . . . 20.0 114.313 -173.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.42 -32.11 10.98 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.775 1.23 . . . . 20.0 111.848 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.16 -21.28 39.85 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 113.818 1.044 . . . . 20.0 113.818 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -63.4 157.47 23.09 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.011 0.924 . . . . 20.0 111.804 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.0 mt -103.67 162.98 12.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.154 1.381 . . . . 20.0 110.408 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -83.22 -3.89 57.86 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.377 1.071 . . . . 20.0 111.677 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -148.93 176.19 10.63 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.733 2.013 . . . . 20.0 111.069 -175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 150.29 -166.29 30.04 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.133 0.873 . . . . 20.0 112.317 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -135.82 7.69 4.19 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.499 1.523 . . . . 20.0 114.047 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.4 m -68.9 173.53 5.27 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.801 1.24 . . . . 20.0 111.918 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.2 t -96.76 -5.43 38.59 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.119 1.367 . . . . 20.0 112.544 -177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.2 t -147.27 -49.12 0.18 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.278 1.031 . . . . 20.0 111.76 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -162.94 145.01 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.975 1.71 . . . . 20.0 108.164 -177.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 13.1 t -114.27 151.76 32.37 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.285 1.034 . . . . 20.0 110.567 166.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.82 129.04 22.26 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.127 1.371 . . . . 20.0 109.574 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.16 137.44 33.34 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.156 0.982 . . . . 20.0 110.445 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.9 mt -111.16 0.68 16.91 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.502 1.521 . . . . 20.0 112.633 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -60.15 -32.08 70.7 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.075 0.95 . . . . 20.0 111.917 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -68.44 -31.3 70.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.227 1.411 . . . . 20.0 112.284 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.1 mt -70.42 -48.85 54.08 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.142 0.977 . . . . 20.0 111.054 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.7 t -75.07 -4.68 39.93 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.55 1.14 . . . . 20.0 113.06 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.135 0 CA-C-O 117.695 -1.614 . . . . 20.0 110.602 174.528 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.511 -0.551 . . . . 20.0 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -62.14 -30.96 71.4 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.985 0.914 . . . . 20.0 112.741 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -50.46 53.59 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.359 0.664 . . . . 20.0 110.555 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -69.46 -32.24 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.589 1.156 . . . . 20.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.4 t -64.03 -39.79 94.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.503 1.121 . . . . 20.0 111.56 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -72.47 -6.0 40.67 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.689 1.196 . . . . 20.0 113.262 170.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.53 4.22 64.15 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.338 1.447 . . . . 20.0 114.625 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -77.45 171.22 15.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.55 1.14 . . . . 20.0 112.069 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.97 177.8 31.68 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.262 1.41 . . . . 20.0 113.136 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -133.6 69.17 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.84 1.656 . . . . 20.0 107.451 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.2 mp -63.43 159.84 47.18 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.973 1.709 . . . . 20.0 110.914 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.54 166.0 30.95 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.846 2.364 . . . . 20.0 111.0 174.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -67.72 -19.71 65.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.87 1.268 . . . . 20.0 112.786 -175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -83.69 -16.97 42.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.992 1.317 . . . . 20.0 113.062 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -124.84 5.45 8.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.285 1.434 . . . . 20.0 113.157 -174.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -120.08 78.15 24.8 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.092 0.957 . . . . 20.0 110.43 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.82 172.68 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.536 2.824 . . . . 20.0 111.7 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -65.19 -13.36 58.05 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.516 1.127 . . . . 20.0 113.33 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.41 -32.56 20.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.042 1.337 . . . . 20.0 112.215 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 -18.33 22.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.28 1.032 . . . . 20.0 113.454 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -70.04 155.48 40.53 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 118.606 0.639 . . . . 20.0 110.6 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.11 177.45 6.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.051 0.94 . . . . 20.0 110.204 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -68.73 -21.93 64.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.333 0.653 . . . . 20.0 111.835 171.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.21 171.4 14.45 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.294 1.838 . . . . 20.0 111.66 -168.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.98 177.36 31.01 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.239 0.923 . . . . 20.0 112.812 175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.96 21.58 0.59 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.083 1.325 . . . . 20.0 113.367 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -63.13 176.87 0.68 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.374 1.469 . . . . 20.0 112.234 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -69.22 -29.63 67.61 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.724 1.209 . . . . 20.0 111.47 -176.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.8 t -143.5 -41.31 0.29 Allowed 'General case' 0 C--N 1.344 0.354 0 CA-C-O 117.944 -1.027 . . . . 20.0 113.435 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.1 m -153.88 151.79 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.538 1.135 . . . . 20.0 109.68 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.5 t -118.93 135.17 54.73 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 125.474 1.51 . . . . 20.0 109.226 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 m -131.94 148.16 52.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.984 1.314 . . . . 20.0 110.039 173.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -74.73 166.28 23.85 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.611 -0.722 . . . . 20.0 111.476 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.6 mt -124.43 11.49 8.66 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.407 1.483 . . . . 20.0 111.521 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.0 t -63.9 -19.7 65.29 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.815 1.646 . . . . 20.0 113.449 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -63.13 -24.93 68.12 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.628 1.171 . . . . 20.0 113.498 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.4 mt -77.48 -43.46 32.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.323 1.049 . . . . 20.0 110.882 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.0 p -82.66 70.53 9.65 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.015 1.726 . . . . 20.0 110.255 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.145 -1.919 . . . . 20.0 111.204 176.636 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.47 HD21 ' HA ' ' A' ' 27' ' ' CYS . 19.1 t-20 . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.636 -0.505 . . . . 20.0 109.636 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -66.64 -32.92 74.55 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.706 0.803 . . . . 20.0 112.756 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.9 t -70.59 -43.4 69.44 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.392 0.277 . . . . 20.0 110.4 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.4 -39.92 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.048 1.339 . . . . 20.0 111.161 173.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -68.1 -32.05 72.1 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.267 1.027 . . . . 20.0 112.35 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -75.28 -9.95 59.02 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.63 1.572 . . . . 20.0 112.479 171.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.11 -2.96 69.39 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.254 1.407 . . . . 20.0 114.572 176.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -77.14 170.19 16.98 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.762 1.281 . . . . 20.0 111.72 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -94.54 160.13 23.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 123.907 0.765 . . . . 20.0 113.067 -176.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.1 m -124.35 65.78 1.07 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.866 1.666 . . . . 20.0 109.189 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.5 mt -65.43 163.22 34.85 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.88 1.272 . . . . 20.0 111.512 174.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.62 170.93 18.27 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.036 2.491 . . . . 20.0 110.753 168.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -60.69 -27.05 67.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.429 1.092 . . . . 20.0 112.505 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.1 m -74.31 -10.6 59.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.861 1.264 . . . . 20.0 113.847 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.96 -5.27 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.044 1.338 . . . . 20.0 113.174 -177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.9 t -124.19 83.49 56.36 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.219 1.408 . . . . 20.0 109.809 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.89 173.48 14.43 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.966 3.11 . . . . 20.0 111.933 176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -14.81 56.14 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 20.0 113.048 173.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.78 -29.26 50.77 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.138 . . . . 20.0 112.909 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.68 -8.68 14.92 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.457 1.103 . . . . 20.0 113.477 -170.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -70.22 159.63 33.65 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 123.522 0.729 . . . . 20.0 112.108 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.11 176.91 5.39 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.878 1.271 . . . . 20.0 110.946 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -70.58 -4.96 25.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.841 1.256 . . . . 20.0 113.187 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -139.98 176.29 8.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.152 1.781 . . . . 20.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.4 72.91 0.36 Allowed Glycine 0 C--N 1.34 0.751 0 C-N-CA 124.688 1.137 . . . . 20.0 111.96 -174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.42 -18.88 79.94 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 118.83 -0.983 . . . . 20.0 114.103 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.47 ' HA ' HD21 ' A' ' 1' ' ' ASN . 83.5 m -70.16 179.68 2.28 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.938 1.295 . . . . 20.0 112.52 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.2 m -86.09 -8.77 57.65 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.955 1.302 . . . . 20.0 112.264 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.0 t -148.53 -52.62 0.18 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 117.863 -1.065 . . . . 20.0 111.845 170.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.6 m -148.13 145.31 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.328 0.967 . . . . 20.0 112.012 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.6 t -122.85 112.28 17.69 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.959 2.103 . . . . 20.0 109.309 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -121.02 142.71 49.55 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 125.101 1.361 . . . . 20.0 111.726 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.73 137.99 31.92 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.182 1.393 . . . . 20.0 109.947 172.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 32.9 mt -124.84 14.43 8.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.19 2.196 . . . . 20.0 111.891 -169.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.7 t -59.94 -17.63 39.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.791 2.036 . . . . 20.0 114.961 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -63.84 -22.12 66.77 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.473 1.033 . . . . 20.0 112.706 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.6 mt -117.14 -72.39 0.69 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.811 2.045 . . . . 20.0 109.096 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.1 p -86.08 68.3 10.25 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.979 1.712 . . . . 20.0 109.687 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.212 -1.882 . . . . 20.0 110.395 176.717 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 110.132 -0.321 . . . . 20.0 110.132 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -59.54 -46.75 87.97 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 121.889 -0.507 . . . . 20.0 112.288 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.6 t -56.28 -48.07 77.36 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.605 1.162 . . . . 20.0 111.212 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.06 -39.32 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.622 1.169 . . . . 20.0 111.485 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.6 t -67.73 -32.72 73.53 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.725 1.21 . . . . 20.0 112.603 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -70.33 -13.02 61.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.153 1.381 . . . . 20.0 112.483 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.46 0.4 61.09 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.362 1.458 . . . . 20.0 114.163 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -79.04 171.64 14.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.671 1.235 . . . . 20.0 111.672 176.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.54 176.62 41.64 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.169 1.366 . . . . 20.0 112.259 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -141.16 56.45 1.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.906 -1.146 . . . . 20.0 107.906 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 29.6 mt -57.24 157.5 12.12 Favored Pre-proline 0 C--N 1.345 0.375 0 C-N-CA 125.601 1.56 . . . . 20.0 111.666 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.36 167.51 20.31 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.822 2.348 . . . . 20.0 110.513 173.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -62.32 -22.12 65.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.558 0.743 . . . . 20.0 112.451 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.7 p -84.41 -12.55 54.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.216 1.806 . . . . 20.0 114.441 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.51 -4.41 11.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.189 1.395 . . . . 20.0 112.977 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.7 t -116.45 80.76 10.38 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 125.16 1.384 . . . . 20.0 108.824 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.07 170.73 18.26 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.654 2.903 . . . . 20.0 111.665 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -58.51 -28.78 65.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.708 1.603 . . . . 20.0 112.719 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.22 -40.43 64.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.832 1.253 . . . . 20.0 112.169 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.2 -5.66 57.99 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.934 1.087 . . . . 20.0 113.934 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -61.96 140.09 58.35 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.883 0.873 . . . . 20.0 110.957 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 mt -75.86 173.04 11.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.115 0.96 . . . . 20.0 110.743 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 t -66.94 -12.62 60.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.373 1.069 . . . . 20.0 112.691 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.05 165.65 26.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.075 2.15 . . . . 20.0 110.869 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.65 86.79 0.35 Allowed Glycine 0 C--N 1.342 0.894 0 C-N-CA 125.798 1.666 . . . . 20.0 110.404 -172.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.5 1.37 60.18 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-O 118.448 -1.196 . . . . 20.0 115.575 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.1 m -97.42 174.35 6.72 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.643 1.177 . . . . 20.0 110.791 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -88.05 -5.13 58.65 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.403 1.081 . . . . 20.0 112.178 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 t -137.53 -61.26 0.64 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.676 1.591 . . . . 20.0 110.362 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.5 m -150.82 135.79 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.318 1.047 . . . . 20.0 110.952 -171.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.9 t -120.51 115.31 23.2 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.5 1.92 . . . . 20.0 109.146 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 m -126.12 146.7 49.83 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.776 1.63 . . . . 20.0 109.916 174.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.93 164.96 24.66 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 122.957 0.503 . . . . 20.0 111.82 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.45 6.04 10.63 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.364 1.466 . . . . 20.0 111.861 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.8 t -71.03 -9.79 58.64 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.551 0.945 . . . . 20.0 113.551 -177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -69.01 -27.64 65.86 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 119.166 0.894 . . . . 20.0 112.134 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.67 -45.16 83.93 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.687 0.795 . . . . 20.0 110.759 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.3 p -78.19 -12.73 60.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.928 1.291 . . . . 20.0 112.856 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.299 0 CA-C-O 117.8 -1.555 . . . . 20.0 112.334 174.705 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.573 0.225 . . . . 20.0 111.134 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -73.02 -46.02 54.4 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.122 0.969 . . . . 20.0 112.539 -175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.9 t -72.02 -25.5 61.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.389 0.676 . . . . 20.0 112.686 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.83 -36.42 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 123.729 0.812 . . . . 20.0 109.62 173.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 63.0 m -69.32 -13.46 62.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.631 1.173 . . . . 20.0 113.249 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -69.6 -10.04 56.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.347 1.059 . . . . 20.0 112.085 169.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.15 -3.06 56.74 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.558 1.551 . . . . 20.0 113.791 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -90.07 -96.59 0.11 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.296 1.048 . . . . 20.0 109.583 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.37 -155.06 25.4 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.303 1.43 . . . . 20.0 111.188 -170.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -149.89 145.11 26.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.749 1.22 . . . . 20.0 109.378 176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.439 HD22 ' HB2' ' A' ' 32' ' ' CYS . 2.2 mp -123.55 160.58 50.19 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.651 1.581 . . . . 20.0 110.152 -177.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.82 171.79 16.75 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.163 3.242 . . . . 20.0 112.705 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -67.96 -2.13 6.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.855 2.462 . . . . 20.0 114.298 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.9 m -130.06 5.63 4.94 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.564 1.546 . . . . 20.0 112.933 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -136.04 9.59 3.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.552 1.141 . . . . 20.0 112.896 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.9 t -115.59 80.72 8.38 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.481 1.112 . . . . 20.0 109.361 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.8 161.53 43.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.238 2.625 . . . . 20.0 110.705 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -58.77 -28.5 65.99 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.086 1.354 . . . . 20.0 113.106 -176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.8 -44.88 84.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.925 1.29 . . . . 20.0 111.789 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.28 -8.07 59.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.7 1.2 . . . . 20.0 113.848 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -62.74 141.9 58.38 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.338 0.972 . . . . 20.0 110.579 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 18.3 mt -73.67 170.23 15.67 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.305 0.574 . . . . 20.0 110.874 173.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 t -66.89 -11.24 55.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.397 1.079 . . . . 20.0 112.381 175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -144.68 165.65 27.45 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.575 2.35 . . . . 20.0 110.291 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.24 -169.67 15.05 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.481 1.515 . . . . 20.0 112.153 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 154.68 -7.22 0.33 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.891 1.234 . . . . 20.0 113.523 176.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 m -73.15 -179.1 3.15 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.457 1.503 . . . . 20.0 113.043 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.8 t -65.58 -30.14 70.83 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.49 1.516 . . . . 20.0 111.393 176.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -155.55 -38.28 0.09 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.152 0.981 . . . . 20.0 113.009 169.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.0 m -140.5 139.85 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 119.328 0.967 . . . . 20.0 111.056 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 14.6 t -129.68 131.21 46.31 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 125.165 1.386 . . . . 20.0 110.762 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HB2' HD22 ' A' ' 11' ' ' LEU . 13.0 m -133.09 148.0 52.17 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.049 1.739 . . . . 20.0 109.601 176.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -70.39 148.77 48.01 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.051 0.94 . . . . 20.0 111.429 -175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -102.19 -6.21 23.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.834 0.854 . . . . 20.0 112.279 172.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.1 t -64.55 -29.88 70.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.269 1.028 . . . . 20.0 111.941 -178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -62.4 -32.55 73.4 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.159 1.384 . . . . 20.0 112.958 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.02 -44.41 65.91 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 124.486 1.114 . . . . 20.0 111.013 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 p -77.72 -20.36 53.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.016 1.327 . . . . 20.0 113.015 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 CA-C-O 116.98 -2.011 . . . . 20.0 113.542 173.196 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.712 -0.477 . . . . 20.0 109.712 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' H ' ' HA3' ' A' ' 26' ' ' GLY . 5.0 tp10 -64.12 -26.53 68.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.25 1.02 . . . . 20.0 112.833 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -60.03 -62.46 1.85 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.38 1.072 . . . . 20.0 108.936 172.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.21 -27.38 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.02 1.728 . . . . 20.0 112.15 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -60.0 -44.61 94.44 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.718 1.207 . . . . 20.0 111.695 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -85.88 -5.11 59.29 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.74 1.216 . . . . 20.0 113.423 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 100.96 -7.44 57.24 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.7 1.619 . . . . 20.0 114.918 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.11 171.03 6.04 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.339 1.456 . . . . 20.0 111.932 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.09 -167.09 13.18 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.658 1.123 . . . . 20.0 113.293 173.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.9 m -139.02 83.56 1.96 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.57 1.948 . . . . 20.0 107.874 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.42 HD13 HD22 ' A' ' 34' ' ' LEU . 5.3 mp -66.97 159.84 73.7 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.844 1.258 . . . . 20.0 110.233 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -69.47 162.75 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 20.0 110.977 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -69.72 3.92 2.24 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.742 1.617 . . . . 20.0 113.464 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.5 t -113.3 -0.68 14.48 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.997 2.119 . . . . 20.0 112.616 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.21 0.11 2.54 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.187 1.181 . . . . 20.0 114.187 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.5 t -111.39 110.22 55.87 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.171 0.989 . . . . 20.0 110.758 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.57 158.9 55.56 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.877 2.384 . . . . 20.0 111.119 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -62.21 -23.95 66.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.746 1.218 . . . . 20.0 113.534 -171.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -83.37 -30.97 26.99 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.324 1.45 . . . . 20.0 112.246 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.42 -11.97 58.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.723 1.209 . . . . 20.0 112.968 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.0 mtt180 -71.37 108.36 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.307 1.443 . . . . 20.0 109.219 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.91 159.63 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.957 0.903 . . . . 20.0 110.89 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.5 t -77.47 1.09 20.29 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.903 1.281 . . . . 20.0 113.165 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -148.2 170.0 18.81 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.752 1.621 . . . . 20.0 111.148 -172.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.82 171.56 21.71 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.29 0.947 . . . . 20.0 113.055 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.404 ' HA3' ' H ' ' A' ' 2' ' ' GLU . . . -96.26 -16.18 38.68 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.681 1.134 . . . . 20.0 113.332 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 79.0 m -72.71 175.21 6.64 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.372 1.086 . . . . 20.0 110.587 168.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.2 t -126.82 8.63 6.87 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.003 1.321 . . . . 20.0 111.92 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -126.58 -64.28 1.03 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.298 1.439 . . . . 20.0 109.404 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.8 m -147.69 156.91 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.932 1.693 . . . . 20.0 110.151 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.5 t -142.12 82.72 1.81 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.257 2.223 . . . . 20.0 107.082 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 152.64 40.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.819 -0.628 . . . . 20.0 111.613 -173.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -102.18 104.61 15.2 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.734 1.214 . . . . 20.0 110.129 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.504 HD23 ' H ' ' A' ' 34' ' ' LEU . 1.1 pt? -114.89 3.77 14.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.585 2.754 . . . . 20.0 112.153 169.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.7 t -63.6 -24.44 67.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.247 1.019 . . . . 20.0 111.072 165.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -71.37 -21.26 62.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.062 1.345 . . . . 20.0 113.082 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.0 mt -91.2 -41.51 10.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.849 1.26 . . . . 20.0 112.113 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.2 t -143.59 -22.23 0.59 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.251 1.021 . . . . 20.0 113.638 -173.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 116.516 -2.269 . . . . 20.0 112.676 -177.774 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.607 -0.146 . . . . 20.0 110.607 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -65.87 -53.16 43.37 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.515 0.726 . . . . 20.0 111.6 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 m -63.87 -38.2 90.22 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 118.888 -0.577 . . . . 20.0 112.236 -175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.0 t -67.04 -39.71 83.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.68 0.792 . . . . 20.0 110.741 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.3 t -62.72 -35.5 79.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.38 1.072 . . . . 20.0 111.662 174.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -81.1 -4.97 57.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.856 1.662 . . . . 20.0 113.302 176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.54 85.53 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.784 1.183 . . . . 20.0 114.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -75.54 174.84 9.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.391 1.476 . . . . 20.0 111.487 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -123.63 173.09 16.44 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.973 0.797 . . . . 20.0 114.139 -174.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 75.8 m -126.28 72.15 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.979 1.711 . . . . 20.0 109.239 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.2 mt -68.33 162.02 64.61 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.873 1.269 . . . . 20.0 111.514 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.23 169.8 18.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.488 2.792 . . . . 20.0 110.665 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.95 -21.17 65.9 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.888 0.699 . . . . 20.0 112.888 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 t -65.26 -54.51 28.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.49 1.516 . . . . 20.0 111.21 172.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.51 -7.63 57.36 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.755 1.02 . . . . 20.0 113.755 -173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.4 t -115.86 81.07 9.31 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.82 1.248 . . . . 20.0 110.322 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.69 172.96 15.2 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.926 3.084 . . . . 20.0 112.477 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.03 -7.41 22.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.567 1.547 . . . . 20.0 113.52 174.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.24 -28.1 17.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.308 1.443 . . . . 20.0 112.209 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.08 -11.11 19.11 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.782 1.233 . . . . 20.0 113.851 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -59.99 139.56 57.34 Favored 'General case' 0 C--N 1.345 0.386 0 C-N-CA 124.182 0.993 . . . . 20.0 111.291 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.35 165.65 17.08 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.339 0.59 . . . . 20.0 110.423 172.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.3 t -76.49 -7.61 55.47 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.834 0.854 . . . . 20.0 112.321 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.23 173.24 11.7 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.402 2.281 . . . . 20.0 110.488 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.67 171.1 32.41 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 121.559 0.533 . . . . 20.0 113.713 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.85 20.53 2.52 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.525 1.536 . . . . 20.0 112.847 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.9 m -68.17 179.21 1.61 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.706 1.202 . . . . 20.0 110.698 169.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.3 t -84.5 -21.74 30.48 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.034 0.534 . . . . 20.0 111.814 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -136.5 -60.35 0.71 Allowed 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.72 1.208 . . . . 20.0 111.048 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.1 153.99 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.39 1.476 . . . . 20.0 110.476 -172.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.8 t -133.12 132.08 41.26 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.213 1.405 . . . . 20.0 110.371 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.4 m -130.96 144.14 51.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.114 1.366 . . . . 20.0 110.37 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -74.19 103.96 4.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.16 0.984 . . . . 20.0 109.405 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.4 pp -113.05 0.44 15.0 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.092 1.757 . . . . 20.0 112.543 170.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -61.65 -23.23 65.93 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.288 1.835 . . . . 20.0 113.376 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -62.42 -48.2 80.74 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.322 1.049 . . . . 20.0 111.511 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 64.6 mt -78.15 -55.32 5.37 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.275 1.43 . . . . 20.0 110.437 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . 0.258 12.5 t 41.47 44.11 2.39 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.218 2.607 . . . . 20.0 113.951 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 C-N-CA 124.97 1.271 . . . . 20.0 113.392 -175.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 109.857 -0.423 . . . . 20.0 109.857 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -68.0 -35.87 79.04 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.741 0.817 . . . . 20.0 111.997 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 m -64.62 -36.11 83.19 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.653 0.781 . . . . 20.0 112.364 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.35 -38.26 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.864 0.866 . . . . 20.0 110.479 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -62.98 -35.51 80.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.038 0.935 . . . . 20.0 111.918 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -81.72 -4.68 56.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.502 1.521 . . . . 20.0 113.041 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.1 2.71 90.6 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.966 1.269 . . . . 20.0 114.948 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -71.53 174.11 7.1 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.802 1.301 . . . . 20.0 112.38 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.54 -177.96 51.86 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.097 1.332 . . . . 20.0 112.744 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.7 t -152.94 59.02 0.79 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.567 1.147 . . . . 20.0 110.006 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.3 mt -69.57 153.38 95.76 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.039 0.536 . . . . 20.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.03 172.71 14.15 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.6 3.533 . . . . 20.0 111.475 175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -62.28 -13.9 33.28 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.716 1.376 . . . . 20.0 114.716 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.7 m -95.28 -9.54 32.82 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.294 1.438 . . . . 20.0 113.476 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.83 -2.69 9.76 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.032 1.733 . . . . 20.0 112.354 175.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.9 t -120.98 85.71 40.95 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.539 1.535 . . . . 20.0 109.721 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.18 175.87 10.68 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.184 3.256 . . . . 20.0 112.326 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -64.69 -12.99 52.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.33 1.452 . . . . 20.0 113.42 173.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.89 -39.02 17.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.389 1.075 . . . . 20.0 112.04 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.72 -10.45 26.82 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.739 1.014 . . . . 20.0 113.739 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -63.37 149.78 45.02 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.92 0.782 . . . . 20.0 111.251 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.8 mt -85.99 171.83 11.12 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.225 0.536 . . . . 20.0 110.528 175.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -67.71 -4.73 13.1 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.202 1.401 . . . . 20.0 112.907 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -148.97 162.21 40.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.316 1.846 . . . . 20.0 110.763 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -112.8 75.35 0.23 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 125.101 1.334 . . . . 20.0 111.022 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.58 7.7 61.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.986 1.279 . . . . 20.0 114.786 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 55.7 m -102.93 -172.72 2.17 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.23 1.812 . . . . 20.0 110.384 170.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.7 m -72.45 -27.16 62.13 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 124.586 1.154 . . . . 20.0 112.082 -178.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.1 t -155.82 -32.81 0.09 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.44 0.904 . . . . 20.0 113.44 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.8 p -138.6 130.09 36.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 124.905 1.282 . . . . 20.0 110.732 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.1 t -132.78 141.46 48.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.724 1.61 . . . . 20.0 110.716 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.3 m -135.47 157.56 46.58 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.101 1.76 . . . . 20.0 110.495 173.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.24 160.34 24.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.175 0.59 . . . . 20.0 111.614 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pp -123.85 6.48 8.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.912 1.685 . . . . 20.0 113.341 171.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.5 t -60.39 -26.09 66.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.079 1.352 . . . . 20.0 112.562 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -73.32 -35.88 66.13 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.53 1.132 . . . . 20.0 112.287 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.72 -42.98 73.28 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.256 1.022 . . . . 20.0 111.251 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 32.7 p -75.33 -9.53 58.64 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.315 1.446 . . . . 20.0 112.914 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.591 -1.672 . . . . 20.0 111.331 178.265 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.8 p30 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 121.075 0.464 . . . . 20.0 111.724 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -66.5 -48.27 70.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.326 1.05 . . . . 20.0 111.347 -178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.0 t -61.24 -41.77 97.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.392 1.077 . . . . 20.0 111.742 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.23 -37.87 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.449 1.1 . . . . 20.0 110.811 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.2 t -65.4 -34.69 78.89 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.2 1.0 . . . . 20.0 112.214 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -68.16 -17.67 64.4 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.778 1.231 . . . . 20.0 112.66 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.19 -4.53 38.27 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.721 1.629 . . . . 20.0 114.245 175.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -68.79 168.5 13.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 118.908 1.354 . . . . 20.0 112.022 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.84 -160.94 27.27 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.406 1.479 . . . . 20.0 113.171 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 t -154.1 72.6 0.89 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.019 0.928 . . . . 20.0 108.793 175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.56 162.36 43.51 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 125.3 1.44 . . . . 20.0 111.154 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.85 157.76 47.24 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.815 2.343 . . . . 20.0 110.766 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -63.37 -20.09 65.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.636 1.174 . . . . 20.0 113.112 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.9 m -87.79 -0.49 57.01 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.556 1.542 . . . . 20.0 113.715 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -129.53 -36.24 1.67 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.612 1.096 . . . . 20.0 113.362 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.79 113.2 38.33 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 124.107 0.963 . . . . 20.0 109.182 175.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.78 168.33 23.75 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.99 2.46 . . . . 20.0 111.994 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.49 -4.79 32.56 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.937 1.295 . . . . 20.0 113.544 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -91.69 -34.55 14.61 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.634 1.174 . . . . 20.0 112.217 171.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.19 -18.11 35.07 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.636 1.174 . . . . 20.0 113.605 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -62.01 149.6 40.44 Favored 'General case' 0 C--N 1.343 0.288 0 C-N-CA 123.357 0.663 . . . . 20.0 112.205 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.62 172.09 8.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.202 1.401 . . . . 20.0 110.451 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -73.93 -7.22 51.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.689 1.196 . . . . 20.0 113.338 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -85.65 -179.63 6.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.712 1.605 . . . . 20.0 113.063 -171.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -136.62 32.85 2.41 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.114 1.816 . . . . 20.0 112.852 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.22 1.9 54.19 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.221 1.391 . . . . 20.0 115.708 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 92.1 m -128.16 172.36 11.07 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.202 1.401 . . . . 20.0 110.197 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.1 p -92.25 -12.83 31.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.939 0.896 . . . . 20.0 112.353 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.6 p -130.18 -65.03 0.83 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.092 1.357 . . . . 20.0 109.574 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 23.4 m -151.36 159.32 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.451 1.1 . . . . 20.0 111.228 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.7 t -133.49 149.19 51.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.732 2.013 . . . . 20.0 108.507 172.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.11 149.37 52.42 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.313 1.045 . . . . 20.0 111.069 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -89.57 77.44 7.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.737 1.215 . . . . 20.0 113.398 -168.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.48 -3.37 17.52 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.703 1.371 . . . . 20.0 114.703 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.3 t -64.32 -15.97 61.31 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.944 1.298 . . . . 20.0 113.222 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -64.13 -24.98 67.89 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.948 1.299 . . . . 20.0 112.511 173.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.45 -17.11 63.6 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.919 1.288 . . . . 20.0 113.395 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 t -119.66 5.13 11.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.667 1.587 . . . . 20.0 111.891 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 117.228 -1.873 . . . . 20.0 110.305 179.126 . . . . . . . . 0 0 . 1 stop_ save_